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Chapter I 
Synopsis of this 
investigation 
18 
completely ineffective. Reasons for these two major findings are discussed in 
chapter VII. The literature survey and the data from this study indicate further 
that the glucose tolerance and the exercise-EGG are of little significance for 
mass screening. In fact great caution appears necessary in advising patients 
about the possibility of the existence. of coronary artery disease (CAD) when 
during a single exercise test ST-segroent abnormalities are found in asympto· 
matic individuals. Most of the data collected during the visits to the general 
practitioners also show that the physicians in general were not well informed 
about the need for prevention and were not well equipped to deal with data 
obtained from this screening program. 
In the final chapter (VIII) the conclusions of the study are given. They can be 
summarized by the statement that only three risk indicators are at present 
amenable for the prevention of CAD. These are hypertension, (cigarette) 
smoking and hypercholesterolemia. Since it is also evident that, until the 
present, there is no mass screening test available to detect presymptomatic 
CAD, a major effort should be mounted to reduce the prevalence of the three 
major risk indicators. In view of the highly disappointing performance of the 
existing medical system various ways and means to improve the situation are 
suggested. 
Chapter II 
Literature survey 

2.1 
2.2 
Introduction 
The basis of medical action is often formed by experience achieved from the 
examination of groups. This data supply information for epidemiology, which 
in tum can be made subservient to the individual patient. Research in the field 
of the occurrence of cardiovascular diseases demonstrated large differences in 
frequency between various I sub )populations. In order to explain this 
phenomenon and to achieve possible prevention, characteristics have been 
looked for in which the populations with a high frequency of cardiovascular 
diseases discern themselves from populations with a low frequency. 
In the course of the years many of these characteristics have been described. 
"Coronary risk factors are those habits, traits and abnormalities associated 
with sizeable (100% or more) increase in susceptibility to premature coronary 
heart disease" (Froelicher, 1972). It is not necessary that the risk indicators 
have direct causal connection with cardiovascular diseases. The significance of 
a risk indicator not only depends on the nature, but also on the extent to which 
it deviates from the standard. As major risk indicators are considered: high 
blood pressure, smoking and an increased cholesterol level of the blood 
(Stamler, 1970; Froelicher, 1972; Blackburn, 1974; May, 1974). Other items 
mentioned are a disturbed sugar metabolism, overweight, physical inactivity, 
personality structure, behaviour and stress, heredity, age, sex and race 
(Froelicher, 1972). A number of these risk indicators, such as blood pressure, 
cholesterol level and smoking are of direct preventive medical interest, because 
they can be influenced. After identification of these risk indicators it has been 
tried to push back the occurrence of cardiovascular diseases by means of 
influencing the risk indicators. 
This literatllre survey does not pretend to supply an exhaustive rundown of the 
study results, opinions (and petty opinions) related to the above mentioned set 
of problems, but must be considered as a supplement to the research by Baart 
( 1973 ). Results of this analysis are described for each risk indicator . 
. Screening 
The large scale identification of people with increased chances of sustaining 
cardiovascular diseases is often realised by means of screening (Stamler, 1968; 
Rosenman, 1970; Schoenberger, 1972; Wilber, 1972; Baart, 1973; Hinkle, 
1973; Charman, 1974; May, 1974). After a literature study, Whitby (1974) 
describes definitions and criteria which must be met by screening programs. 
"Screening is defined as the presumptive identification of unrecognized disease 
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or defect by the application of tests, examinations or other procedures which 
can be applied rapidly". Screening can be effected with large population groups 
(mass screening) or with certain subgroups (selective screening), it can be 
focussed on one single defect or on many defects (multiphasic screening). 
Examination methods have to be applied for screening programs with which 
it is possible to sort out apparently well persons who have a disease from those 
who probably do not. In principle these tests - effected without clinical 
indication - do not have to have diagnostic value per se. 
When the results of the tests are being interpreted the concepts validity, 
sensitivity and specificity must play an essential part. The validity of a 
screening test is defined as the frequency with which the results of the test were 
later confirmed by an acceptable diagnostic procedure and the sensitivity as the 
ability of a test to give a positive finding when the person tested truly has the 
disease under study. The specificity is the ability of a test to give a negative 
finding when the person tested is free of the disease under study. Combinations 
between sensitivity and specificity of screening tests have to be seen as 
compromise solutions in practice. 
The result of a screening test is either normal or abnormal. The normal group 
consists of: 1. "true negatives" (test negative and no disease) and 2. "false 
negatives" (test negative, disease). 
The abnormal group consists of: 1. "true positives" (test positive, disease) and 
2. "false positives" (test positive, no disease). 
"The sensitivity of a screening test can be set at such a level that it always 
gives a positive result when disease is present ( 100% sensitivity, no false 
negatives) but this will inevitably be at the expense of loss of specificity due to 
the selection of false positives. Alternatively, the specificity can be raised but 
usually at the expense or loss of sensitivity and the appearance of false 
negatives. 
Whitby's article (1974) again summarizes the "principles of early disease 
detection as formulated by Wilson and Jungner". (W.H.O. 1968 ). 
1. 
2. 
3. 
4. 
5. 
6. 
7. 
8. 
9. 
10. 
"the condition being sought should be an important health problem, for 
the individual and the community"; 
"there should be an acceptable form of treatment for patients with 
recognisable disease''; 
"the natural history of the condition, including its development from 
latent to declared disease, should be adequately understood"; 
"there should be a recognisable latent or early symptomatic stage"; 
"there should be a suitable screening test or examination for detecting 
the disease at the latent or early symptomatic stage, and this test should 
be acceptable to the population"; 
"the facilities required for diagnosis and treatment of patients revealed 
by the screening programme should be available"; 
"there should be an agreed policy on whom to treat as patients"; 
"treatment at the presymptomatic, borderline stage of a disease should 
favourably influence its course and prognosis"; 
"the cost of case-finding (which would include the cost of diagnosis and 
treatment) needs to be economically balanced in relation to possible 
expenditure on medical care as a whole"; 
"case-finding should be a continuing process, not a "once and for all" 
project". 
2.3 The arterial blood pressure 
The sphygmomanometer, introduced some 70 years ago by Riva-Rocci, is often 
used for measuring the arterial blood pressure. This method of blood pressure 
determination involves many drawbacks. One of them is the inaccuracy of the 
instrument, which issues from technical error sources - both diastolic and 
systolic pressure may have an error of plus or minus 8 mm Hg - the influence 
of arrhythm and tachypnea and the position and size of the arm (Page, 1972). 
Other variable error sources are the time that has elapsed between the latest 
meal and the measurement with which the person is to be examined, his 
consumption of tobacco, the state of micturation, pain, excitement, the 
pressure of the cuff and the climate. The level of the blood pressure is also 
influenced by the day and night rhythm (Page, 1972). 
The measuring point of the diastolic blood pressure is a major source of 
confusion. Both the muffling (phase IV) and the disappearance I phase Vi of the 
Korotkoff sounds are advised. Phase IV is 7 to 10 mm Hg above the direct 
diastolic blood pressure, measured intra-arterially, phase V generally 
corresponds with the intra-arterial pressure. The American Heart Association 
recommends phase IV as the best index for the diastolic blood pressure. An 
important part is also played by the accuracy with which the observer reads the 
blood pressure (Page, 1972). 
Many large-scale epidemiologic studies have demonstrated that high blood 
pressure strongly increases the chances of contracting cardiovascular diseases 
(Stamler, 1970; Blackburn, 1974). As the Atherosclerosis Study Group 
(Stamler, 1970) puts it: "this relationship between blood pressure and cardio-
vascular heart disease risk is continuous. At each higher step of the blood 
pressure scale risk is increased. Hypertension has also been established as a 
major risk indicator for cerebrovascular disease, including atherothrombotic 
cerebral infarction and cerebral hemorrhage.'' 
This knowledge, coupled to the fact that hypertension occurs with a great 
many adults and is often known by the sufferer, makes prevention of this 
disease, within the scope of the fight against cardiovascular diseases, of 
extreme importance. 
Schoenberger et al. (1972) find with an industrial population IN= 22, 929) 11.8 
per cent of people with high blood pressure (systolic blood pressure ). 160 mm 
Hg and/or diastolic blood pressure > 95 mm Hg) measured in recumbent 
position. 
Reid et al. 1197 4 I have diagnosed hypertension I systolic blood pressure > 200 
mm Hg or diastolic blood pressure > 115 mm Hg) in the age group 40-64 years 
IN= 18,403) in 3.2 per cent of the cases. 
Wilber et al.(1972) observed in 6,012 persons of 15 years and over 195 per cent 
negroes) in 28.5 per cent of the cases hypertension (hypertension: systolic blood 
pressure :;, 160 mm Hg and/or diastolic blood pressure :;, 95 mm Hg). 
Lew I 1973) provides imposing figures obtained from life insurance companies. 
The blood pressure for an optimal life expectancy is systolically less than 110 
mm Hg and diastolically less than 70 mm Hg. In the U.S.A. 20.2 percent of the 
23 
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Caucasian male population in the age group of 55-64 years have a systolic blood 
pressure over 160 mrn Hg or a diastolic blood pressure over 95 mm Hg. 
Borderline hypertension (blood pressure ranging between 140/90 mm Hg and 
160/95 rnm Hg) occurs in 28.4 per cent of the cases. A systolic blood pressure of 
178 mm Hg or over combined with a diastolic pressure of 108 mm Hg or over 
shows a mortality rate of about 60 per cent. A blood pressure of 140/90 mm Hg 
with men over forty is attended by an extra mortality of 45 per cent. 
In The Netherlands there are also a great number of people with hypertension. 
De Soto-Hartgrink (1968) found with civil servants (40-49 years) in 41 per cent 
of the cases a blood pressure ;;, 160 mm Hg systolically and/ or ? 95 mm Hg 
diastolically (phase IV). A research by May (1974) in the village of Vlagtwedde 
demonstrated that these values occur in 18 per cent of the determinations in 
this age group. 
The Veterans Administration Co-operative Study Group on Antihypertensive 
Agents (1967, 1970) has shown that effective treatment of patients with 
hypertension is possible. A group of 143 male hypertension patients \diastolic 
blood pressure 115-129 rnm Hg, age between 40 and 60 years) have been treated 
in a stringent program at random, with drugs or with a placebo. In the placebo 
group occurred 27 serious complications against 2 in the medically treated 
group. The examination, started in April 1964, was stopped in the blood 
pressure group of 115-129 mm Hg diastolic in December 1966. The study was 
terminated in the 115 mm Hg and higher group at an earlier date than expected 
when it became apparent that the risk rate increased sharply at these levels of 
diastolic blood pressure and that the clinical course of such patients appeared 
to be favourably influenced by antihypertensive drug treatment. Also in the 
group of people with a diastolic blood pressure between 90 and 114 mm Hg, 
included in this study, a beneficial effect of antihypertensive treatment has 
been observed. The estimated risk of developing a morbid event over a five year 
period was reduced from 55% to 18% by treatment. The degree of benefit was 
related to the level of prerandomization blood pressure. It is pointed out that 
the examination was performed with a strictly selected group. However, this 
does not alter the fact that promising information has been made available in 
order to achieve an effective fight against the "silent killer": hypertension. 
Indeed since this information has come available much more attention has been 
paid to the detection of patients with hypertension. 
Wood et al. (1971) published "Guidelines for the Detection, Diagnosis and 
Management of Hypertensive Patients", Wilber eta!. (1972 a) "High Blood 
Pressure Program Methods of Community Hypertension Screening", Wilber et 
al. (1972 b) "Hypertension - a Community Problem" and Charman (1974) 
"Hypertension Management Program in an Industrial Community". 
According to Wood et a!. ( 1971) there are two possible methods of approach to 
trace patients with hypertension, the incidental screening and the organized 
community screening. After screening care must be taken of the diagnostic 
evaluation and, where necessary, of effective therapy. 
Wilber (1972 a; 1972 b) says on the basis of his data: "It is suggested that 
community screening programs combined with simplified diagnostic evaluation 
and intense patient education and follow-up greatly increase the percentages 
under continuous treatment and control". It appears that the aftercare of the 
hypertension patients, once he has been traced, is miserable. "In this 
community, for each 100 persons screened, twentyfive will be hypertensive, 
sixteen will reach a physician for diagnosis and treatment, eight will continue 
treatment and four will achieve blood pressure control for at least one year". 
During Wilber's study a number of methods have been tested to reach a major 
part of the populations. Invitations for an examination of the blood pressure 
via mass media and via letters to families only resulted in an attendance 
percentage of about 10 per cent. The greatest success has been scored by door 
to door visits and with mobile examination facilities in busy shopping streets. 
However, both methods have their obvious disadvantages. 
Charman (1974) describes a study concerning the occurrence of hypertension in 
the employees of two factories. A total of 2,672 people were invited by letter for 
an examination; attendance amounted to 55 per cent. The refusers were then 
approached by telephone which resulted in·a total attendance of 63 per cent. A 
second request by telephone did not decrease the number of refusers (86.8 per 
cent remained not interested; 5.4 per cent were not able to come at short notice; 
7.8 per cent were already under medical treatment). A striking aspect of this 
study is the high percentage of participants (96.8 per cent) that co·operated in a 
further evaluation of the high blood pressure. After one year 86 per cent of the 
participants with a diastolic blood pressure over 100 mm Hg were still 
scheduled for drug therapy. 
Schoenberger et al. ( 1972) find 2, 725 people with hypertension among the 
22,929 people examined. "Prior knowledge of the diagnosis was denied by 
58.9% of the cases. Of the remaining 41.1% giving a history of hypertension 
about 40% were not currently receiving treatment when surveyed, and about 
another third were being treated but were still hypertensive. Only about a 
quarter of these known hypertensives (representing only 11.2% of all the 
identified hypertensives I were having treatment with resultant reduction of 
blood pressure to levels below 160·190 mm Hg". 
The European Working Party on High Blood Pressure in Elderly Patients 
(Amery, 1975; Birkenhager, 1975) tries to give an answer to the question 
"Should elderly hypertensives be treated?". "In this study workers from 5 
European countries designed a trial in which patients over 60 with mild to 
moderate hypertension are allocated at random into either a group treated with 
placebo or a group treated with antihypertensive drugs and followed under 
double·hlind conditions. A one year study is completed and has shown that a 
multinational study is possible and that a significant reduction in blood 
pressure can be achieved in the active treatment group without major side· 
effects. In this pilot study no significant differences in the 140 patients in 
cardiovascular events have been observed". 
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2.4 Smoking 
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The deliberate strong pollution of inhaled air by the smoke of burning tobacco 
is a widespread habit. In The Netherlands 40-45 per cent of the boys and girls 
in the age of 13-18 years are now smoking cigarettes, at the age of 19-23, 70% 
and over 60% respectively. With men this percentage remains on the same 
level until the age of 50 {De Haas, 19731. In the U.S.A. these figures are 41.3% 
for men in the age group of 17-24 years, for women 29.4%, for the group 24-44 
years this is 54. 7%, 40.2% respectively (Lew, 19731. 
Tobacco smoke contains a great number of chemicals. The smoke can be 
divided in a gas phase 192% of the smoke I and a particle phase ( 8% II N eukomm, 
19741. Some of the chemicals are poisonous to a certain degree: carbon-
monoxyde strongly decreases the oxygen transport capacity of the red blood-
corpuscles, nicotine influences the nervous system and a number of tar 
products are causing cancer. The latter are left out of consideration within the 
scope of this review. 
Tobacco smoke contains some 4% of carbonmonoxyde IWald, 19731.- After 
inhalation the carbonmonoxyde combines with the haemoglobin IHbl in the 
red blood corpuscles. The percentage of Hb combined with CO I HbCO I is a 
standard for CO poisoning. With heavy smokers this percentage can soar to 15. 
Not more than 2.5% HbCO can be ascribed to atmospheric CO. The prognostic 
significance of a high HbCO percentage is impressive. "In the age group 30-69 
years a person with a HbCO level of 5% or more was found to be 21 times as 
likely to be effected by atherosclerotic diseases including ischemic heart 
disease I IHD) as another person of the same age and sex with similar smoking 
history and current smoking habits but with a HbCO level of less than 3% 
{Wald, 19731." 
From experiments with laboratory animals it appears that the carbon-
monoxyde increases the permeability of the vascular wall from which 
accelerated atherosclerosis will occur lAstrup, 1974). With human beings the 
occurrence of heart failure and mortality as a consequence of coronary heart 
disease iCHD) appears to be significantly higher with heavy cigarette smokers 
than with light cigarette smokers {Aronow, 1974). The smoking pleasure 
depends on the nicotine level in the blood INeukomm, 19741. The number of 
cigarettes necessary to obtain the desired blood level is decided by the nicotine 
percentage of the tobacco. The lower the nicotine percentage, the higher the 
number of cigarettes needed. However, this entails an increase of the quantity 
of carbonmonoxyde inhaled {Russell, 19741. Nicotine increases the systolic 
blood pressure and the cardiac frequency. This causes a higher oxygen demand 
on the heart. As the blood not only assimilates the nicotine but also carbon-
monoxyde, this decreases the quantity of oxygen available for the body. Thus 
smoking fosters an oxygen shortage by various mechanisms {Aronow, 1974). 
The advice to stop smoking cigarettes and to change to smoking a pipe seems 
rather senseless because. ex-cigarette smokers generally also inhale the pipe 
tobacco smoke and thus again absorb carbonmonoxyde in the blood {Castleden, 
1973). 
The mortality as a consequence of CHD decreases when smoking has stopped. 
The CHD rates of ex-cigarette smokers are below that of smokers {Stamler, 
1970; Doll, 19741. With younger people this difference is greater than with 
middleaged men I Stamler, 1970 ). 
It has never been proven that smoking has any favourable aspect (Blackburn, 
1974), but it appears to be very difficult to break with the habit. In a follow-up 
study with 125 heart attack patients who had been frequently advised to stop 
smoking, 62 per cent appeared to have stopped smoking after 1-3 years, with a 
comparable group of 85 persons who had not frequently been advised to do so, 
this percentage amounted to 27.5. 
Russell (1974) tries to give a recommendation to achieve a decreased 
consumption of cigarettes. "With the combined effect of health education 
coupled by selective taxation to the powerful price disincentive, it should be 
possible gradually to phase out dangerous cigarette smoking in favour of 
acceptably safe, light to moderate, controlled, non-inhaled smoking of pipes or 
medium to large-sized cigars". 
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2.5 Cholesterol 
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There have been several studies concerning the serum cholesterol level of 
various populations. When the results are compared, the study method used 
must be taken into account when the data are interpreted as the determination 
of the cholesterol can be realised both in plasma and in serum. The 
determination in serum must be preferred in connection with great and 
inconstant differences between plasma cholesterol values and constant serum 
cholesterol results (Boerma, 1974 ). 
During a comparative study of the cholesterol level in the serum of Australians 
and natives on New Guinea (Whyte, 1958) it appeared that in newly born 
babies the serum cholesterol level of umbilical cord blood was the same with 
both groups. After one year this had doubled with both groups. After that the 
serum cholesterol level of the Australians continued to increase whereas that of 
the natives fell gradually to adult levels ( 130 mg% ). Comparable results have 
been achieved by a study among Indians in Surinam, living under primitive 
conditions ( Geerdink, 1973 ). With all age groups the cholesterol level is rather 
constant and averages 137 mg per 100 ml of serum. These values differ markedly 
with those found in countries with high mortality and morbidity of cardio-
vascular diseases (table 2.1) (Kannel, 1971; Goldstein, 1973 ). 
Table 2.1 
Serum cholesterol concentrations of various populations 
(mg%). 
Years 0-10 10-20 20-30 30-40 
New Guinea natives 
(Whyte, 1958) 126 128 130 -
Surinam Indians 137 133 134 136 (Geerdink, 1973) 
Tecumseh 178 1 I 172 189 208 (Johnson, 1965) 
Vlagtwedde 234 260 (May, 1974) - -
Dutchmen 171 21 192 231 31 IDe Wijn, 1972) -
-
Finnish men 208 242 !Karvonen, 1959) - -
1) 4-10years 
2) 16-19 years 
3) 30-50 years 
4) 65-75years 
40-50 50-60 >60 
- - -
147 136 138 
225 239 255 
269 
- -
231 31 
-
255 4 ) 
248 250 
-
In the U.S.A. the average cholesterol level of fifty years old men amounts to 
about 250 mg/100 ml of serum, 26 per cent have a percentage of 260 mg% or 
over and 5 per cent have 300 mg% or over (Wynder, 1972; Lew, 1973, annex 10). 
Cardiovascular diseases occur very frequently in these Americans, contrary to 
Japanese who have an average cholesterol percentage under 180 mg%. This 
introduces the question: "Blood lipids: How normal is normal?", posed by 
Wynder et al. (1972). When the question was posed~to a numf>er of experts in 
the field of atherosclerosis, which levels they consider normal cholesterol levels, 
146, 174 and 185 mg% respectively for 10,30 and 50 years old were suggested as 
normal levels. The Framingham Study (Higgins, 1965) gives an incidence rate 
of 9. 7 per 1000 of cardiovacular diseases with men with a serum cholesterol level 
of 220 mg% and for cerebrovascular accident (CVA) of 2.3. With a serum 
cholesterol percentage of 280 mgo/o or over these are 22.1 and 3.1. 
These figures correspond with those of The National Co-operative Pooling 
Project (Lew, 1973). In this project Caucasian males in the age group of 30-59 
years with a serum cholesterol of 300 mgo/o or over were found to have an 
incidence of first major coronary events that is about three times that for men 
with serum cholesterol levels of 175 to 224 mgo/o. 
Although no solid, conclusive evidence has been obtained, there are indications 
that modification of the diet which decreases the cholesterol level of the blood, 
will decrease also the occurrence of coronary heart disease (CHD), if only in the 
short term (Stamler, 1970; Miettinen, 1972; Evans, 1972; Blackburn, 1974). It 
appears that the effect of the cholesterol decreasing diet depends on the initial 
value of the cholesterol percentage. According to Ederer ( 1972) this can be 
explained with two hypotheses: the diet-hypothesis and the regression-
hypothesis. The diet-hypothesis presumes that an initial high serum cholesterol 
percentage will be influenced more by cholesterol decreasing diets than a low 
cholesterol percentage. The regression-hypothesis assumes that, independent 
of the diet intervention the higher serum cholesterol values generally decrease 
at a faster rate (or increase at a reduced rate) than lower values. The two 
hypotheses do not negate each other and both principles appear to be of 
importance. 
Apart from the positive correlation between the blood cholesterol percentage 
and CHD, the inverse correlation between the serum cholesterol percentage 
and colon carcinoma has been outstanding (Rose, 1974). These data necessitate 
"further study of the relation in individuals between carcinogenproducing 
faecal bacteria and the dietary intake of polyunsaturated fat and fibre" (Rose, 
1974). 
Blackburn rejects determination of the triglyceride percentage of the blood as 
risk indicator. "For the general population outside hospitals, there is no 
evidence that triglyceride levels contribute information on CHD risk, which is 
independent of the associated serum cholesterol level" (Blackburn, 1974 ). 
29 
2.6 Glucose tolerance 
The significance of adult-onset diabetes mellitus as a risk indicator for the 
contraction of cardiovascular diseases is not yet clear (Blackburn, 1974). This is 
caused to a large extent by the fact that no well defined predictive screening 
criteria concerning diabetes mellitus are available. Many different criteria are 
being used in the literature, which makes it a rather precarious undertaking to 
compare the studies with each other (annex 1). 
The items generally used in epidemiologic studies as screening tests are: the 
determination of the glucose percentage of the blood, the glucose percentage of 
the urine or a combination of the two determinations. The blood can be taken 
by needle directly from a vein (venous blood) or via a stab in the earlobe or 
fingertip (capillary blood). The determination can be effected in venous or 
capillary blood, but also in plasma or serum. The concentrations determined are 
depending on the medium in which they have been determined and on the 
method followed for their determination. Often employed methods are: the 
reduction of ferricyanide to ferrocyanide under the i,nfluence of glucose, copper 
(Ill to copper (III) ions, or the direct coloration with 0-toluidine. Enzymatic 
determinations must also be included (Boerma, 1974). 
The investigation of blood and urine can be effected after a period of fasting 
(the fasting examination) or at a certain time after a meal. The glucose 
percentage of the blood can also be determined after administration of an 
overdose of glucOse. This method of examination is called the Glucose 
Tolerance Test (G.T.T.). The glucose can be administered orally (Oral Glucose 
Tolerance Test: O.G.T.T.) or directly into the vascular system (Intravenous 
G.T.T.: I.V.G.T.T.). 
At national and international levels attempts have been made to issue 
directives in order to define diabetes mellitus (World Health Organization, 
1965; Fajans, 1974) and to standardize the G.T.T. Notably much attention has 
been paid to the uniform way of preparation of a patient (fasting or not fasting) 
the way and site of tapping the blood (venous, capillary), the time schedule of 
the glucose tolerance test and the interpretation of the examination results 
(Kiimt, 1968; Teuscher, 1971). 
In 1965 a World Health Organization report (W.H.O., 1965) included 
definitions of potential diabetics, latent diabetics, asymptomatic diabetics and 
clinical diabetics (annexes 2 and 3). Depending on the budget and cultural 
pattern (West, 1971) an examination of urine is recommended for screening 
which has been collected two hours after the consumption of sugar or a meal 
that was rich in carbohydrates. Blood examination must be effected in blood 
that has been collected two hours after a loading dose of glucose or a meal rich 
in carbohydrates. Attention is drawn to the importance of the performance of a 
glucose tolerance test. ''The oral glucose tolerance test seems to be more 
meaningful than the intravenous glucose tolerance test in estimating the 
efficiency of glucose disposal in patients with mild abnormalities of glucose 
tolerance" ( Olefsky, 1973). 
30 
The Committee on Statistics of the American Diabetes Association (Kiimt, 
1968) has published directions for the standardization of the oral glucose 
tolerance test in 1968 (annex 4). 
It has been recommended to classify the results of the examinations as 
"diabetic" and "non-diabetic" for each of the following criteria: 
the "Wilkerson Point Method"; 
the "Fajans- Conn criteria"; 
the ''Summation of fasting, 1, 2 and 3 hours plasma glucose levels''; 
other criteria. 
Where possible the measured results should be mentioned. 
In 1971 the "Medizinische Sektion der Schweizerischen Vereinigung fiir 
klinische Chemie" published "Neue schweizerische Richtlinien zur Diagnose 
des Diabetes Mellitus" (Teuscher, 1971). In that study it has been tried to 
provide advice focussed on actual practice. One of the detection methods is the 
determination· of the bloodsugar percentage after a period of fasting. As 
separation values are mentioned: 
50- 100 mg%: normal (2.7- 5.6 mmol/1). 
100- 130 mg%: borderline (5.6 -7.2 mmol/l). 
) 130 mg%: pathological ( ) 7.2 mmol/1). 
The determination has to be repeated when a borderline or pathological blood-
sugar percentage is found. When the results of two or more determinations 
exceed the 130 mg% limit the diagnosis diabetes mellitus is considered likely 
and further examination must follow. 
A second detection method is the determination of the blood glucose percentage 
two hours after a meal rich in carbohydrates. For capillary blood the following 
standards are indicated: 
< 130 mgo/o glucose: diabetes unlikely ( < 7.2 mmol/1). 
130- 180 mgo/o glucose: suspicion of diabetes (7.2- 10.0 mmol/1). 
> 180 mg% glucose: diabetes ( > 10.0 mmol/1). 
For venous blood the standards are 20 mgo/o (0.1 mmol/l)lower. With a result of 
130-180 mgo/o a glucose tolerance test must be carried out for ultimate 
diagnosis. For values over 180 mg% a G.T.T. is contraindicated and in that case 
the determination must be repeated. 
The oral G.T.T. with a loading dose of 50 g of glucose is recommended as a 
screening test which can be performed in a simple manner (annex 5). The 
criteria for the interpretation of the values are given in table 2.2. 
Table 2.2 
Interpretation of the 50 g G.T.T. in capillary blood. 
capillary blood fasting 60min. 120 min. 
mgo/o glue.; mmol/1 mgo/o glue. ; mmol/l mg% glue. ~ mmol/1 
normal ' : ' < 100 ' < 5.6 ( 160 < 8.9 ( 120 ' < 6.7 I • 
' borderline 100- 130 
• 
5.6- 7.2 160-220 ; 8.9- 12.2 120- 150 : 6.7-8.3 
pathological > 130 • > 7.2 > 220 • > 12.2 >150 • > 8.3 , 
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For the oral G.T.T. with 100 g glucose loading and venous blood sampling the 
study indicated that this should be carried out only on strict indication I e.g. 
with an ambiguous 50g test, or in order to test the maximum insulin secretion, 
etc.). As normal values for the G.T.T. with 100 g burdening are considered: 
venous blood: fasting 100 mg% glucose (5.6 mmol/l) 
1 hour 170 mgo/o glucose (9.4 mmol/1) 
2 hours 120 mgo/o glucose I 6. 7 mmol/1) 
3 hours llO mgo/o glucose (6.1 mmol/1) 
For interpretation of the data this study refers to the recommendations of the 
American Diabetes Association (Klimt, 1968). It is mentioned that it will be 
necessary to consume 250 g of carbohydrates in the three days preceding the 
G. T. T., as otherwise the chance of falsely positive findings will be great. 
Another major complication in the early diagnostics of diabetes is the bad 
reproducibility of the G.T.T. (McDonald, 1965; Logie, 1974). "Technical" and 
"host" variables have their influences on the result. "Technical" variables are 
the quantity of glucose administered, the hour of the day on which the glucose 
is administered and the time elapsed since the last meal. "Host" variables 
include the nature of the foodstuff used for the test, the consumption of 
medicine and psysical activity (Klimt, 1968). This all renders the result of the 
test unique. It has also appeared that in the natural development of diabetes 
mellitus progression and regression are possible with an unpredictable speed 
(Fajans, 1974). 
The significance of the decreased glucose tolerance in older people has not yet 
become quite clear (Andres, 1971). When the standard values for young people 
are also being used for older people, a high percentage of disturbed G.T.T.'s will 
be found in the higher age groups. Neither the WHO Expert Committee nor 
the American Diabetes Association Committee quantify the effect of ageing on 
the test of the glucose burdening examination. 
Reubin Andres (1971) describes a nomogram with the variables age and 2-hour 
value of the G.T.T. "The percentile rank compares the subject's performance to 
that of his own age cohorts" (annex 6). As a warning he adds: "Until it is 
dear exactly what level of test performance truly carries with it increased risk, 
and until it is clear that prophylaxis is possible, and that therapy is helpful, it 
behooves us to adopt a conservative stand at the moment in our willingness to 
classify a middle-aged or older subject as diabetic on the basis of poor test 
performance alone''. 
This conservative attitude has been justified by results from other studies 
(Klimt, 1970; Logie, 1974; Jackson, 1974). The University Group Diabetic 
Program I Klimt, 1970) including in its goals "the evaluation of the efficacy of 
hypoglycemic treatments in the prevention of vascular complications in a long 
term, prospective clinical trial and study of the natural history of vascular 
disease in maturity onset, non insulin dependent diabetics" states that the 
data suggest that "tolbutamide and diet may be less effective than diet alone or 
than diet and insulin at least insofar as cardiovascular mortality is concerned". 
In the group treated with tolbutamide or phenformin the mortality due to 
cardiovascular diseases was 14.7% and 12.7% respectively and 4.9% in the 
placebo group. Since no bias was found during statistical analysis the 
tolbutamide study was stopped in 1969. The phenformin study was terminated 
in 1971. 
Feldman ( 197 4) did not observe long term improvement of the glucose tolerance 
during the treatment of chemical diabetics with tolbutamide, but there was 
"suggestive - although not conclusive - evidence that phenformin may be 
of practical benefit to patients in this phase of the disease". 
Logie eta!. (1974) state the results in 72 patients with chemical diabetes which 
have been treated with a placebo. Only 4 patients developed overt diabetes. 
Jackson I 197 4) found "a significant improvement in mean glucose tolerance in 
those so called asymptomatic diabetics who lost weight and no change in those 
who did not diet or lose weight" I one year follow-up). 
A detailed analysis of the results of the University Group Diabetes Program 
(UGDP) and other controlled trials with hypoglycemic agents was published in 
1975 by the Committee for the Assessment of Biometric Aspects of Controlled 
Trials of Hypoglycemic Agents (Gilbert, 1975). This committee states that 
"On the question of cardiovascular mortality due to tolbutamide and 
phenformin, we consider that the UGDP trial had raised suspicions that 
cannot be dismissed on the basis of other evidence presently available. We find 
most of the criticism levelled against the UGDP findings on this point 
unpersuasive' '. 
"The possibility that deaths may have been allocated to cardiovascular causes 
preferentially in the groups receiving oral therapy exists and, in view of the 
"non-significance" of differences in total mortality, some reservation about the 
conclusion that the oral hypoglycemics are toxic must remain. Nonetheless, we 
consider the evidence of harmfulness moderately strong''. 
Chalmers (1975 concludes on the basis of this study: "The probability that oral 
hypoglycemic agents cause premature deaths from cardiovascular disease 
remains valid''. 
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2.7 Overweight 
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There are no indications that overweight is an independent risk indicator for 
coronary heart disease (CHD ). Indirectly, however, it does have its 
significance. Overweight tends to increase the blood pressure whereas it also is 
often combined with glucose intolerance (Keys, 1972). 
The Minnesota Group (Keys, 1972) found that a multivariate analysis of the 
data showed that no measure of relative weight or obesity made a significant 
contribution to future coronary heart disease, when the factors of age, blood 
pressure, serum cholesterol and smoking were comparable. As an index for the 
relative weight the Quetelet index ( W IH2) has been used. Analysis of length/ 
weight ratios has demonstrated that this was the least undesirable index 
(Khosla, 1967; De Wijn, 1968; Florey, 1970). 
In the Framingham Study a statistically significant correlation has been 
demonstrated between coronary heart disease and 35% or more overweight 
(compared against the Metropolitan life insurance standard tables). "The 
CHD risk ratio is small; 1.6 in men and 1.4 in women" (Blackburn, 1974). The 
seven countries study showed "no significant relationship of relative body 
weight, body mass index and sum of skinfolds to non fatal infarct plus coronary 
heart disease death or death from all causes. Addition of body mass index to 
the logistic· discriroinant equation based on age, blood pressure, serum 
cholesterol and cigarette smoking of the multivariate analytical model, showed 
that the discrimination of coronary heart disease events was not significantly 
iroproved" (Blackburn, 1974). Blackburn concludes: "moderate overweight is 
not a strong contributor to future CHD risk in any population but weight 
reduction is desirable when indicated in an attempt to reduce the level of blood 
pressure, glucose intolerance, or serum lipids and to enhance a healthy self· 
image''. 
2.8 Physical inactivity 
The significance of physical inactivity as a risk indicator for the contraction of 
coronary heart disease ( CHD) is still far from clear. Froelicher (1972) puts after 
analysis of 35 epidemiologic examinations that "the results are both 
contradictory and inconclusive'' (annex 7). Blackburn 11974) reaches the same 
conclusion: "Over 20 years of systematic researches have failed to provide a 
clear answer". This failure is partly due to inherent methodological factors, 
such as: "difficulty in accurately assaying physical activity; inability to assess 
the type of exercise that is most protective; lack of gradient of physical activity 
in general population and insufficient sample size to permit adjustment for 
confounding factors, or no available data regarding them" (Froelicher, 1972). 
2.9 Personality structure, behaviour and 
stress 
There is an anecdote in circulation about an upholsterer who had to do a repair 
job on the chairs of the Mount Zion Hospital in San Francisco. He drew the 
attention of the cardiologists Friedman and Rosenman to the peculiar wear of 
their waiting-room furniture. Of all the chairs in the hospital both back and seat 
were worn, in their department only the front edges of the seats (Appels, 1974). 
These and analogous experiences induced the aforementioned cardiologists to 
pay special attention to the behaviour of their patients. This resulted in a 
classification system of behaviour types. It is claimed that the chance of 
coronary heart disease I CHD) differs with the behaviour types to be 
distinguished. 
Unfortunately there is strong doubt concerning the reproducibility of the 
classification system and its usability in other cultural patterns (Blackburn, 
1974). "That is not to say that individual or group behaviour is unrelated to 
pathogenesis or to the precipitation of coronary attacks in those susceptible in 
United States cultures. They probably are related; how much of the influence 
operates through neurohumoral influences on circulation, coagulation, 
inflammation, immunity, catecholamine activity, and lipid metabolism and 
how much these are related to "goal-less drives" and "chronic struggle", simple 
frustration, bad habits, overeating and depression etc.? No one is yet in a good 
position to answer". "Why die the rural fat-eating Finns, one of man's most 
civilized, calm, stolid outdoor working people at the highest rate of CHD known 
to man? Why is the CHD rate still very low in Japan where the frantic turmoil, 
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overcrowding, social competition and confusions of modern life are big 
problems?'' 
According to Blackburn (1974) these questions cannot be answered by making 
the factors stress and behaviour primarily responsible. Nor do the data 
collected by Jenkins ( 1971 a + b) clarify the significance of the psychic and 
social factors as precursors of coronary heart disease (Blackburn, 1974). 
2.10 The electrocardiogram 
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The electrocardiogram (ECG) renders graphical information concerning the 
electrical activity in the heart. The classification of ECG patterns in "normal" 
and "abnormal" appears to entail problems in practice, partly caused by 
differences in observation, partly by differences in interpretation (Blackburn, 
1965; Higgins, 1965; Elgrishi, 1970). Despite these, however, the ECG remains 
a valuable screening tool for coronary disease. The information is objective, 
simple, rapidly obtained and painless and largely independent of co-operation 
or language differences. 
Blackburn et al. suggested a detailed classification of ECG's based on precisely 
defined criteria (Blackburn, 1960; 1969). This standardized coding system has 
become known as the Minnesota Code and it has been widely recommended for 
initial classification of ECG's for epidemiological purposes. "We have 
attempted to provide, in the words of the recommendation of the Research and 
Social Committees of the International Society of Cardiology," the reporting of 
findings in uniform, clearly defined, and objective terms with the least risk of 
confusion in regard to interpretation" (Blackburn, 1960). Rose says that the 
Minnesota Code represents a great advance in standardized reporting on 
electrocardiograms. Nevertheless, as before, it fails to provide an adequate 
basis for comparing the results of different workers. This situation can be 
improved by (a) standardized training with supplementary rules on exact 
techniques of measurement and (b) testing performance routinely". He shows 
that medically unqualified technicans can be readily taught such a system 
(Rose, 1965). 
Higgins et al. ( 1965) deal more extensively with the reproducibility of the code. 
In order to obtain an impression of the interindividual observation differences, 
he describes the classification according to the Minnesota codification of 31 
ECG's with deviations. In 14 cases there is a marked difference between the 
classifications. Also the intra-individual observation differences are important. 
Of 440 ECG's read on two occasions, 239 were classified as showing no 
recordable items each time. Similary 169 were classified as having one or more 
reportable items on both occasions, 22 were called normal on the first occasion 
but abnormal on the second. Ten were called abnormal on the first and normal 
on the second. Exact measuring of the ECG's (width and depth of Q, 
magnitude of R, S and T in all leads, height of P and P-R interval in lead II) 
considerably improves the results (Higgins, 1965). 
"However, an important degree of human observer variation persists even in 
such an "objective" attempt to characterize the "abnormal ECG", and even 
among trained coders" (Blackburn, 1965). 
The "Groupe d'Etude sur l'Epidemiologie de l'Atheroscl<\rose" iGREA) has 
used a particular protocol for the Minnesota Code since 1966 and examined the 
reproducibility of the code (Elgrishi, 1969, 1970). The GREA concludes that 
"although the reproducibility of the interpretation is still imperfect and much 
effort is still required, the Minnesota Code, with its procedural application, 
remains at the present time the only means of achieving a standardization of 
the manual coding of electrocardiograms in the course of epidemiological 
investigation. 
Much of the element of reproducibility is improved by computer programming 
for ECG coding but there is still a large commitment of many population 
studies with conventional paper tracings" (Elgrishi, 1970). Then also there is 
the statement by Blackburn in 1969: "Computer programs dealing with 
detailed ECG amplitudes and other characteristics may provide different 
classifications, and provide them more efficiently". 
Deviations, found on the resting·ECG supply a contribution towards the 
identification of people with an increased chance to contract CHD. Rose (1971) 
finds in 1127 people (35·59 year old) in the first seven years of a follow-up study 
"79 men who developed major coronary illnesses (37 deaths, 34 cases of non 
fatal myocardial infarction, and 8 cases of major angina only). In 23 of these 
men the first major illness had been preceded by a positive ECG". According to 
the Coronary Drug Project Research Group (1972) "Ambulant post infarct 
patients with a normal ECG had one third the mortality risk of those with 
residual ECG findings and an ST-segment depression of the ischemic type was 
the most important independent risk predictor of all clinical and ECG findings 
studied". "Also patients with frequent ventricular premature beats on a single 
ECG at time of entry of the study had over twice the mortality of those with 
rare or no ectopic activity. This difference was significant even after correction 
for other coronary heart disease I CHD I risk indicators was made" I Lawn, 
1971). 
"If the resting-ECG is normal, evidence suggestive of coronary disease may be 
obtained in a proportion of cases by reporting it under some form of stress, 
usually exercise. The combined results of 16 studies show that 68% of the 
patients with coronary artery narrowing of over 50% reveal ST-segment 
depression of 1 mm or more by a graded exercise test on a bicycle ergometer or 
treadmill. When the coronary angiogram was normal, only 9% showed an 
abnormal ECG during graded exercise tests" (Simoons, 1973). When a 
horizontal ST depression of 0.05 mV (0.5 mm) is interpreted as an abnormal 
finding the sensitivity for detection of coronary heart disease I CHD I increases to 
83% but the specificity declines to 67%. Thus the number of false positive 
findings becomes too high to be acceptable. On the other hand ST depressions 
of 0.2 mV (2 mm) or more are very seldom found in patients without obstructive 
coronary artery disease. The specificity for this degree of ST depression is 98%. 
These results were obtained by visual interpretation of the ECG during exercise 
in 34 7 patients in different series. However, the interpretation of exercise 
ECG's is often difficult when baseline drift and noise from skeletal muscles is 
present. Therefore it has been attempted to improve the diagnostic value of the 
exercise·ECG by computer processing. Ascoop 11974) studied 87 patients who 
underwent selective coronary arteriography. Most patients were selected 
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because they had a normal exercise-ECG previously. Visual analysis yielded a 
sensitivity of only 17%, while the specificity was 100%. Measurement of the 
amplitude and slope of the ST-segment by computer in lead C.C.5 increased the 
sensitivity to 72% and reduced the specificity to 90%. Similar results were 
obtained by Simoons (1975) who studied the exercise-ECG in 139 normal 
subjects and 95 patients with CHD and a normal ECG at rest. Best results in 
his study were obtained when the ST measurements were compared with the 
normal range of the measurements at the same heartrate. A likelihood ratio was 
employed to express the probability that a given individual has significant 
obstructive coronary artery disease. Computer processing in this study also 
permitted the design of criteria for interpretation of the exercise-ECG in 
patients with an abnormal ECG at rest. 
Doyle et al. (1970) describe "the prognosis of an abnormal electrocardiographic 
stress test of 2003 men who had at least two ECG stress tests, 264 developed 
some manifestation of ischemic heart disease I IHD) and 75 of them had an 
abnormal electrocardiographic response to exercise as their first manifestation 
of IHD. Over the next 5 years there was a 85% probability that these 75 men 
would develop another manifestation of IHD, namely angina pectoris, 
myocardial infarction or sudden death. Only transient ischemic flattening or 
caving of the ST-segment induced by exercise, proved to be a diagnostically 
useful index of potentially inadequate coronary arterial perfusion. Ischemic 
T-wave changes and paroxysmal left bundlebranch block were not useful 
criteria''. 
"The angiographic severety of coronary artery disease correlates strongly with 
the frequency of positive tests (40%, 66% and 76%, with 70% or greater 
occlusion of one, two or three vessels respectively)" (Bartel, 1974). This study 
has also shown "that the angiographic occurrence of collateral vessels was 
related to the extent of coronary disease and was associated with a higher 
percentage of positive exercise tests; no protective effect of coiiateral 
circulatior. could be demonstrated". 
"The incidence of both ventricular and supraventricular complexes increased 
with age" (McHenry, 1972). In this study "the incidence of ventricular 
premature complexes for any given age group was also greater in patients with 
definite or suspected cardiovascular disease. However, the appearence of 
unifocal ventricular premature complexes during maximal or near maximal 
exercise testing should not be equated with the presence of clinically significant 
cardiac disease". 
Jelinek (1974) did not succeed in giving a clear answer to the question whether 
the occurrence of ventricular premature activity with exercise stress is a 
specific marker for CHD". 
Fisch et al. (1973) analysed the ECG's of 40 patients with "rate dependent 
aberrancy (RDA). The types of aberrancy were left bundlebranch block (LBBB) 
in 32 patients, right bundlebranch block (RBBB) in four, left anterior 
hemiblock (LAH) in three and in one patient incomplete RBBB was present. In 
the conclusion he puts "obvious heart disease was present in ali but one of our 
patients with RDA. On the other hand, in some instances of established LBBB 
evidence of significant heart disease may be absent. It is possible that in such 
patients the bundlebranch block is due to a localized area of fibrosis 
interrupting the bundlebranch, with the rest of the myocardium and the 
coronary vessels normal. However, if rate dependent BBB is a function of 
altered local perfusion, significant clinical heart disease is most likely to be 
present''. 
2.11 Combined risk indicators 
It has appeared from prospective studies that the "morbidity and mortality 
rates from coronary heart disease (CHD) among Americans differ markedly, 
particularly when classified with respect to serum cholesterol, blood pressure 
and cigarette smoking, considered simultaneously" (Stamler, 1970). "Those 
free of the three risk indicators experienced much lower CHD morbidity and 
mortality rates over a ten year period than did the group of men with any two 
or all three of these traits". There was fpund that the "CHD mortality rate was 
one-third to one-sixth as high and the sudden death rate was one-fourth to 
one-sixth as high". 
Keys eta!. ( 1972) "using multivariate analysis, related the characteristics of 
11,132 menaged40-59 years and free from CHD at entry to follow-up experience 
( 5 years follow-up). The characteristics used were Body Mass Index ( BMI = 
weight in kilograms divided by the square of height in meters, systolic blood 
pressure in supine position, serum cholesterol, smoking habits and age). These 
characteristics were related to two categories of CHD: hard CHD and any 
CHD. Hard CHD means death from CHD or definite myocardial infarction, any 
CHD included four categories: classical angina pectoris, clinical heart disease; 
clinical diagnosis of possible heart disease and a history of myocardial 
infarction; defined Minnesota ECG codes". It appears to be possible, with the 
aid of a formula "to estimate the probability of the development of CHD in an 
individual. There is no indication that BMI makes a significant contribution to 
the risk or its evaluation. Consideration of only four variables (age, systolic 
blood pressure, serum cholesterol and smoking habit) suffices to identify men 
whose likelihood of dying from CHD or having definite infarction within 5 years 
is greatly above the average. By the same token, it is possible from these 
characteristics to identify men who are most unlikely to become CHD victims 
in 5 years." 
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2.12 Aspects of ageing 
"Despite the great strides of modern medicine the estimated life expectancy of 
men who reach and surpass the age of 40 is actually unimproved in 1970 
compared to that in 1900" (Lew, 1970; table 2.3). 
Table 2.3 
Observed and Projected Expectation of Life for White U.S. Men. 
Age (years) 1900 1930 1960 1970 
0 52.8 63.4 67.4 67.7 
5 59.9 63.8 64.4 64.4 
10 56.0 59.3 59.6 59.6 
20 47.9 49.9 50.1 50.1 
30 39.6 40.9 40.9 40.9 
40 31.2 31.7 31.7 31.7 
50 23.1 23.2 23.2 23.2 
60 15.7 15.9 15.9 15.9 
70 10.2 10.2 10.2 10.2 
80 5.9 5.9 5.9 5.9 
"Whatever social affluence and medicine have achieved, something else has 
taken away; that something else is principally the atherosclerotic, coronary and 
cardiovascular disease epidemic" (Blackburn, 1974). 
Hypertension 
With Americans the prevalence of hypertension increases when getting older 
(Lew, 1973; annex 8). The mortality as a consequence of hypertension decreases 
with age. "For instance, in men under 40 with casual pressures of 150/100 mm 
Hg, mortality was approximately 325 per cent that of standard insured risks, 
whereas men aged 40 and over showed a mortality of about 225 per cent I annex 
9). With 45-54 years old male Caucasians 17.3 per cent have a systolic blood 
pressure of 160 mm Hg or over or diastolic 95 mm Hg or higher, for 55-64 years 
old this percentage amounted to 28.4. 
Smoking 
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According to American and Dutch data the prevalence of smoking cigarettes 
decreases with men of 45 year and over, but judging by social medical 
standards the situation is still very unfavourable IDe Haas, 1973; Lew, 1973). 
"The relationship of cigarette smoking to CHD risk in American studies is 
strongest at younger ages, and its "effect" is independent of, and at least 
additive to, that of serum cholesterol, blood pressure and activity habits. 
Though relative CHD risk related to smoking declines with age, absolute CHD 
risk increases" (Blackburn, 1974). 
Serum cholesterol 
From examinations of Americans (Johnson, 1965; Lew, 1973) and Dutchmen 
(De Wijn, 1972; Geerdink, 1973) it appears that the cholesterol percentage in 
the serum is on the average higher with older people than with young people 
(annex 10). "Although there is no evidence of a critical level of serum 
cholesterol which separates high from low risk individuals, elevated serum 
cholesterol as a risk indicator in coronary heart disease is strong at the younger 
ages only" (Stamler, 1970; Lew, 1973). 
Diabetes mellitus 
"If standards of normality for all ages are constructed from data derived from 
studies on young adults, then fully half of the older population will fail the test 
and thus be judged diabetic (Andres, 1971). This distressingly high apparent 
prevalence of diabetes in older individuals has led to the evolution of two 
schools of opinion: one considers the progressive decline in glucose tolerance 
with age "to be due to the gradual evolution of increasing numbers of true 
diabetics, i.e. a pathological change. The other view maintains that these 
changes are non-pathological manifestations of the ageing process in the 
general population. This leads to different approaches to the technique of 
interpretation of test results". At this moment there are still no data available 
on the basis of which an opinion can be given about the fact whether or not the 
test results must be corrected for the age. 
There are doubts about the usefulness of the treatment of adult·onset diabetes 
mellitus with medicine (Klimt, 1970). "Hygienic emphasis on weight 
reduction, physical activity, blood pressure lowering, with reduction of serum 
lipids and smoking habits, might well be a more rational, effective and safer 
approach than the traditional pharmacological one" (Blackburn, 1974; 
Chalmers, 1975; Gilbert, 1975). 
Electrocardiogram 
Simonson ( 1972) describes ''the effect of age on the electrocardiogram''. ''There 
are significant electrocardiographic age trends in adult healthy populations 
from the third to the fifth decade in QRS and T amplitudes. The amplitudes 
decrease. Overweight accelerates the age trends. Poor progression of the R 
wave in the anterior chest leads, often interpreted as compatible with anterior 
wall myocardial infarction, is a normal age trend. The frequency of ischemic 
response to exercise increases clearly with 40 year old people and older". 
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Chapter HI 
The repeat screening 

3.1 Introduction 
In 1971 the Occupational Health Service for the Port of Rotterdam has started 
a standardized screening effort within the scope of optimal health care for older 
dockworkers. The program of the Committee for Detection and Prevention of 
Ischemic Heart diseases (COPIH, Commissie Opsporing en Preventie van 
Ischaemische Hartziekten) of the Dutch Association for Labour and Industrial 
Medicine (NV AB, Nederlandse Vereniging voor Arbeids· en Bedrijfsgenees· 
kunde ). has provided the bais for this screening. 
It has been supplemented with a roentgenogram of the chest (Odelca) and a 
dynamic stress test on the bicycle ergometer. During this first investigation 
(which will hereafter be called screening I) data have been collected from 503 
persons that were 55 years old or over on January 1, 1971. 
Between October 1972 and November 1973 the 503 participants of screening I 
have been invited for a repeat screening. The attendance of this screening 
(called screening II hereafter) was as follows: 
Total number of persons invited. . . . . . . . . . . . . . . . . . . . . . . . . . . . . 503 ( 100 %) 
Total number of persons non appearing . . . . . . . . . . . . . . . . 56(10.9%) 
l. deceased between screening I and II ...... 9( 1.8%) 
2. prolonged illness ....................... 17( 3.4%) 
3. moved/inaccessible ..................... 7( 1.4%) 
4. refusers ............................... 22 ( 4.4%) 
5. below age limit ........................ . 1 ( 0.2%) 
56 (10.9%) 
Number of people that appeared for screening II............... 447 (89.1 %) 
All those who refused the initial invitation for rescreening, have been 
personally visited by the author where possible. This resulted in the fact that 25 
initial refusers did consent to participate in screening II and this reduced the 
total number of participants not involved in the follow-up study further to 56. 
Through these visits an impression of the motivation for refusal has been 
obtained. Details of the reasons why a number of people did not appear ·have 
been specified in annex 11. The motive for the initial refusal by the group of 
25 that ultimately did participate in the examination has also been given. 
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3.2 Procedure 
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The examination has been carried out at the Occupational Health Service for 
the Port of Rotterdam by a team, consisting of 7 members. These were: 
Piet Ophof industrial physician; 
Adri Schelling physician; 
Willem Westerveld occupational health male nurse; 
CobyBuys laboratory technician; 
AnkMohlmann laboratory technician; 
Lieke Hillen - van N oort secretary; * 
Sjanie den Boef-de J ong secretary. * 
After consultation with personnel supervisors at their place of work the dock-
workers were invited by letter to participate in screening II. The screening was 
done during regular working hours, and was free of charge. Those workers who 
had retired also could participate, while their travelling expenses were 
reimbursed. All these steps were taken to achieve maximal attendance. 
In general 4, but at times 5 people were examined each day. The participants 
were received by the secretary, who provided guidance in the completion of the 
questionnaire. Next the X -ray examination of the thorax was carried out. The 
male nurse prepared the patient for the remainder of the examination. The 
exercise test was done under supervision of one of the physicians. The 
physicians performed the physical examinations every other day. All essential 
decisions were made after mutual consultations. All blood samples were 
obtained in a fasting state. Instructions for the fasting test were sent by letter 
to the participants (annex 12). Approximately one week later the participants 
were invited to revisit the physician that had performed the examination in 
order to discuss the results of the examination. In certain cases advice was 
given during this interview to change occupation or to contact the general 
practitioner for further treatment. All examination results were sent by letter 
to the respective general practitioners. 
* Lieke Hillen- van Noort has assisted in the repeat screening until December, 1973 after which date Sjanie den 
Boef-de Jong took over the care for the secretariat. 
3.3 Characteristics of the population 
The age criterium employed was that the participant had to be fifty-five years 
old or over on January 1, 1971. The occupational criteria for inclusion were 
dockworker, stevedore I, stevedore-deck, deckhand, cold store operator, 
forwarding hand, trimmer and rivercraft skipper. 
At screening II it appeared that 120 participants (26.8%) were no longer active 
in any of these positions. In 70 of them this was because of health conditions and 
in 50 because of retirement upon reaching the age of 65. 
3.4 Method of examination 
3.4.1. History 
Anamnestic information has been collected by means of a standardized 
questionnaire. The secretary, who had been especially trained for this purpose, 
interviewed the participants and entered the replies to the questions on the 
questionnaire herself (annex 13 ). 
3.4.2. Examination 
The biometric determinations (height, weight and resting-electrocardiogram) 
have been performed according to the insructions provided by the Committee 
for Detection and Prevention of Ischemic Heart diseases (COPIH handboek 
versions '72-'73 ). All were done by the male nurse. The measurement of the blood 
pressure was carried out by the male nurse and by the physician. A cursory 
physical examination was carried out by the physician which included 
auscultation of heart and lungs with palpation of peripheral arteries and 
inspection for varicose veins. 
The electrocardiogram 
For the electrocardiogram a three-channel automatic cardiograph (Hewlett & 
Packard, 1514A ECG-Phonosystem) was utilized. Standard electrodes were 
used on the limb leads, for the chest leads suction electrodes were employed. 
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The ECG was taken while the examinee was reclining comfortably on a wide 
examination bench. The standard 12leads (I, II, III, aVR, aVL, aVF, V1- V5) 
were obtained at 50 mm paper speed. · 
The arterial blood pressure measurement 
The measurement of the arterial systolic and diastolic blood pressure was 
carried out after the resting-ECG had been recorded. The participants were left 
at least 7 minutes in the same recumbent position before the blood pressure was 
measured. The first measurement was carried out by the male nurse, who had 
been especially trained for this purpose during screening I. The second 
measurement was done by the physician. When the results of both diastolic 
blood pressure measurements differed by more than 5 mm Hg the physician 
carried out a third measurement. Of the two measurements closest together the 
lowest was taken as the representative value. The Erkameter cuff manometer 
utilized had a width of the inflation cuff of 12.0 em. The supporting band was 
14.5 em. Calibration was performed before and after the examination. 
Ventilation 
By means of a Book spirograph (Medisch Technische Industrie Haarlem) and 
the Wright Peak Flow meter, the following ventilatory lung functions were 
determined. 
Forced Expiratory Volume 1 sec.; 
Forced Expiratory Volume 5 sec.; 
Vital Capacity; 
The quotient FEV 1 I FEV5 sec.: 
Peak Expiratory Flow rate. 
Chest roentgenogram 
A chest roentgenogram was obtained with a camera with automatic developing 
system*. The interpretation of these miniature photographs (10 x 10 em) was 
done by two qualified industrial physicians. They employed a double reading 
system. The same physicians involved in screening I carried out the inter-
pretations in screening II. 
In addition to a general description of the photograph, a number of abnor-
malities were coded according to table 3.1: 
* Odelcacamera 100- XVII- S 2801 f = 213 mm GRA 1: 0.6510 x 10 em. Development aid Odelcamatic 
type ODM 4, Nr. L02445 KW 3. 
Table 3.1 
Coding list of the chest roentgenogram. 
no abnormalities. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 
emphysema. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . l 
otherlung abnormalities. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2 
elongated aorta or prominent aortic knob......... . . . . . . . . . . . . . . . . . . . . . 3 
hypertrophy ofthe heart or enlarged heart. . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4 
code 3 + code4.................................................... 5 
code3+codeslor2 ............................................... 6 
code4+codeslor2 ............................................... 7 
code 1 or code 2 + code 3 + code 4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8 
3.4.3. Biochemical determinations 
Urine examination 
The urine, collected in the evening prior to the examination, was analysed by 
means of the Haemacombistix (Ames) for the presence or non presence of 
albumen, glucose and blood. 
Blood examination 
Samples of venous blood, obtained under fasting conditions, were analysed for: 
haemoglobin percentage (cyanide haemoglobin HiCn method); 
blood sedimentation rate (BSR); 
blood sugar percentage ( orthotoluidine method); 
serum cholesterol percentage (Liebermann-Burchard); 
total lipid percentage (phosphovanilline method). 
In contrast to screening I, during which the serum cholesterol, the total lipid 
and the blood sugar percentages were determined in the Gaubius Institute at 
Leyden, this time only the determination of the total lipid percentage was 
performed there. 
Since recent evidence has shown that the determination of cholesterol in blood-
plasma showed large and inconstant differences, only serum determinations 
were made (Boerma, 1974). The total lipid percentage was also made on serum. 
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Comparison of the blood tests done in the Gaubius Institute and our own 
laboratory 
In 50 blood samples the serum cholesterol and the blood sugar percentage have 
been determined according to the "COPIH" instructions, both at the Gaubius 
Institute and in our own laboratory. A comparison was carried out to determine 
the extent of interlaboratory differences operative at time of screening II. 
The result of the cholesterol determinations 
The average difference between the result of the Gaubius Institute and the 
result of the Rotterdam laboratory for serum cholesterol was - 0.03 g/1 and 
significant at the level of 5% (table 3.2). A systematic measuring error may be 
the cause. However, considering the amount of the difference, the practical 
significance is quite small. 
Table3.2 
The results of the serum cholesterol and the blood sugare 
determinations. 
Serum 
cholesterol 
Number of determinations (n) 50 
Mean difference (results of our laboratory minus 
-
results of the Gaubius Institute) (V) -0.03 g/1 
Standard deviation (s.d.) 0.09 
The paired t·test (t(49)) -2.33 
Tail-probability p <0.05 
The result of the blood sugar determinations 
blood sugar 
50 
0.10 mmol/1 
0.23 
2.95 
< 0.01 
For blood sugar the average difference between our own laboratory and Lyden 
was also significant, P < 0.01 (table 3.1). The Rotterdam values were on an 
average 0.10 mmol/1 higher than those of the Gaubius Institute. Again the 
practical significance is quite small. 
The significant differences in the methodology of the two laboratories do have 
consequences when differences between screening I and II are found, but since 
observed differences were small and of little clinical importance, they have been 
ignored in this study. It is furthermore possible that the measuring error has 
changed with time. For this reason the cholesterol values were checked weekly 
against a standard serum, Dade Monitrol II, during screening II. The reliability 
limit was 125-153 mg% (3.2·4.0 mmol/1) for 46 determinations. The reliability 
limits were not exceeded in a single instance. The same was done with blood 
sugar. Checking serum again was Dade Monitrol II. The reliability limits were 
211-243 mg% (11.7·13.5 mmol/1) for 44 determinations. The lowest reliability 
limit was exceeded only once with a volume of 11.6 mmol/1. 
The oral glucose tolerance test 
An appointment for an oral glucose tolerance test (G.T.T.) was made when 
the blood sugar percentage of the fasting blood sample exceeded 5.6 mmol/1 or 
when a positive reduction was found in the urine. When an abnormal glucose 
tolerance test or the existence of diabetes mellitus was known prior to screening 
II it was not repeated. 
Appointments were made to return to the laboratory in a fasting state. First a 
blood sugar was determined in capillary blood. Then the glucose tolerance test 
was performed after drinking 106 grams of glucose dissolved in water ( 1 bottle 
of Hycal). Capillary blood samples were obtained half an hour, one hour and 
two hours after ingestion of the glucose solution. 
3.4.4. The determination of the exercise tolerance 
The available equipment existed of: 
a bicycle ergometer with an Eddy current brake (Lode-bicycle patent 
number 65391). 
This type of brake is based on electrical resistance. The resistance of the 
brake is calibrated in Watts and was continuously adjustable. The 
product of a selected level of Watts and a variable number of rotations per 
minute (between 40 and 85) is automatically held constant in order to 
provide a constant work load. Calibrations were performed before and 
after the examination. No differences were found between these. 
a three-channel automatic cardiograph (Hewlett & Packard, 1514A 
ECG-Phonosystem ). 
The ECG recorder measures the bio-electric potentials of the heart and 
automatically records these voltages on a thermal chart recorder within 
the apparatus. The instrnment is capable of recording the conventional 
12-lead electrocardiogram. 
oscilloscope (Hewlett & Packard Sanborn 780-6A Visoscope). 
In this oscilloscope the cathode-ray tube has a 10 x 10 em parallax-free 
internal display marked in em squares. Major horizontal and vertical axes 
have 2 mm subdivisions. On the oscilloscope the ECG was continuously 
monitored. 
a cardio-tachometer (Rood, type 106 ). 
This cardio-tachometer provides a continuous beat by beat calculation of 
the heart rate (range 30-150, 60-300 and 120-600 beats per minute). An 
EGG-output permits the recording of the cardia-tachogram simultane-
ously with the ECG. 
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a direct writer ( Goerz type RE 511). 
With the aid of this writer the heart rate was simultaneously recorded as a 
curve of frequency (on theY-axis) versus time (on theX-axis). 
a frequency printer (MFI- Sodeco printer). 
The printer provides the mean cardiac frequency at each successive 
minute during the exercise test. 
a pneumography accessory (Hewlett & Packard 108). 
The pneumography accessory provides a signal of the respiratory 
movements both for monitoring on the oscilloscope and for recording on 
the third channel of the ECG recorder. 
Erka blood pressure meter. 
Since manual inflation of the cuff of the blood pressure meter is too time 
consuming compressed dry nitrogen was used to inflate the cuff during 
the exercise test. 
The exercise test was carried out only when at the pre-examination no contra-
indications were present. In 17 out of the 447 participants (3.8%) this proved 
the case. Individual causes are stated in annex 14. The exercise test took a 
maximum of 35 minutes. At the onset the participants were allowed to relax for 
three minutes while sitting on the bicycle. During this period reference data 
were recorded. Then according to a stepwise schedule with an initial load of 3 
minutes of 15 Watt, followed by 3 minutes of 45 and again of 75 Watt, exercise 
was carried out. The following 3 steps at loads of 105 Watt, 135 Watt and 165 
Watt had to be maintained for 5 minutes each. When this proved necessary 
the examination was stopped before maximum load was achieved (see for 
indications annex 15). Immediately after the test was terminated the 
participants were observed for another 8 minutes while sitting on the bicycle in 
resting conditions. 
During the exercise and recovery phases the following observations were made: 
the clinical appearance of the participant such as his complexion, his 
locomotion pattern and the degree of perspiration. 
ECG leads CM4 and CM6. These leads were continuously visible on a 
oscilloscope. The two electrocardiographic leads were recorded for 10 
seconds during every third minute and at the last minute of the various 
levels of stress. During the recovery phase registration took place for 10 
seconds during every minute including the eighth minute. 
cardiac frequency: This was continuously observed on the cardiotacho-
gram. The number of beats per minute was printed every minute on a 
strip of paper with the aid of the frequency printer. 
respiratory frequency: This was written simultaneously with the ECG 
and calculated later from the record. 
arterial blood pressure: the measurement of the systolic and diastolic 
blood pressures took place in the finall5 seconds of each minute. At the 
start of the first minute of the recovery phase the systolic blood pressure 
was also measured for 30 seconds, in order to trap rapidly changing peak 
pressure levels. 
3.4.5. Interpretation of the data 
The author and his co-workers interpreted the collected data jointly to the 
farthest possible extent. Also my colleague Baart, the project director of 
screening I, was frequently consulted. The aim was to liroit interindividual 
observation differences as much as possible. 
The following procedure was adopted: 
resting·ECG; 
The record was interpreted before physician and male nurse started with 
the exercise test. When abnormal, the exercise test was not executed. All 
resting-ECG's were subsequently reread under supervision of Prof. Dr. 
A. C. Amtzenius*. 
After the examination the resting-ECG's of screening I and II were coded 
again in a few weeks tiroe by one observer. 
exercise-ECG; 
The interpretation and classification of the exercise-ECG's have been 
done in consultation with Baart. The criteria used are specified in annex 
16. When differences of opinion arose the advice of Prof. Dr. A.C. 
Arntzenius was asked. Moreover the author and Simoons** restudied the 
exercise-ECG's of screening I and II in order to select records showing an 
ST-segment depression of 1 mm or more during the exercise and/or 
recovery phases relative to controle value. 
3.4.6. The result of the individual examination and the advice 
regarding capacity for work 
In principle, the result of any examination can be divided into an occupational 
health aspect and a curative aspect. The occupational health aspect concerns 
mainly the balance between working capacity and stress level. Since the 
dynamic exercise test supplies quantitative information regarding the 
maxiroum level of tolerable physical stress suitable measures can be taken 
when disturbances of this balance exist. 
In terms of workcapacity the following options are open: 
1. the participant will be declared completely able to work in his 
function; 
* Professor of cardiology at Leyden University. 
** Head of the Exercise Laboratory, Thoraxcenter, Erasmus University Rotterdam (Head ProfP. G. 
Hugenholtz). 
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2. the participant is partly able to fulfill his function. This means that 
the physically most exerting tasks in his job must be decreased or 
eliminated. 
3. the participant is declared completely unable to carry out his 
function. In this instance there are two alternatives possible: 
either the participant is completely unable to perform any 
activity; 
or the participant is completely unable to carry out his 
function, but is able to perform another (physically less demanding) 
function. 
The examination results concerning the work capacity were discussed with the 
participant and when he agreed with his personnel manager. The personnel 
manager took care of job adaption in co-operation with the doctor. To change 
job or to stop work had only minor financial complications for the man. 
The examination results concerning the work capacity were discussed with the 
participant and when he agreed with his personnel manager. The personnel 
general practitioner since Dutch law forbids an industrial physician to take 
curative measures himself. An exception to this situation is the provision of 
first aid in case of accidents (Nederlandse Staatswetten, 1974). During the 
study no need for such first aid existed. All examination data have been sent by 
letter to the general practitioners concerned (annex 17). 
Chapter IV 
Visits to the general 
practitioners 

4.1 Introduction 
After examination I, Baart (1973) gave a number of the participants the advice 
to contact their general practitioners in order to discuss the abnormalities 
which were found. In order to obtain an impression of the extent and nature of 
the corrective and curative measures taken, a large number of general 
practitioners to whom patients had been referred were contacted. After an 
introductory letter requesting co-operation, the author visited all these general 
practitioners at their homes or offices (annex 18 and 19). By means of a 
standardized questionnaire information was obtained regarding the medical 
policy that had been followed for these patients after the initial advice. He also 
asked the opinion of the general practitioners about a number of general 
aspects such as their opinion on screening examinations and the relationship 
between industrial medicine and their practices (annex 20 ). 
4.2 Organization 
After screening I, 129 participants have been advised to contact their general 
practitioners on the basis of the following findings: 
the serum cholesterol percentage was equal to or exceeded 3.0 g/1; 
the 2 hour value of the glucose tolerance test was 5.6 mmol/1 or over; 
the diastolic blood pressure (phase IV) during exercise rose to 100 mm Hg 
or over or the diastolic blood pressure during rest in recumbent position 
was 100 mm Hg or higher. 
These 129 participants were distributed over the practices of 108 physicians. 
The regional distribution of these general practitioners showed that 67 of them 
practised within the city limits of Rotterdam and 41 outside Rotterdam 
(annex 18). 
A questionnaire was drawn up by the author, in consultation with Prof. P.G. 
Hugenholtz, Prof. Dr. J.H. de Haas and colleagues of the Occupational Health 
Service for the port of Rotterdam and included the advice of several retired 
general practitioners. Next a pilot study was carried out in 12 Rotterdam 
practices, not included in the group of 108 general practitioners. 
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The questionnaire consisted of two parts (annex 20 ). Part I includes questions 
that aim at getting an impression of the treatment of the risk indicator(s) found 
in the participants. Part II contained the questions regarding the general 
opinion of the physician about screening procedures, of industrial medicine in 
particular and also of the communication between the screening team, the person 
examined and the general practitioner. The author entered the answers to the 
questions directly on the forms. At the Occupational Health Service the 
secretary checked whether the questionnaire was complete. The data were then 
filled in on a mark sensing form (annex 21). Before the mark sensing forms were 
handed in for processing another check for completeness was carried out by the 
male nurse. 
ChapterV 
Statistical methodology 

5.1 General 
All data collected from the COPIH questionnaire and by the examination 
including the exercise tests were transferred to punchcards at the "Institute 
TNO" for Mathematics, Data Processing and Statistics. The statistical 
evaluation of all data (the follow-up study and the information collected from 
the general practitioners) has been carried out at the Institute of Biostatistics 
of the Erasmus University at Rotterdam.* 
5.2 Statistical data processing 
5.2.1. Checking for the accuracy of the raw data 
The punched data were checked for accuracy as follows: 
a) extreme values 
All excessively high and low values on punchcards, as compared to stated 
borderline values, were checked against the data given in the records of 
the participants. Where errors were detected the data on the punchcards 
were altered accordingly. Data on borderline values have been given in 
annex22. 
b) consistency 
The response to mutually related questions entered on the punchcards 
have been checked for consistency. If not, the cause was traced and the 
punchcards were properly corrected. 
5.2.2. Descriptive statistics 
The information collected has been summarized with the aid of a number of 
statistics (Siegel, 1956; DeJonge, 1963, 1964 ): 
*) Head : R. van Strik 
Projectsupervision: Drs. H.J.A. Schouten 
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the sample mean: X = fr E x i 
the sample standard deviation: s.d. = ~ 1 -- ~ (x ,· _ x) 2 
n - 1 
the percentage elements in the sample with characteristic E: 
percentage = 100 x number of elements with characteristic E 
n 
In the formulas n symbolizes the total number of values Xi in the sample. 
Since the individual measurements fluctuate around their mean the standard 
deviation indicates the order of magnitude of the difference between an 
individual value and the mean value. In some cases this difference will be 
smaller, in other cases larger than the standard deviation. 
5.2.3. Statistical tests 
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Statistical significance of either observed differences as to means or 
proportions, or observed correlations, has been tested according to 
conventional methods described below. These tests have always been 
performed in a so-called two-step manner (Siegel, 1956; DeJonge, 1963, 1964). 
1. Rank tests 
The two-sample test of Wilcoxon, somethnes also called the Mann-
Whitney U-test, and Spearman's test for rank-correlation were employed. 
a) Wilcoxon's test 
This test indicates the degree of confidence of the assertion that two 
population means do or do not differ from each other. 
When the tail-probability Pis calculated, it is assumed that the two 
samples follow the same distribution i.e. stem from the same 
population. This is called the null-hypothesis. The credibility of this 
null-hypothesis is judged from the value of P, the probability under 
the null-hypothesis of the observed, or a larger, difference. P is 
obtained via the, approximately, unit normal deviate z. When P 
exceeds 0.05, it is normal practice to consider chance as the cause of 
the observed difference and no difference between the two 
populations has been demonstrated. When P is below 0.05 the 
difference is considered statistically significant and it is not likely 
that the difference is caused by chance. It must be kept in mind that 
significant differences are not necessarily important differences. It 
must also be evident that about 5 out of every 100 statistical tests 
may turn out to be significant when both samples have actually 
been taken from the same population. This must be taken into 
account when a large number of tests is performed and relatively 
few of these tests supply a significant result. This was found to be 
the case in the present study. 
b I Spearman's test 
Whether two variables are significantly correlated or not has been 
studied with Spearman's rank correlation test. 
2. Test for proportions 
5.3 
When a variable can assume only two values it is called a dichotomy. This 
is particularly so when possible answers are yes and no only ("no cpinion" 
left out of consideration). 
a. one sample 
Whether in a sample one question was significantly more frequently 
responded to than another question has been judged with the 
McNemar test. 
b. two samples 
Whether the tested populations gave in one sample a certain answer 
significantly more often than in another sample was checked with 
Fisher's exact test. 
Presentation of the results 
The results of screening I and II have been expressed in an uniform way by 
crosstabulation. This makes it possible to recognize changes of a certain 
characteristic with time. The tables have been composed according to the 
following principles which are illustrated here by the example found for serum 
cholesterol (table 5.1). 
Table 5.1: Crosstabulation of the serum cholesterol percentage(%) 
screening I screening II 
results j no second known g/1 
g/1 screening I , screening screening II < 2.6 2.6-2.8 2.8-3.0 
< 2.6 242 24 218 49.0 32.4 8. 1 5. 8 
2.6-2.8 85 13 72 16.2 5. 6 3.6 2.9 
2. 8-3.0 71 10 61 13. 7 2.2 1.8 5.2 
3.0-3.2 43 4 39 8. 8 0. 7 2.0 2.7 
> 3.2 60 5 55 12.4 0. 7 L3 1.3 
Total 501 56 455 100.0 41.6 16.9 18.0 
Numbers Percentages 
column column ! column column I column column T column column 
A B c D . E F \ G H 
' 
0. 2 % ::::: 1 person screening II 
mean 2. 66 g/l 
st. dev. 0, 42 
screening II - I 
v 0. 05 g/1 
3.0-3.2 )3. 2 
1.1 1.6 
--'----
2. 9 1.1 
2.9 1.6 
1.1 2.2 
2.7 6.3 
10.8 12.8 
column column 
I J 
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Column A: In this column the subdivision of the characteristic (e.g. serum 
cholesterol) has been expressed in groups (serum cholesterol 
percentage < 2.6 g/1; 2.6-2.8 g/1; etc.). 
Column B: In this column the division in groups of all participants in screening 
I has been expressed in absolute numbers (e.g. the number of people 
that had a serum cholesterol percentage < 2.6 g/1 etc. during 
screening I). 
Column C: Here the division in groups has been expressed in terms of those 
participants in screening I who did not participate in screening II 
(e.g. the number of people that did participate in screening I but not 
in screening II and that had a serum cholesterol percentage < 2.6 
g/1 at screening I, etc.). 
Column D: In this column the division in groups has been expressed as the 
absolute numbers of the participants in screening I and II. 
Column E: In this column the frequency division of column U has been 
expressed in percentages. The total of column D has been expressed 
as 100 per cent. 
Column 
F-J: 
In these columns the classification of the results of screening II in 
groups has been expressed in percentages of the total for every 
group formed during screening I for example, 49.0% of the 
participants in screening I and II had during screening I a serum 
cholesterol percentage < 2.6 g/1. This group divided during 
screening II into 32.4% still with a value <. 2.6 g/1 while 8.1% now 
had a serum cholesterol percentage of 2.6-2.8 g/1. 
The resnlts of screening I stated in the text regard people who participated 
both in screening I and in screening II (column F). All percentages have been 
calculated according to the formula described on page 62 . This may have the 
consequence that the subtotal calculated according to this formula deviates to a 
slight extent from the summarized subtotal as a result of the addition of errors 
resulting from rounding off percentages. 
Chapter VI 
The results of the repeat 
.. 
screening 

6.1 General 
The average time elapsed between screening I and II was 19 months (standard 
deviation 4 months; minimum 11 months; maximum 32 months). It was found 
for no obvious reasons' that the older participants were the first to return for 
screening I I. 
In fact between the data of the individual examination and the age of the 
person examined an inverse correlation was found (screening I: correlation 
coefficient: - 0.66 s < 0.001; screening II correlation coefficient: - 0.41 s 
< 0.001). From this follows that any correlation that may be demonstrated 
could suffer from a certain bias which may make the results statistically 
speaking incorrect. 
6.2 Anamnestic data 
Chest pain 
Of the 447 participants to screening II, 75 ( 16.8%) have stated both in screening 
I and II that they occasionally experienced chest pain (question B1, 2 and/or 3 
answered with yes). The location of the pain was in 26.7% precordial both in 
screening I and II (annex 23). When climbing steps 36.2% had chest pain, when 
excited 34.2% and with sudden temperature changes 9%. Not one individual 
from this group had any postprandial complaints. 
Hypertension 
During screening II when asked whether the participants had been aware of 
arterial hypertension, 88.4% responded negative and 11.6% positive. Of these 
52 participants ( 11.6%) in fact 37 were hypertensive at the time of screening II 
e.g. with an elevated diastolic blood pressure p 100 mm Hg, (phase IV). 
Twentysix participants said that they got no treatment in connection with the 
hypertension, 11 patients were prescribed a diet, 5 patients medication and 10 a 
combination of diet and medicines. 
Smoking 
The question "Have you ever smoked" has been answered affirmatively by 416 
participants during screening I and II. Eleven participants (2.5%) answered 
on both occasions that they had never smoked. Several changes in the smoking 
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pattern between screening I and II were observed (annex 24). In 19.9% it was 
found at both screenings that cigarettes were no longer smoked, 5.8% indicated 
that they smoked more and 22.2% stated that they smoked less. No change in 
smoking pattern of cigarettes took place in 51.9% of the participants. During 
screening II, 5.0% of the participants stated that they smoked more than 20 
cigarettes per day. 
6.3 Biometric and biochemical data 
The resting-electrocardiogram 
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The resting-electrocardiograms have been classified according to the criteria of 
the Minnesota Code. Following this classification a division has been made into 
five groups (annex 25). 
probable Ischemic Heart Disease ( IHD) (column 68 code 1 or 2 or column 
74 code 1); 
possible Ischemic Heart Disease ( IHD) (column 68 code 3 or column 72 
code 1, 2 or 3); 
slight ST or ST-J deviations (column 71 code 3 or 4); 
other deviations according to the Minnesota Code; 
no deviations. 
The findings of the screening are given in table 6.1. 
Table 6.1 Crosstabulation of the resting-ECG code(%) 
screening I 
code known 
screening IT 
0 197 
1 176 
2 1 
3 46 
4 9 
Total 429 
Numbers 
0.2% ~ 1 person 
Code 0: no deviations 
45.9 
41.0 
0.2 
10.7 
2.1 
100.0 
screening II 
code 
0 1 2 
33.8 9.3 
8.4 28.9 0. 2 
0.2 
2.3 3.0 
0.2 
44.8 41.5 0.2 
Percentages 
Code 1: other deviations according to the Minnesota Code 
Code 2: column 71 code 3 or 4 (slight ST or ST-J deviations) 
Code 3: possible Ischemic Heart Disease (IHD) 
Code 4: probable Ischemic Heart Disease (IHD) 
3 4 
2.1 0.7 
2.8 0.7 
5.1 0.2 
0. 2 1.6 
10.3 3.3 
The total number of electrocardiograms that were classified comes to 429 
1100% ). Of the participants present at both screening I and screening II, 45.9% 
appeared to have no deviations according to the Minnesota Code during 
screening I, with screening II 33.8% had again no deviations, 9.3% showed 
other deviations, 2.1% possible IHD, and 0.7% probable IHD. 
Possible IHD was found during the first screening in 10.7% of the participants. 
During screening II this group divided into 2.3% without deviations, 3.0% with 
other deviations, 5.1% with possible IHD and 0.2% with probable IHD. 
The systolic blood pressure in rest 
Systolic blood pressure measurements in rest are given in annex 26. At 
screening II the mean systolic blood pressure was found to be 3 mm Hg higher 
than at screening I. 
The diastolic blood pressure in rest (phase IV) 
The results of the determination of the diastolic blood pressure have been 
summarized in table 6.2. 
The table suggests for all groups a higher diastolic blood pressure during rest. 
At screening I, 20.7% of the participants had a diastolic blood pressure equal to 
100 mm Hg or over but at screening II, 38.9% of the participants were found to 
have this. At screening I, 2.9% had a blood pressure equal to 120 mm Hg or 
over. Half of this group still had a diastolic blood pressure equal to 120 mm Hg 
or over at screening II. Only 0.2% 11 participant) from this group had returned 
to normal values under 100 mm Hg at screening II. The mean diastolic blood 
pressure (phase IV) was during screening II 7 mm Hg higher than during 
screening I. 
Table 6.2 Crosstabulation of the diastolic blood 
pressure in recumbent position (phase IV) 
screening I 
results 1. no second known 
mmHg 
screening I '! screening screening II 
< 80 48 3 45 ! 10.1 
80- 90 172 ! 21 151 34.0 
90-100 171 ! 15 156 35.1 
100-110 ! 68 10 58 13.1 
110-120 25 4 21 4.7 
) 120 17 4 13 2.9 
501 57 444 100,0 
Numbers 
0. 2 % ::::: 1 person screening II 
mean 96 Hg 
st. dev. 10 
< 80 
1.1 
1.1 
0. 7 
2. 9 
screening II 
mmHg 
80-90 90-100 100-110 
3. 6 4. 5 o. 7 
8. 6 18.2 5. 8 
3. 6 15.1 11. 5 I 
0. 2 3.4 7.o I 
o. 7 ! 1. a I 
0.4 0. 4 ! 
16,0 42.3 1 27.2 1 
Percentages 
screening II - I 
V 7 mm Hg 
110-120 )- 120 
0. 2 
0. 2 
3. 6 o. 7 
1.8 0. 7 
1.4 0. 9 
o. 9 1.4 
8. 1 3. 6 
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The diastolic blood pressure in rest (phase V) 
At screening I and II, 51.4% and 36.0% respectively of the participants had a 
diastolic blood pressure under 90 mm Hg (phase V) (annex 27). A diastolic 
blood pressure between 80 and 90 mm Hg has been observed in screening I in 
38.4% of the cases. 
During screening II this group showed the following blood pressure levels: 
2.9%: < 80 mm Hg, 
15.7%: 80- 90 mm Hg; 
15.7%: 90- 100 mm Hg; 
4.0%: 100-110 mm Hg. 
Body length 
The results of the measurements of the body length are stated in annex 28. 
Body weight 
In annex 29 the results are given of the determinations of the body weight. On 
an average the weight has increased 0.3 kg. 
Quetelet index 
With the aid of the formula W IL2 x 10 the relation between length en weight 
(Quetelet index) has been expressed. In this formula L represents the length in 
metres and W the weight in kilogrammes. The results have been given in 
annex 30. 
Forced Expiratory Volume 1 sec. (FEV 1 sec.) 
As will be evident from annex 31 the average FEV 1 sec. was 2.52 litres 
(standard deviation 0.54) in screening II, which was 0.16 litres under the level 
of screening I. 
Forced Expiratory Volume 5 sec. (FEV 5 sec.l 
In screening II the average FEV 5 sec. has been 3.48 litres (standard 
deviation 0.60) which was 0.25\itres under the level of screening I. Further data 
are given in annex 32. 
Vital Capacity expiratory (V.C.) 
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The results of the determination of the Vital Capacity are rendered in annex 33. 
The average expiratory Vital Capacity was 3.67 litres in screening II (standard 
deviation 0.62) which was 0.31\itre under the level of screening I. 
Peak Expiratory Flow Rate 
The Peak Expiratory Flow (PEF) in screening I and II is given in annex 34. In 
screening I the average PEF amounted to 436 litres per minute I standard 
deviation: 891/m). As can he seen from annex 34 the average deviation between 
screening I and II was 3 1/m. 
The chest roentgenogram 
In annex 35 the findings have been expressed from the interpretation of the 
chest roentgenogram. In screening I emphysema (code 1) has been found in 22 
cases (5.0%). In screening II this picture has been observed only once (0.2%) in 
these 22 participants. An analogous result has been found for code 3 I elongated 
aorta or prominent aortic knob). In screening I this picture was observed in 82 
cases (18.6% ), while only 16 of these 82 participants demonstrated this 
appearance again in screening II. 
Haemoglobin 
During screening I 95.5% of the participants had an Hb percentage between 
8 mmol/1 to 11 mmol/1; in screening II this amounted to 97.8%. A haemoglobin 
percentage below 6 mmol/1 occurred in screening I in 0.2% and in screening II 
in 0.5% of those examined (annex 36). 
Cholesterol 
The results of the determination of serum cholesterol percentage of the blood 
are given in the following table. 
Table 6.3 Crosstabulation of the serum cholesterol 
percentage I%) 
screening I 
0. 2 % »:: 1 person screening II 
mean 2. 66 g/1 
st. dev. 0. 42 
screening II 
screening II - I 
v 0,05 g/1 
In screening I 21.2% of the participants had a serum cholesterol percentage of 
3.0 g/1 or over, in screening II this amounted to 23.6%. In screening I 51% had 
a serum cholesterol percentage over 2.6 g/1. In screening II these participants 
showed the following findings: 
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9% of the participants now had a serum cholesterol percentage of 2.6 g/1 or 
lower. 28% remained on the same level or had a slightly lower serum cholesterol 
percentage while 14% had a higher serum cholesterol percentage during 
screening II than during screening I. 
The average serum cholesterol percentage during screening II was 2.66 g/1 
(standard deviation: 0.42). It was 0.05 g/1 higher than during screening I. 
Total lipids 
The average total lipid percentage amounted to 7. 78 g/1 in screening II 
I standard deviation 1.32 ), which was 0.19 g/1 under the result of screening I. 
During screening I, 54% of the participants had a total lipid percentage under 
8.0 g/1. At screening II, 58% had a total lipid percentage under 8.0 g/1. Both in 
screening I and in screening II 0.4% of the participants had a total lipid 
percentage of 12 g/1 or over, although these were not the same participants. 
Details are given in annex 37. 
Blood sugar 
As is shown in annex 38 the average blood sugar percentage during screening 
II was 4.5 mmol/1 (standard deviation 0.9), which brings it 0.2 mmol under that 
of screening I. 
At screening I and II, 92.2% and 94.9% respectively of the participants had a 
fasting blood sugar below 5.6 mmol/1. During screening I, 1. 7% had a fasting 
blood sugar percentage of 6. 7 mmol/1 or over. At screening II this was 1.2%. 
None of the people examined during screening I with a blood sugar percentage 
below 4.5 mmol/1 (38.7% of the participants) had elevated values of 5.6 mmol/1 
or higher during screening II. 
The glucose tolerance test 
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An oral glucose tolerance test (G.T.T.) has been performed each time the blood 
sugar percentage was 5.6 mmol/1 or higher or a positive reduction of the urine 
was found. When an abnormal G.T.T. was found during screening I or 
pre-existed or the existence of diabetes mellitus was already known, no G.T.T. 
was carried out. The reasons for performing an oral G.T.T. are summarized in 
table 6.4. 
Table 6.4 Reasons for performing an oral G.T.T. 
during screening I and II 
screening I screening II 
fasting glucose )5. 6 mmol/1 20 8 
positive reduction in urine 2 8 
fasting glucose )5. 6 mmol/1 in 
combination with positive 5 2 
reduction in urine 
total 27 18 
total 
28 
10 
7 
45 
As shown in the above table, the indication for performing an oral G.T.T. 
during screening I was in 25 out of the 27 G.T.T.'s a fasting blood sugar 
percentage > 5.6 mmol/1. With 27 participants in screening I an oral G.T.T. 
was performed and with 18 during screening II which resulted in a two hour 
value > 5.6 mmol/1. In these individuals no follow-up of the G.T.T. took place. 
Table 6.5 Relation between the baseline percentage of 
the G.T.T. during screening I and the 
fasting blood sugar percentage in screening II 
fasting blood sugar 
blood sugar baseline blood sugar percentage screening II 
percentage percentage G. T. T. 
( 5. 6 mmol/1 ) 5. 6 mmol/1 
< 5, 6 mmol/1 14 14 0 
). 5. 6 mmol/1 11 5 6 
total 25 19 6 
In table 6.5 the fasting blood sugar percentage during screening I is compared 
with the baseline percentage of the G.T.T. and the fasting percentage during 
screening II. The data show that at the time of the G.T.T. 14 out of 25 had a 
baseline blood sugar percentage < 5.6 mmol/1. These 14 participants had 
during screening II also a fasting blood sugar percentage < 5.6 mmol/1. In 11 
participants a baseline blood sugar percentage ·;;, 5.6 mmol/1 was found. Six of 
these had during screening I a fasting blood sugar percentage ) 5.6 mmol/1. 
The exercise test on the ergometer bicycle 
The exercise test could be carried out at screening I and II in 430 participants. 
The respiratory frequency, cardiac frequency and systolic blood pressure 
during exercise in the last comparable minute are given in the tables 39, 40 and 
41. There were no significant trends when the results of these items were 
compared during screening I and II. 
The electrocardiogram during exercise 
In table 6.6 the results of the exercise-ECG's are summarized. The exercise-
EGG's are classified in 2 groups. One group includes the ECG's with an 
ST-segment depression of 1 mm or over during the exercise- and during the 
recovery phase. The second group includes the remaining ECG's (table 6.6). 
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Table 6.6 Crosstabulation of the exercise·electrocardio· 
grams 
screening I screening II 
~1 mm ST-depression 
during exercise 
± during reco- only during the 
very phase recovery phase 
during exercise 
~ :t during reco- 23 16 
> 1 mm ST- very phase 
"' depression ~ only during the 6 2 
recovery phase 
other characteristics 401 11 7 incl. a normal exercise-ECG 
total 430 27 9 
other characte-
ristics incl. a 
normal exercise 
ECG 
7 
4 
383 
394 
During screening I in 29 of the 430 exercise-ECG's an ST-segment depression of 
1 mm or over was seen, 23 times during the exercise and recovery phases. or only 
during the exercise phase and 6 times only during the recovery phase. During 
screening II this finding was again present in 18 instances. Of the 6 
participants with abnormalities in the recovery phase 2 had these findings 
again during screening II and 4 now had no abnormalities. With screening II in 
18 participants an ST-segment depression of 1 mm or more was observed. A 
complete left bundlebranch block was found twice, both in screening I and II 
and a rate dependent left bundlebranch block was found in screening II in one 
participant. 
6.4 The results of the 
general practitioners 
visits to 108 
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The visits to the general practitioners took place between the middle of August 
and November 1974. A distance of 4,386 kilometres has been covered by car in 
order to reach the general practitioners at their homes. The average length of 
the interview amounted to about 45 minutes. Of the 108 practising physicians 
who together provided 129 patients, 5 refused the interview. All these 
physicians lived within greater Rotterdam. The motivation for their refusal has 
been varied: 
"I consider it ethically unjustified to discuss my patients with an 
industrial physician"; 
"I am too old to consider my opinion of any importance for you"; 
"No time, you can screen as much as you like"; 
"I don't want to waste any time on this"; 
"Not interested". 
The bulk of information has been collected from the remaining 103 general 
practitioners who took care of 122 patients. 
The intervention policy carried out by the general practitioners 
A letter with relevant patient information, found during screening I and II was 
sent to the general practitioner concerned. In total some 122 letters were sent to 
these doctors. These were received in 113 instances during screening I and 
during screening II in 110 cases. One hundred and twenty of the 122 patients 
had an obligatory health insurance. One hundred and fourteen of them had an 
health insurance policy with their general practitioner for more than 12 months. 
A hundred and twenty two participants were advised to visit their doctor. It 
was found that only 72 of them in fact went to see their doctor. This happened in 
68 cases because the participant decided to go and in 4 cases at the initiative of 
the general practitioner. The reason why they visited their physician varied. 
Hypertension was the cause in 11 participants, hypercholesterolemia in 43, an 
abnormal G.T.T. in 8, hypertension in combination with hypercholesterolemia 
in 4, hypertension in combination with an abnormal G.T.T. in 2, and 
hypercholesterolemia in combination with an abnormal G.T.T. in 4 
participants. 
The intervention measures have been analysed for each of these three items. 
Hypertension 
In the 17 instances with hypertension treatment was given to 14. In 9 
cases this was on the initiative of the general practitioner who in 5 
patients consulted a specialist. In 3 cases no treatment was given because 
during the re·measurement by the general practitioner blood pressure was 
normal.In one instance a specialist stated that no treatment was 
necessary despite the existence of hypertension and once the general 
practitioner did no further examination. The treatment consisted in 6 
patients of antihypertensive drugs, in 7 cases of a low salt diet and in 1 
case of a combination of these. In 6 of the 14 patients the initial treatment 
program was subsequently changed. The follow·up of the patients with 
hypertension showed that 6 were controlled at least 4 times a year, 5 were 
seen at least 2 times a year and 1 once a year. Although he was given 
treatment one patient was not controlled at all and in one instance the 
control frequency could not be elucidated by the general practitioner. 
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Hypercholesterolemia 
The intervention policy could be analysed in 51 patients. Treatment was 
started in 34 patients, 30 times by the general practitioner, 3 times by a 
specialist and once by a dietician. In 17 patients no treatment was given 
at all. In 13 of these cases no re-examination of the serum cholesterol was 
carried out and in 4 cases again no treatment was begun in spite of 
confirmative re-examination results. The treatment given consisted in 24 
cases of a cholesterol lowering diet, in 9 of a diet in combination with 
cholesterol lowering medication while in one the exact treatment could not 
be verified. In one patient the treatment program was changed when a 
cholesterol lowering medication was added to his diet. In 13 of the 34 
patients with hypercholesterolemia regular follow-up and re-examination 
took place. Four of these were controlled at least 4 times a year, 7 at least 
2 times and 2 at least once a year. Of 3 patients the follow-up frequency 
could not be established in the files of the general practitioners. 
The Glucose Tolerance Test 
Of 14 participants with an abnormal G.T.T., 9 received treatment, 5 from 
the general practitioner, 4 from a specialist and in one case the physician 
had no information. In 4 cases no treatment was given. In 3 of these 4 no 
supplementary diagnostic measurements were performed while in one 
case the specialist advised not to treat the participant. The initial 
treatment consisted in 3 patients of the advice to reduce the sugar 
consumption in the diet and in 5 cases of a special diet in combination 
with oral hypoglycemics. In one case the manner of treatment could not 
be elucidated. Changes in treatment, a different kind of oral hypo-
glycemic, occurred for 2 participants. Systematic follow-up was carried out 
in 7 cases. In 3 at least 4 times a year, 2 at least 2 times a year and 2 at 
least once a year. One patient was not followed at all and in another 
patient the control frequency could not be established. 
Opinions of 103 general practitioners concerning screening examination 
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Of the general practitioners visited, 85.5% consider the organization of large 
scale screening examinations to trace cardiovascular diseases in The 
Netherlands significant. A negative attitude towards this matter was 
encountered in 9. 7%. 
Of the physician 85.4% think that this screening ought to be done by 
screening teams, while 12.6% are of the opinion that the general practitioner is 
the right man to do so. The majority of the general practitioners (97%) think 
that they can follow and care for people who, during a screening examination 
would appear to have an increased risk to contract cardiovascular diseases. One 
general practitioner is of the opinion that it will be absolutely impossible for 
him to take care of the follow-up. 
Eightyfive and a half per cent of the doctors expect a favourable influence on 
the physical health condition of the people with a cardiovascular screening 
examination every third year. A favourable effect on the mental health 
condition was expected by 69.9%. Of the general practitioners, 48.5% expect no 
change in the number of visits to their consulting hours when a cardiovascular 
screening examination would be performed every three years; 43.7% expect a 
higher attendance and 6.8% expect less busy consulting hours. 
According to 93.2% of the physicians the decrease of the cardiovascular risk 
indicators in adults under 40 years will bring about a decrease in the chances on 
acquiring cardiovascular diseases. For the age groups 40-55 years, 55-65 years 
and 65 years and over this is 91.3%, 77.7% and 63.1% respectively. Only 5.8% of 
the general practitioners considered screening in their own practices possible 
for adults under 40, for the age groups 40-55 years, 55-65 years and > 65 years 
these percentages were 8.7, 5.8 and 5.8 respectively. In 69.9% of the cases lack 
of time was given as the major reason that no screening can be performed. 
Other factors that play a part: too busy a practice (8.7%), inadequate 
knowledge of ECG's ( 6.8% ), insufficient staff (5.8% ). 
Of the general practitioners visited, 17.5% own or have ECG equipment at their 
disposal, 22.3% claims to judge the ECG's themselves. When during a 
screening examination no abnormalities are found slightly over half of the 
general practitioners think that this should be told to the person examined by 
the screening team. In 38.8% the opinion was voiced that this ought to be done 
by the general practitioner himself. In the case of borderline deviations, these 
percentages are 20.4 and 77.7 respectively and for outright pathology 12.6 and 
87.4 respectively. The replies to these questions were found to be consistent. 
When borderline deviations have been found 61.2% considered it acceptable 
when the screening teams give suitable advice while 36.9% consider this not 
acceptable. 
A great many general practitioners feel the need to refer people to a 
cardiovascular screening team at their own request. In 46.6% this is frequently 
felt, 22.3% would do so occasionally and 30.1% claim to feel no need for this 
avail. Most of the general practitioners (92.2%) would appreciate information 
regarding a medication or a reference advice. In 7.8% no advice is needed. 
Extensive information is wanted in 42.7% while 57.2% would be content with 
concise information. The performance of screening examinations by an 
industrial health service was considered correct in 88.4%, only 7.8% objects 
against this. As reason for performing screening examinations by an industrial 
health service 39.8% considers the interest of man first, in 17.5% it was the 
interest of the employer and in 42.7% the opinion was given that both interests 
are of equal importance. 
Favourable experiences with industrial physicians existed in 76.7% of the 
general practitioners. Not so favourable experiences were reported in 6.8%. The 
number of years that the general practitioners were practising actively were in 
15.5% .( 5 years, 14.6%, 6 to 10 years, 22.3%, 11 to 15 years, 13.6%, 16 to 20 
years, 13.6%, 21 to 25 years, 20.4% > 26 years. The size of the practice was in 
5.8% less than 2000 patients, in 16.5% 2000-2500 patients, in 15.5% 2500-3000 
patients, in 27.2%, 3000-3500 patients and in 34.9% more than 3500 patients. 
Fourty seven general practitioners (45.6%) had additional functions. These 
additional functions demanded less than 4 hours per week for 19 physicians; for 
12,4 to 8 hours; for 9, 8-16 hours and for 7 more than 16 hours. There appeared 
to be no relation between the number of years that these physicians had been 
practising (question 42) and the size of their practice I question 38 ). Also the 
size of the practice or the number of years of experience appears to have no 
influence on the replies to questions 21, 23, 24.1, 25, 28, 32, 33, 34 and 41 
(annex 20). 
Physicians in practice for more than 26 years are slightly more often of the 
opinion that a three yearly screening (question 24.2) may have a negative 
influence on the mental health condition of the people than the younger 
physicians. There is no relation with the size of the practice. Four general 
practitioners with practices of more than 3500 patients, and who had been 
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practising over 16 years, were of the opmwn that a decrease in the risk 
indicators would not decrease the chance of cardiovacular diseases in adults 
under40. 
Three physicians had no opinion in this matter and 96 expected a favourable 
effect (annexes 42 and 43). Physicians with smaller practices were more often of 
the opinion that they can screen adults under 40 themselves than the 
physicians with more comprehensive practices (question 27.1). For the other 
age groups (questions 27.2, 3 and 4) no differences can be demonstrated. The 
number of years of practising experience has no influence on the answering of 
question 27. 
As the severity of the abnormalities found increases, more physicians, 
regardless size of their practice or their years of experience, are of the opinion 
that the doctor himself should inform the result of the screening examination to 
the person examined (annexes 44 and 45). When no special details have been 
found general practitioners with busy practices prefer that the results are told 
to the person examined by the screening team. Although physicians with one or 
more additional functions are generally older than physicians without 
additional functions a relation with the size of the practices could not be 
demonstarted. 
Chapter VII 
Discussion of the results 

7.1 General overview and relevance of 
the investigation 
Wilson and Jungner have summarized ten conditions which a screening 
examination, designed for early disease detection, must meet in principle 
(WHO, 1968; Whitby, 1974). In this chapter the results of this selective 
multiphasic screening will be discussed in relation to these prerequisites. 
1. "The condition being sought should be an important health 
problem, for the individual and the community" 
The results of epidemiologic research over the past decade to detect cardio-
vascular disease in the "industrialized" countries have emphasized the 
significance of this disorder for the community and the individual !Stamler, 
1970; Lew, 1973; Blackburn, 1974; De Haas, 1975). Hypertension, smoking 
and an increased serum cholesterol percentage are risk indicators which 
increase the chances on contracting coronary heart diseases. In our population 
of 447 dockworkers about 30% of the participants had a systolic blood pressure 
~ 160 mm Hg and 39% a diastolic pressure > 100 mm Hg. So hypertension is 
an important health problem in this population too. The same applies to 
smoking. Of the persons examined 422 said during screening I and/or II to 
smoke cigarettes, and 44.1% of them smoked more than 10 cigarettes per day. 
A serum cholesterol value )- 2.6 g/1 is found in 58.4%. This information 
represents but the tip of the proverbial iceberg because it shows nothing about 
preclinical and clinical disease. In keeping with the first rule by Wilson and 
Jungner the screening fore the occurrence of cardiovascular diseases in older 
dockworkers can be classified as an activity which qualifies an important health 
problem both for the individual and for the community. 
2. "There should be an acceptable form of treatment for patients with 
recognisable disease" 
Since so far it has been impossible to identify one single cause for the origin of 
coronary heart disease, which implies that there can be no causal therapy. In 
stead, a number of risk indicators which considerably increase the chances on 
contracting coronary heart diseases have been identified. Of these, the major 
risk indicators are high blood pressure, smoking and an increased serum 
cholesterol percentage (Stamler, 1970; Froelicher, 1972; Blackburn, 1974). 
Since each of these 3 risk indicators can be modified, they should be of 
importance in the prevention of coronary heart diseases. Now how far has the 
evidence for "acceptable form of treatment or prevention" accumulated? 
High blood pressure 
I'he Veterans Administration Co-operative Study Group (1967, 1970) has 
demonstrated that effective treatment of patients with hypertension in the age 
group 40-60 years is possible. While the effect on reduction of cerebrovascular 
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stroke has been clear cut, the effect on coronary artery disease has been less 
convincing. Nevertheless, antihypertensive treatment is favourable in the view 
of CVD. However, it has appeared in practice that effective treatment is 
extremely difficult to sustain !Wilber, 1972a, 1972b; Schoenberger, 1972). 
Analysis of the intervention policy in 24 participants who during screening I 
had a diastolic blood pressure ~ 100 mm Hg !phase IV) both under resting 
conditions and during exercise, showed that only 17 of them went to their 
general practitioners. In 14 persons, treatment was given which consisted of 
antihypertensive drugs with or without a low salt diet. None of them had a 
diastolic blood pressure below 100 mm Hg at screening II. One of the reasons of 
the disappointing result may be that this form of treatment is unacceptable for 
those persons. 
Smoking 
About 7% of the participants who still smoked during screening I indicated 
during screening II that they did not smoke cigarettes anymore. However, 6% 
said to have increased the number of cigarettes daily smoked. The WHO expert 
Committee 11975) stated that: "cigarette smoking is an important cause of an 
increased risk of ischemic heart disease, contributing both to the athero-
sclerotic process itself and to the condition that precipitates a heart attack and 
determines a fatal outcome". "Smoking related diseases are such an important 
cause of disability and premature death in developed countries that the control 
of cigarette smoking could do more to improve health and prolonged life in 
these countries than any other single action in the whole field of preventive 
medicine''. 
Modification of the smoking habits can be done by motivating people to stop 
smoking, by reducing tobacco dosage and by reduction of the harmful 
components in tobacco smoke (WHO, 1975 ). Our results confirm that the actual 
"treatment" of smokers is very difficult and in this small series it proved 
impossible to modify the habit in a significant manner. 
Increased serum cholesterol percentage 
The significance of an increased serum cholesterol percentage for the 
development of atherosclerosis has been shown in many studies !Higgins, 1965; 
Stamler, 1970; Lew, 1973). There are indications that a decrease of the serum 
cholesterol percentage is accompanied by a decrease in the occurrence of 
coronary heart disease !Stamler, 1970; Evans, 1972; Miettinen, 1972; Black-
burn, 1974). 
Of 89 participants with a serum cholesterol level ~ 3.0 g/1 during screening I, 
51 seeked the help of their physician. Treatment was started in 34 patients and 
consisted (;fa cholesterol lowering diet in combination with cholesterol lowering 
medication. In only 5 patients seen at screening II a decrease in serum 
cholesterol percentage to less than 3.0 g/1 was noted. 
Then there is the sobering fact that in the 38 persons who did not visit their 
general practitioner 18 had a lowering of the serum cholesterol to 3.0 g/1 or less. 
It is not clear whether this result may be explained as a regression towards the 
mean or as a result of the general campaign to lower fat intake in The 
Netherlands. 
It must be concluded that causal "treatment" of people with recognisable 
disease is not very rewarding, although lowering of the risk indicators is 
possible in principle and good evidence that it will decrease the CHD risk is 
available. Again unacceptability of the present form of treatment may be one of 
the explanations. Onother reason could be that the guidance and follow-up has 
not been sufficiently consistent or constant. 
3. "The natural history of the condition, including its development 
from latent to declared disease, should be adequately understood" 
It has been demonstrated that coronary risk indicators like hypertension, 
smoking and elevated serum cholesterol percentage increase the susceptibility 
to premature coronary heart disease (Froelicher, 1972; Blackburn, 1974). This 
relationship is cumulative in that with each additional step the total risk is 
increased. Furthermore the excess risk is proportionally greater for younger 
men (Stamler, 1970; Lew, 1973; WHO, 1975). Since reduction of blood 
pressure, cessation of cigarette smoking and lowering of the serum cholesterol 
percentage have been shown to lead to a reduced mortality rate from ischemic 
heart disease, the fact that natural history is not adequately understood formed 
one additional stimulus to conduct this (longitudinal) study. 
4. "There should be a recognisable latent or early symptomatic stage" 
In 1974·1975, the state of medical knowledge does not permit the recognition of 
latent disease, since most diagnostic tests fail in this respect. Only coronary 
artery arteriography could be considered as reliable in this regard and it is 
obviously not suited as a screening technique on a large scale, although it has 
been done in selected asymptomatic groups such as aircraft pilots (Froelicher, 
1973). In the next paragraph the inadequacy of the next most frequently 
employed test for the determination of latent disease, the exercise test, is 
described consequently. One is forced to state that condition 4 cannot he met. 
5. "There should be a suitable screening test or examination for 
detecting the disease at the latent or early symptomatic stage, and 
this test should be acceptable to the population" 
When the consequences of atherosclerosis manifest themselves in the form of 
coronary heart disease, cerebrovascular or peripheral vascular diseases, 
extensive damage usually has already been done to these arteries and organs. 
An impression of the damage done to the heart can be obtained from the 
electrocardiogram, particularly during exercise. Simoons ( 1973) stated on the 
basis of a literature study that an ST·segrnent depression of 2 mm or more 
( 0.2 m V) during exercise was accompanied in a very large proportion of 
the cases by obstructive coronary artery disease (specificity 98% ). In most of 
these cases however the disease has reached the symptomatic stage. When the 
more readily found criterium of a 0.5 mm ST decrease was used as a limit, 
sensitivity declined to 83% and specificity to 67%. Follow·up data on 2, 700 
subjects who had had maximum stress tests showed that a positive test, 
characterized by ST·segment depression > 1.5 mm, predicted an incidence of a 
new coronary event of 9.5% a year, compared with 1. 7% in those who had a 
negative test (Ellestad, 1975). Froelicher (1974) demonstrated in a follow·up 
study of 1,390 asymptomatic men that "maximal treadmill testing 
demonstrated a 60.9% sensitivity, 92% specificity and 20% probability that 
coronary artery disease would develop in a subject with an abnormal response. 
However, neither a normal test nor an abnormal test predict the future ominious 
presentation of coronary artery disease. In appropriate instances when the 
minimal risk of coronary angiography is justified, this invasive procedure can 
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determine the anatomic correlation of exercise induced ST-segment changes. 
While an important advantage of the electrocardiogram as a screening test is 
that it does not cause unacceptable discomfort even during exercise it does not 
give reliable information about the condition of the coronary arteries in 
asymptomatic individuals. Furthermore, since the effort and time involved are 
considerable, the exercise-electrocardiogram cannot be applied for mass 
screening. During screening I in 29 of the 430 exercise-ECG's an ST-segment 
depression- ;> 1mm was seen, 23 times during exercise and 6 times only during 
the recovery phase. During screening II this finding was again present on 16 of 
the 23 ECG's with abnormalities during exercise and/or recovery phase and in 
2 of the 6 with only post exercise ST-segment depression. The follow-up time is 
too short to say anything about the prognostic value of our results but the data 
in the present study are consistent with the observations made elsewhere that 
condition 5 cannot be readily met. 
6. "The facilities required for diagnosis and treatment of patients 
revealed by the screening programme should be available" 
In order to investigate this aspect of the study the response of the medical 
community to the screening program was tested. Since the findings during 
screening I and II were reported in each case, the response of the general 
practitioner holds a key position in the delivery of medical care. About 70% of 
the people in The Netherlands are members of a sickfound and have to be 
inscribed in the list of a general practitioner. The general practitioner's 
response is therefore quite essential in evaluating the efficacy of screening 
programs. Most ( 85.5%) of the general practitioners interviewed considered the 
organization of a large scale screening effort by a screening team to trace 
cardiovascular diseases in The Netherlands significant. The majority of the 
general practitioners (97.7%) think that they can follow-up and care for people 
who are detected as having a positive risk during a screening. This expectation 
is in great contrast with the results of our intervention study. Lowering of 
blood pressure to normal levels was never reached and only rarely a lowering of 
the serum cholesterol level was achieved. Nevertheless 77.7% of the general 
practitioners state that they expect a favourable influence of the decrease of 
risk indicators in the age group 55-65 years on cardiovascular diseases. 
Although theoretically the general practitioners in The Nether lands are in the 
key position to effectuate lower risk indicators in high risk individuals, yet our 
study results do not concur with this theory. 
7. "There should be an agreed policy on whom to treat as patients" 
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This prerequisite was most easily implemented. All participants of screening I 
were referred to their general practitioner when they had a diastolic blood 
pressure ;> 100 mm Hg both during resting and exercise, a cholesterol 
percentage.;;;, 3.0 g/1 or a 2 hour G.T.T. value 3 5.6 mmoVI or a combination of 
these factors. For hypertension effective therapy with antihypertensive drugs 
is now pos,sible (Veterans Administration Co-operative Study Group, 1967, 
1970 ). It is also not controversial to recommend cholesterol lowering diets 
(Stamler, 1970; Evans, 1972; Miettinen, 1972; Blackburn, 1974). In chemical 
diabetes a diet low in sugar is readily prescribed since there is moderately 
strong evidence that treatment with tolbutamide or phenformin may be 
harmful (Kiimt, 1970; Blackburn, 1974; Chalmers, 1975; Gilbert, 1975). 
However, each of these methods of treatment require a regular follow-up of the 
patients. Since it was found that only 72 out of 122 participants who received 
the advice to visit their physicians in fact went to see their doctors, one wonders 
about the "agreed policy" however. In total these 72 participants had 82 
abnormalities. Twentyfive of these abnormalities were not treated at all and in 
7 not one follow-up took place. The "agreed policy" does not work at all in over 
one third of those screened to have definite abnormalities. Particularly the 
finding that during screening II all 17 found to have high blood pressure in 
screening I were still hypertensive was highly disappointing. Also only 13 
patients out of 34 had regular follow·up and re-examination for their elevated 
cholesterol levels. Just five of them saw their serum cholesterol levels decline to 
below 3.0 g/1 during screening II. Then there is the sobering fact that in 38 
participants who did not visit their doctors 18 persons had "spontaneous" 
lowering of serum cholesterol to below 3.0 g/1. On the other hand of the 14 
persons with an abnormal G.T.T. 9 received treatment. There the need for 
treatment and follow·up was best understood and accepted by the general 
practitioners. These results emphasize the findings of Wilber ( 1972b) that while 
in principle there excists good agreement about whom to treat, practice 
demonstrates otherwise if not the opposite. 
8. "Treatment at the pre-symptomatic, borderline stage of a disease 
should favourably influence its course and prognosis" 
As the results of the literature survey show, treatment of hypertension and 
hypercholesterolemia favourably influences CHD risk. The same applies to the 
reduction of smoking (Veterans Administration Co-operative Study Group, 
1967, 1970; Stamler, 1970; Evans, 1972; Miettinen, 1972; Blackburn 1974; 
Doll, 1974; WHO, 1975). In the present study the mean follow-up time was only 
19 months. In this short tiroe no meaningful morbidity or mortality analysis 
can be carried out. Prerequisite 8 remains unfulfilled. 
9. "The cost of case-finding (which would include the cost of diagnosis 
and treatment) needs to be economically balanced in relation to 
possible expenditure on medical care as a whole" 
An impression of the cost of case· finding may be obtained from the following 
figures: 
per examination total 
Screening I: 1971 
cost of a single examination Hfl. 260.-
loss of productivity during a half working 
day of a participant Hfl. 75.-
costs per active participant 
number of examinations: 503 
+ 
Hfl. 335.-
Hfl. 168,505.-
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Screening H: 197 4 
cost of a single examination Hfl. 340.-
loss of productivity during a half working 
day of a participant _H_fl__:._. __,9:o:O:_. -~ 
+ 
costs per participant 
number of examinations in working 
participants: 327 
number of examinations in inactive 
participants: 120 
Hfl. 430.-
Hfl. 140,610.-
Hfl. 40,800.-
+ 
Hfl. 181,410.-
The WHO ( 1975) states about smoking "It should be kept in mind that 
economic cost-benefit studies are not conclusive, since the true gain from 
reducing smoking will be in human terms and in the reduction of ill·health and 
of premature death, rather than merely in. mortality terms". This can also be 
stated for the other risk indicators while no clear cut answer can be given to this 
prerequisite the cost per examination seems to be reasonable if not 
"economically balanced". However when one considers the total number of 
patients in whom one or more abnormalities exist and in whom no follow·up 
was done and one divides these costs into the small number in whom 
intervention did result the co;;ts per positive screening intervention rise 
considerably. In fact they then may be considered to be prohibitive. E.g. the 
costs of 44 7 serum cholesterol determinations during screening I were 
Hfl. 5,587.50. There were 89 positive findings. This makes Hfl. 62.78 per 
positive finding. Only 5 of them had an "effective" treatment. This results in 
Hfl. 1,117.50 per "effective" treatment. This is of course a "tongue in cheek" 
calculation. 
10. "Case-finding should be a continuing process, not a "once and for 
all" project" 
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The fact that new cases were found during screening II demonstrates the need 
for a continued effort in order to achieve optimal health care for older 
dockworkers. Despite the disappointing results of the intervention policy thus 
far, every effort must be made to achieve better co-operation between 
screening team, general practitioner and patient. 
All ten prerequisites of Wilson and Jungner taken together, screening I and II 
"make the grade". Investigations to detect the occurrence of cardiovascular 
diseases are activities qualifying an important health problem, both for the 
individual and for the community. While the presymptomatic stage is not 
recognisable with the screening tests used, the risk indicators accelerating the 
disease, e.g. hypertension, hypercholesterolemia and smoking can be identified. 
Treatment of patients with these risk indicators favourably influences the 
course and prognosis of the cardiovascular diseases. Despite the - up to now 
- desillusioning intervention results and notwithstanding the mounting costs 
the fact that new cases were found during screening II indicates the need to 
continue screening with particular emphasis on more systematic treatment and 
follow-up facilities. 
7.2 Details of the repeat screening 
When the results of screening I and II are compared in an individual case 
attention must be given first to interlaboratory and next to interobserver 
differences. During a pilot study conducted to compare the results of the serum 
cholesterol and blood sugar determinations in our laboratory with those 
determined at the reference laboratory, the Gaubius Institute of the 
department of Biochemistry in Leyden University, it was found that there were 
no differences of major or practical significance. 
Higgins (1965), Rose (1965) and Elgrishi (1969, 1970) have made it clear that 
the description and interpretation of resting-ECG's, even when a standardized 
protocol is followed, provides no guarantee for the avoidance of intra- and 
interobserver differences. Re-classification of the 927 resting·ECG's of 
screening I and II by one trained observer has confirmed these findings. Details 
of these discrepancies are given in table 7 .1. 
Table 7.1: Results of the initial and re-classification of 
the resting-ECG's conform the Minnesota 
Code(%) 
initial classification reclassification 
code N % code 0 code 1 code 2 
0 407 43.9 37.0 ' 6.8 
1 357 38.5 5.2 32.fr 0.1 
2 3 o. 3 0.1 0.1 
3 124 13.4 2.3 1.2 
4 36 3.9 0.5 0.6 
total 927 100.0 45.0 41. 3 0.2 
code 3 code 4 
0.1 
0.4 0.2 
0. 1 
9.9 
0. 5 2.3 
11. 0 2. 5 
The data in table 7.1 indicate a considerable shift within all groups after 
re-classification. These shifts probably are caused by some improvement and 
possibly more accurate measurement by the observer. Comparison in a test 
group of the code of the re-classification of every tenth resting-ECG with the 
code of a third classification made by another trained observer shows that there 
was now agreement in only 76.8% of the cases. 
From table 6.1 it may be concluded that in the short period between screening I 
and II, no large changes occurred in the resting·ECG's in this group of 
dockworkers and that code 2 - slight ST or ST-J depression - occurs in this 
population so rarely that it in fact may be deleted. 
Particularly since its prognostic value is limited, caution must be exercised 
when advice is given on basis of these resting-ECG findings (Rose, 1971 ). 
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Blood pressure 
The mean systolic blood pressure in all 44 7 individuals during screening H is 3 
mm Hg higher than that during screening I. The diastolic blood pressure in 
phase IV is 7 mm Hg higher and in phase V 5 mm Hg higher. The protocol used 
defines the diastolic blood pressure as the lowest pressure of two observations 
made by one observer during screening I and by two observers during 
screening II. The observers were not the same in screening I and II. The 
differences in diastolic blood pressure between screening I and II are probably 
mainly caused by interobserver differences and only partly related to age (Lew, 
1973). Of 24 participants with a diastolic blood pressure (phase IV) ?-100 mm 
Hg during screening I the intervention policy was looked at. It was found 
during screening II that despite treatment in 14 of the 24 individuals all still 
had a diastolic blood pressure > 100 mm Hg. These data justify the conclusion 
that the intervention policy whenever followed, has not resulted in a decrease of 
this particular risk indicator and that whatever differences were found must be 
ascribed to interobserver variations. 
Chest roentgenogram 
The follow-up results of the chest roentgenograms are equally disturbing. Since 
the incidence of emfysema (code 1) and "elongated aorta" (code 3) are reversed, 
it is likely that the classification system is of little value. This time 
interobserver differences can be excluded as a cause since the observers during 
screening I and II were the same. Despite a double reading system 
intraobserver variation must be the main reason for the discrepancies. The 
chest roentgenogram may well be omitted in future screening efforts when used 
as a comparative tool. 
Haemoglobin 
A haemoglobin percentage below 6 mmol/l occurred in 0.2% and in 0.5% during 
screening I and II respectively. Medalie (1973) also observed in only 17 (0.17%) 
out of 10,000 men over 40 years haemoglobin value below 6.2 mmol/l. Again 
this determination appears to have little value in a screening program for an all 
malle population. 
Cholesterol 
In spite of the recommendations given on the basis of screening I the mean 
serum cholesterol remained at the same level. Actually the value has the same 
level as found by Karvonen (1959), Johnson (1965), De Wijn (1972) and May 
(1974) in their studies in different populations. Only in a few instances a 
decrease of this risk indicator could be ascribed to the intervention study. 
Smoking 
De Haas reported in 1973 a decrease in the number of cigarette smokers in The 
Netherlands male population. This was also found in this study carried out over 
the same period. The percentage of non smokers increased from 21.3% during 
screening I to 27.3% during screening II and 22.2% of the participants declared 
that they smoked less. Although these changes are statistically hardly 
convincing they may indicate a trend. It is likely that this trend was 
encouraged by several measures taken in the country as a whole rather than by 
the efforts of the screening team or physicians, as the latter did not make a 
specific effort at counseling against smoking. 
Glucose tolerance 
In view of the limited therapeutical possibilities and the not clearly 
demonstrated preventive effect of treatment in individuals with an 
asymptomatic diabetes mellitus this test has little importance at the present 
time. The lack of definite boundaries between normal, borderline and 
pathological values for glucose tolerance adds to the difficulties. In table 7.2 the 
results of the G.T.T. are classified in percentile groups (annex 6), as shown 24 
participants with a fasting blood sugar > 5.6 mmol/1. 
Table 7.2: Classification of G.T.T.'s during screening I (annex 6). 
total n = 24 * 
general practitioner - no general practitioner -
participant contact (n = 13) participant contact (n = 10) 
percentile n treatment control n 
Abnormal < 1.0 3 2 2 1 
1 - 5 1 1 1 
-
Borderline 6 - 10 1 1 1 1 
Normal 11 - 20 - - - -
21 - 30 2 2 2 1 
31 - 40 1 - - 1 
> 40 5 3 1 6 
Total 13 9 7 10 
* In one case the general practitioner had no additional information. 
It can readily be seen from this table that 16 out of the 24 G.T.T.'s provide 
values "normal" for their age according to the recommendations of Andres 
( 1971 ). Given these meager results it may be advisable to omit this screening 
test for glucose tolerance from a cardiovacular screening program. If such a test 
were still to be desired the following advice can be formulated: determine the 
blood sugar 2 hours after ingestwn. of 50 g sugar as an initial screening test for 
glucose tolerance (Teuscher, 1971; West, 1971). All participants with a score 
below a certain percentile level (e.g. percentile 10) should then be submitted to a 
standardized 50 g oral G.T.T. (annex 5). For the interpretation of the results 
the tables given in annexes 5 and 6 may be utilized. However, with Andres 
(1971) it may be concluded that "Until it is clear exactly what level of test 
performance truly carries with it increased risk, and until it is clear that 
prophylaxis is possible and that therapy is helpful, it behooves us to adopt a 
conservative stand at the moment in our willingness to classify a middle-aged 
or older subject as diabetic on the basis of poor test performance alone". 
The exercise test 
During exercise testing there were no large differences between the populations 
in screening I and II regarding cardiac frequency, blood pressure and 
respiratory frequency. During screening I 29 participants appeared to have an 
ST-segment depression ) 1 mm. These findings were again found during 
screening II in 18 of the 29; in the remaining 11 participants the abnormality 
was not observed during the repeat test. Simoons ( 1973) has found analogous 
results in literature. Again these data urge to great caution as to the 
significance of ST-segment abnormalities during a single exercise test when no 
complaints coexist. 
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7.3 Visits to the general practitioners 
Although the results of these interviews cannot be regarded as representative 
for all Dutch general practitioners, it was encouraging to see in the majority of 
the tested group a positive attitude towards mass screening on cardiovascular 
diseases. This positive attitude manifested itself in the expectation they 
demonstrated regarding the influence of regular screening on the physical and 
mental health conditions of the persons examined. In fact a favourable effect on 
physical health is expected by 85.5% and on mental health by 69.9% of these 
103 physicians. By far the greater part of the general practitioners presumes 
that the influence of decreasing risk indicators will be greater on younger 
people than on older people. Nevertheless 63.1% are of the opinion that a 
decrease of the risk indicators will also have a favourable influence on people 
over 65. It became evident that the physicians are not able to carry out a 
periodical screening examination themselves, mainly due to lack of time. Over 
60% care for more than 3000 patients and cannot readily accept extra duties. 
The majority should appreciate the information provided with an advice on 
medication or referral policy. As regards the communication of the results of a 
screening examination, 87.4% wish to tell their patients themselves the type of 
abnormality found. When borderline abnormalities exist, this percentage still is 
77. 7%. When no abnormalities are found 58.3% voiced no objection that the 
screening team informs the patient directly. 
7.4 Reflections on the role of the general 
practitioner 
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Generally speaking, the major risk indicators, hypertension, smoking and 
hypercholesterolemia identified in this population, were not accompanied by 
complaints. The only motivation provided to participants for a visit to their 
general practitioner was the statement that the individual had an increased 
chance for contracting or having a cardiovascular disease. This "increased" 
chance is possibly not strong or threatening enough to change a style of life 
that has been customary for many years. It may even not be enough 
stimulus to consult a doctor. The participants in fact had to take a number of 
decisions to remain under continue medical care. The first decision was to go or 
not to go to his physician when the results of the screening are already known. 
Many people opted for the least bothersome solution, which is not to go. 
Secondly, when a general practitioner/participant contact had been realised in 
most cases continued control proved desirable. Again for every visit to his 
physician the participant had to take another initiative. Add to this the varied 
responses by the physicians and it is little wonder that so little follow-through 
took place. The system can be improved possibly by a much enhanced 
co-operation between screening team and general practitioner. The screening 
team should take the initiative for periodical screening. Patient information 
accompanied by specific advice is then sent to the general practitioner, without 
informing the patient. The participant must then go to his own physician to 
obtain the results of the examination. When abnormalities are found the 
screening team should handle administrative and medical/technical matters, 
provide for a regular follow-up, letting the general practitioner adapt his 
treatment on basis of data provided by the team. Advantages of this system 
are that more participants with abnormalities will consult their physician since 
they want to know the result of the examination while-the follow-up of patients 
will be more regular. The only alternative is to place the entire screening, 
follow-up and treatment aspects of such populations in the hands of a single 
team. This may well be the only effective solution with the lowest cost-benefit 
ratio if a large screening and (intervention) effort is to be made in The 
Netherlands. 
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Chapter VIII 
" SIODS 

8.1 General 
Four groups of conclusions can be made on basis of this study: 
1. Conclusions concerning the prevalence of risk indicators and other 
abnormalities in the population of 447 dockworkers in screening I and II. 
2. Conclusions about the efficacy of the screening methods and tests used. 
3. Conclusions regarding the efficiency of the intervention policy. 
4. Conclusions relating to the attitudes of the 103 general practitioners 
regarding mass screening, industrial medicine and communication. 
8.1.1 Conclusions concerning the prevalence of risk indicators and 
other abnormalities in the population of 447 dockworkers in 
screening I and II 
In general there were no major changes in the biometric and biochemical 
data in the short follow-up period between screening I and II. An exception was 
the diastolic blood pressure level in rest. During screening II the mean diastolic 
pressures phase IV and V were 7 mm Hg respectively 5 mm Hg higher than 
during screening I. These differences are probably mainly caused by inter-
observer differences and do not reflect an actual increase in blood pressure. 
The percentage of cigarette smokers decreased from 78.7% to 72.7% while 22.2% 
of the participants declared that they smoked less. These data may indicate a 
trend but it can hardly be ascribed to this in the previous study. However, the 
new abnormalities found during screening II justify a continuation of the 
screening program despite the costs involved. 
8.1.2 Conclusions about the efficacy of the screening methods and 
tests used 
Blackburn stated in 1974 that only three data are required for the prevention of 
CVD. These data are the level of blood pressure, details on the smoking habit 
and the level of serum cholesterol. All other tests are of minor importance. Our 
methods and tests also lead to the conclusion that while the "COPIH" 
questionnaire provides useful information concerning changes in smoking 
habits and the determination of the serum cholesterol and the blood pressure 
are sensible, all other tests such as the determination of the haemoglobin and 
the test for diabetes mellitus, as well as chest roentgenograms may be omitted. 
Repeated reading of all resting-ECG's has made it evident that comparison of 
ECG's in a follow-up study even when a standardized protocol is used, is only 
justified when oniy one observer is employed. When such interobserver 
differences are avoided, no marked changes were found to have occurred 
between the resting-electrocardiograms in the short period between screening I 
and II. Code 2(slight ST or ST-J depression) occurs in this population so rarely 
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that it may be deleted. Comparison of the exercise-ECG's during screening I 
and II shows that an ST-segment depression :;> 1 mm during screening I in 
about one third of the cases could not be demonstrated during screening H. 
This leads to great caution in advising patients when during a single exercise 
test no complaints coexist with ST-segment abnormalities. 
The visits to the general practitioners provided a lot of relevant information. 
Most of these data show that the general practitioner is not very well informed 
or not very well equipped to deal with data obtained from present day screening 
and intervention activities. 
8.1.3 Conclusions regarding the efficiency of the intervention policy 
The intervention policy in regard to hypertension (diastolic blood pressure 
phase IV :;> 100 mm Hg during rest and exercise) and hypercholesterolemia 
(serum cholesterol > 3.0 g/l) seems to be completely ineffective. During 
screening I 24 patients with hypertension were referred to their physician. None 
of these had, during screening II, a diastolic blood pressure < 100 mm Hg. 
Either the recognition or the treatment of the arterial hypertension failed. Of 89 
patients with hypercholesterolemia, 51 visited their doctor, but only 5 of them 
had during screening II a serum cholesterol reduced to below 3.0 g/l. On paper 
there appears to be an agreed policy on whom and how to treat as patients but 
in practice this policy does not exist at all. 
8.1.4 Conclusions relating to the attitudes of the 103 general practi-
tioners regarding mass screening, industrial medicine and 
communication 
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The majority of the general practitioners visited exhibited a positive attitude 
towards mass screening on CVD. Nevertheless, far the greater part of them 
(97.0%) think that they can follow and care for people who are found to be at 
risk during screening. About two thirds of these physicians were of the opinion 
that a decrease of the risk indicators in men over 65 years would have a 
favourable influence on CVD. Also 69.9% of them expected a favourable effect 
of CVD screening on the mental health of men. In 76.7% there existed 
favourable opinions on industrial physicians and only 17.5% of these doctors 
indicated that they thought the employers interest came first during these 
screening investigations. Most of the general practitioners (92.2%) would 
appreciate information regarding medication or referral. Yet, despite all these 
favourable omens practical implementation of the given advice hardly existed. 


Samenvatting 
In 1974 schreef Blackburn: "De huidige ontwikkeling op het gebied van de 
epidemiologie van hart- en vaatziekten heeft aangetoond dat er enorme 
verschillen bestaan in het v66rkomen van ischaemische hartziekten tussen 
populaties en dat de kans op het krijgen van de ziekte afhankelijk is van de 
individuele of gemeenschappelijke risico-indicatoren ... De benaderingswijze, 
waarin de kwantitatieve beoordeling van de risico-indicatoren de voorkeur heeft 
hoven de kwalitatieve, zal zich evenals de preventief geneeskundige aanpak van 
de hart- en vaatziekten voortzetten ... De medicus practicus zal de vele op 
zichzelf matig belangrijke risico-indicatoren en slechte gewoontes niet Ianger 
als onbelangrijk beschouwen, maar ze zien als een belangrijke gecombineerde 
risico-indicator die effectief optreden vereist ... Preventief optreden is voor-
alsnog het enig mogelijke; de preventieve geneeskunde dient haar eigen 
aandeel te krijgen; dit houdt meer in - en ik verwacht dat we het daar nu over 
eens kunnen zijn - dan aileen maar praten". 
Enkele jaren voor deze uitspraken, en wei in 1971, is op de Bedrijfsgenees-
kundige Dienst voor de Haven van Rotterdam een gestandaardiseerd 
onderzoek begonnen naar het voorkomen van hart- en vaatziekten bij haven-
werkers van 55 tot 65 jaar. De resultaten van dit eerste onderzoek zijn door 
Baart in 1973 gepubliceerd. Een tweede onderzoek bij deze!fde havenwerkers is 
uitgevoerd tussen oktober 1972 en november 1973. In aanvulling hierop is het 
interventiebeleid nagegaan dat een aantal huisartsen hebben gevoerd bij deel-
nemers met afwijkende bevindingen, aangetoond bij onderzoek I. Deze onder-
zoeken vormen de basis van dit proefschrift. 
De vijfhonderd en drie deelnemers aan onderzoek I werden uitgenodigd aan 
onderzoek II dee! te nemen. Vierhonderd zeven en veertig mensen hebben daad-
werkelijk aan deze uitnodiging gehoor gegeven. Het onderzoek bestond uit het 
met behulp van een gestandaardiseerde vragenlijst verzamelen van een 
aantal anamnestische gegevens, het meten van de lichaamslengte en het ge-
wicht, de bloeddruk, een electrocardiogram opgenomen tijdens rust en inspan-
ning, een thoraxfoto, de bepaling van het serum cholesterol- en het totaal 
lipidengehalte, de bloedbezinkingssnelheid en een aantal ventilatoire long-
funkties. De onderzoekresultaten geven niet aileen informatie over het voor-
komen van risico-indicatoren op twee verschillende tijdstippen, maar bieden 
tevens de mogelijkheid de gebruikte onderzoekmethoden op waarde te schatten. 
Een speciaal onderzoek werd uitgevoerd teneinde inzicht te verkrijgen in de 
doelmatigheid van het door de huisartsen gevoerde interventiebeleid op basis 
van gegevens, die tijdens onderzoek I door het screeningsteam aan hen zijn 
verstrekt. Gedurende de persoonlijke interviews met ieder der 103 huisartsen, 
die bij dit onderzoek waren betrokken, werd voornamelijk aandacht geschonken 
aan de behandeling van mensen met een verhoogde bloeddruk, een verhoogd 
serum cholesterol gehalte of een gestoorde glucose tolerantie test. 
De gegevens zijn, evenals die van onderzoek II, bewerkt op de afdeling 
Biostatistica van de Erasmus Universiteit te Rotterdam. 
De deelnemers aan onderzoek II verschenen gemiddeld 19 maanden na 
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onderzoek I. De resultaten wekken de indruk dat het aantal sigarettenrokers in 
die tijd is afgenomen. Daartegenover staat dat het gevoerde interventiebeleid 
met betrekking tot hypertensie en hypercholesterolaemie volslagen ontoereikend 
blijkt te zijn. Het literatuuronderzoek en de eigen onderzoekresultaten maken 
het voorts aannemelijk dat het inspannings-ECG en het bepalen van de glucose 
tolerantie geringe betekenis hebben bij screeningsonderzoek van grate 
groepen. Grote voorzichtigheid blijkt ook gewenst te zijn bij het geven van 
adviezen over de mogelijkheid van het bestaan van hartziekten aan mensen 
zonder klachten, bij wie ST-segment afwijkingen zijn gevonden tijdens een 
inspanningsonderzoek. 
De meeste gegevens, die bij de bezoeken aan de huisartsen zijn verzameld, 
geven aan dat de artsen in het algemeen niet goed gelnformeerd zijn over de 
noodzaak van preventie en dat zij niet goed uitgerust zijn om slagvaardig op te 
treden naar aanleiding van de verstrekte gegevens. 
Als conclusie kan gesteld worden dat voor de preventie van ischaemische hart-
ziekten op dit moment slechts drie risico indicatoren van groat belang zijn. Dit 
zijn hoge bloeddruk, (sigaretten) roken en een verhoogd serum cholesterol 
gehalte in het bleed. Daar er tot op heden geen testen beschikbaar zijn om op 
grote schaal ischaemische hartziekten in een vroeg stadium op te sporen, dient 
vee! aandacht geschonken te worden aan het verlagen van deze drie risico 
indicatoren. Gezien de teleurstellende ervaringen met de doelmatigheid van het 
bestaande medische systeem worden een aantal stappen aangegeven, die tot 
verbetering zouden kunnen leiden. 
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ANNEX 2 CHAPTER II 
DEFINITIONS OF DIABETES MELLITUS AND RELATED 
STATES 1) 
112 
Potential diabetics 
These are persons in whom diabetes may be prognosticated with reasonable 
reliability. They respond normally to a glucose tolerance test (G.T.T.) 2), but there is a 
clear risk of their developing diabetes. Potential diabetics include: 
Ill The identical twin of a diabetic; 
(2) A person with both parents diabetic; 
(3) A person with one diabetic parent whose other, non·diabetic, parent has or 
had a diabetic parent, sibling, or offspring, or a sibling with a diabetic child; 
(4) A woman who has given birth to a live or stillborn child weighing 4.5 kg or 
more at birth 1), or to a stillborn child showing hyperplasia of the pancreatic islets not 
due to rhesus incompatibility. 
Latent diabetics 
(1) A person in whom the G.T.T. has produced a normal result but who is known 
to have been diabetic according to the G. T. T. at some time during pregnancy, during 
infection, when under some other stress, or when obese. 
(2) A person who has abnormal blood·glucose responses {similar to those found 
in diabetes mellitus) to provocative tests, such as the cortisone·augmented G.T.T. (The 
Committee considered that these tests should at present be largely confined to 
research). 
Asymptomatic (sometimes referred to as subclinical or chemical) diabetics 
(1) A person with a diabetic response to the G.T.T. whose fasting true blood· 
sugar is below 130 mg/100 ml(capillary) or 125 mg/100 ml(venous). 
(2) As above, but with fasting true blood·sugars above the stated values. 
Clinical diabetics 
A person with an abnormal response to the G.T.T. and with the symptoms or 
complications of diabetes. 
1) Derived from: Fitzgerald, M.G. & Keen, H. (1964) Lancet, 1, 1325. 
2) See page 9 for the Committee's views on glucose tolerance tests. 
W.H.O., 1965. 
ANNEX 3 CHAPTER II 
STAGES IN THE NATURAL HISTORY 
OF DIABETES MELLITUS 
Terminology by: . -Subclinical- Latent -
University of Michigan Prediabetes ..- diabetes 
Overt 
..-- diabetes ....- diabetes 
Asymptomatic 
World Health Potential Latent diabetes Clinical 
Organization diabetes diabetes (subclinical or diabetes 
chemical) 
Fasting blood sugar Normal Normal Normalor t l 
Glucose tolerance test Normal Not necessary 
(GTT) Normal Abnormal during Abnormal for diagnose pregnancy, stress 
Cortisone-GTT Normal Abnormal 
Not 
necessary ----
Delayed and/or 
decreased insulin + ++ +++ ++++ 
response to glucose 
Vascular changes ?+ ++ +++ ++++ 
Fajans, 1973. 
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ANNEX 4 CHAPTER II 
STANDARDIZATION OF THE ORAL GLUCOSE TOLERANCE 
TEST. 
114 
Report of the Committee on statistics of the American Diabetes Association June 14, 
1968. 
7. Summary of recommendations for standardized oral glucose tolerance test 
I. Preparatory Phase 
A. Diet: Intake of at least 150gm. of carbohydrate per day for three days 
preceding test, if the patient has been on a normal diet previously. 
B. Acute Illness: Delay of at least two weeks after period of acute illness before 
performing test. 
C. Medication: Discontinuance of drugs proven or believed to influence the GTT, 
including hormones, oral contraceptive drugs and hypoglycemic agents, for at least 
three days prior to test. 
D. Fasting Period: No intake of any food value for at least' eight and not more 
than sixteen hours preceding the test. 
E. Miscellaneous Restrictions: Avoidance of coffee, smoking and unusual 
physical exercise for at least eight hours prior to the test. 
F. Postponement of Test: Omission of test in event of unexpected illness (fever, 
gastritiS, etc.), or if there has been ingestion of food within eight hours. 
II. Testing Phase 
A. Time: .Conduct test between 7 a.m. and 12 noon, i.e., take fasting specimen 
between 7 a.m. and 9 a.m. 
B. Glucose Load: Administer in dose of 40 gm. per square meter of body surface 
diluted to a volume of 300 ml. and consumed within five minutes after obtaining fasting 
blood specimen. 
C. Specimen Timing: Draw antecubital venous blood specimen. at fasting. Note 
time zero when the patient starts drinking the glucose. Draw additional blood 
specimens exactly 60.120 and 180 minutes after time zero (30, 90 en 150 minute 
spe~imens may be obtained for additional definition of the GTT-curve). 
D. Patient Behaviour: Have Patient avoid physical exertion, emotional stress 
and stimulants (tobacco, alcohol, coffee, tea.). 
III. Processing of Specimen 
A. Tjpe of Sample: Plasma or serum are preferable to whole blood. Separation 
by centrifugation should be performed within thirty minutes. 
B. Preservation of Sample: Freezing or addition of sodium EDTA (1 mg. per ml. 
of blood) and sodium fluoride 12 mg. per mi. of blood) are required if chemical 
determination is not performed on the same day the specimen was drawn. Thymol must 
not be present during the color development phase of the chemical test. 
C. Chemical Method: The glucose oxidase (not usable if sodium fluoride is 
present). Nelson·Somogyi and AutoAnalyzer (Hoffman's ferricyanide) methods are all 
acceptable. The importance of primary standards and reference sample determinations 
with every run is stressed. 
IV. Interpretation of Test Results. 
A. Reporting: Wherever possible, all four plasma glucose levels should be 
reported (i.e., fasting, 1, 2, and 3 hour levels). 
B. Diagnosis) Individual or grouped data should be classified into ''diabetic'' and 
''nondiabetic'' according to each of the following criteria and reported accordingly~ 
1) The Wilkerson Point Method (adjusted for plasma glucose and 40 gmlm2 
glucose load) 
Time 
Fasting 
1 hour 
2hour 
3hour 
mg. per 
100 ml Points 
150 or more = 1 
195 or more = V2 
140 or more = 1/2 
130 or more = 1 
Two points or more indicate diabetes. 
2) The Fajans-Conn Criteria (adjusted for plasma glucose and 40 gm/ m2 glucose 
load). 1 hour 185 or more, 1 Y2 hour 165 or more and 2 hour 140 or more= diabetes. The 
test should be reported even if the 1 Vz hour determination is omitted. 
3) Summation of Fasting 1, 2 and 3 hour plasma glucose levels. If the sum is 600 
or more a diagnosis of diabetes is made. 
4) Other methods at the author's discretion. 
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ANNEX 5 CHAPTER II 
ORAL GLUCOSE TOLERANCE TEST (GTT): STANDARD TEST 
WITH 50 GRAMS OF GLUCOSE (TRANSLATION).* 
116 
The generally accepted method for the diagnosis of a diabetes patient in an early stage 
is the GTT. Although its incomplete reproducibility has invoked criticism, the GTT 
still is recommended with numerous modifications. As the GTT varies in its 
applications between specialists, general practitioners and hospital physicians, the 
standard stress test with 50 grams of glucose during two hours, as recommended by the 
study group of the European Diabetes Association, appears to be efficient for the time 
being. 
Indications: 
fasting and/ or postprandial borderline blood glucose concentrations; 
clinical suspicion in absence of elevated fasting and/ or postprandial blood 
glucose, such as could occur with arterial circulatory disturbances, overvveight or 
diabetes in the family; 
every glucosuria even in trace amounts with normal blood glucose concentration 
including those found during pregnancy. 
Contraindications: 
An abnormal fasting and/or postprandial hyperglycemia. 
Glucosuria with a positive acetone test without previous blood sugar 
determination. 
Clinical contraindications such as acute gastric and intestinal disturbances, fever 
or poor general and nutritional state. 
Pharmacological contraindications: hyper- or hypoglycemia including drugs such 
as corticosteroids and antidiabetics. 
Diet preparations. A sufficient carbohydrate supply (at least 150 grams) during three 
days before the test should be employed to enhance the accuracy of the test. 
Time of examination. Optimal results will be obtained after a fasting period of 12 hours 
during the previous night. Results are negatively influenced by physical exertion such 
as walking long distances, bicycling or night work. A resting period of 30 minutes in a 
relaxed position appears essential. 
Test beverage. 50 grams of dextrose solved in some 300 ml. of lukewarm water forms 
the beverage. Aromatized by some drops of lemon juice, it must be drunk within 5 
minutes. 
Position of the person examined during the test. The examination can be::;t be carried 
out in the sitting position. For non ambulatory people best by sitting upright in bed. 
Blood sampling. The European Study Group suggests the use of capillary blood for this 
test. 
Time of blood sampling. Zero time fasting, 1 and 2 hours after the glucose consumption 
(European standard test). 
* Summary of the 'Neue Schweizerische Richtlinien zur Diagnose des Diabetes Mellitus' (Teuscher, 1971). 
Modifications with less informative results. In a general practice it will also be possible 
to determine only the peak value between 30 and 90 minutes after 50 grams of glucose 
intake. In that case the same determination criteria are applied as those for the one hour 
value. It is also possible to effect a screening with only a two hour value. However, no 
definitive diagnosis may be made on the basis of this one value only as the variability is 
considerable particulary with the two hour value. A further simplification may be 
achieved by omission of the fasting glucose determination. 
Examination of urine glucose: At least once at the end of the test. 
Criteria. By the glucose oxidase method, expressed in mg/100 ml. the glucose values in 
capillary blood are: 
N ormallevel 
Borderline levels 
Pathological level 
fasting 60 min. 120min. 
< 100 < 160 < 210 
100. 130 160. 220 120. 150 
> 130 > 220 > 150 
It should be noted that with 50 grams of glucose only a screening test is carried out 
since it is not possible to examine each person in hospital or general practice in a 
standardized way because of time limitations. Age, sex, body weight, medicine, body 
temperature, inactivity, pregnancy and other aspects that may affect the results have 
not been considered further. Intern this results in a relatively large borderline zone. 
Furthermore with a positive test the decision "diabetes yes or no" must not be 
p-rejudiced when the blood sugar values are at a marginal level. Such a test indicates the 
possibility of diabetes and must be repeated. In practice a normal glucose tolerance 
mostly indicates "no diabetes at the time of the test," whereas a pathological glucose 
tolerance test does justify the diagnosis "diabetes mellitus" in most cases. When all 
three values are within normal limits, and yet glucosuria is present, the test must be 
judged as provisionally suspect since the blood sugar peak may have been missed. A 
subsequent repetition of the test will always be necessary dependent on its clinical 
urgency. 
If under fasting conditions marked glucosuria is associated with three blood glucose 
values clearly within normal limits, there may just be renal glucosuria. In this case it 
must be recommended to perform a more extensive optimally standardized glucose 
tolerance test in order to be able to make a definite decision. (Teuscher, 1971). 
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ANNEX 6 CHAPTER II 
ORAL GLUCOSE TOLERANCE TEST NOMOGRAM 
AGE 
80-
75-:: 
70 -= 
65 ...: 
60-= 
55-
50--= 
45-
40-
35 --= 
30-
25 ...: 
20-
TWO HOUR 
BLOOD GLUCOSE 
(mg per 100 ml) 
280-
270-
260-
250-
I 
!' 
,, 
.:"'i je 
/lo 
/~s 
PERCENTILE 
RANK 
/0·.? 
I /'·s 
/.~ 240-
230-
220-
210-
200-
190-
180-
170-
160-
150-
140-
~~<o 
JJo 
130- ~1 "~o 
120- /so 
110- -r:60 
- ' fQ 
100 ~_;80 go -.~'as 
Bs i- ao 
.9ai-
98 ' -70 
i ..':..eo 
-50 
Metabolism Section 
Gerontology Branch 
The percentile rank compares the subject's performance to that of his own 
age cohorts. Thus, a rank of 50 % is an exactly average performance and a 
rank of 2% is poor since it indicates that 98% of subjects of the same age will 
perform better than the subject tested. This type of ranking is necessary be-
cause of the marked decrease in tolerance which accompanies aging and be-
cause of uncertainty as to standard for the diagnosis of diabetes. The table 
below is simply a rule of thumb for current use; it may be need to be adjusted 
in the future. 
Age Group Percentile Rank 
Abnormal Borderline Normal 
20-29 0-2 3-4 5 and over 
30-39 0-3 4-6 7 and over 
40-49 0-4 5-8 9 and over 
50-59 0-5 6-10 11 and over 
60-69 0-6 7-12 13 and over 
70-plus 0-7 8-14 15 and over 
(Andres, 1971) 
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ANNEX 7 CHAPTER II 
SUMMARY OF THE EPIDEMIOLOGY STUDIES OF PHYSICAL 
ACTIVITY AND CORONARY ARTERY DISEASE 
study Primary Approximate Period oi Method of Evaluation Diagnostic Relationship of CAD 
Investigator Population Size Observation Assessing of Risk Criteria for to Physical inactivity 
(Middle-aged Men} Physical Activity Factors CAD and Comments 
Retros12ective Studies 
England-Wales mortality Morris 2.000.000 1930-1932 Occupation on D. C. No CAD listed on D. c. Positive but the diagnosis is 
1949-1952' based on death certificates 
physical activity on the 
title of last occupation 
and part of the data were 
obtained before the ECG 
was available for a 
diagnosis 
Chicago mortality Stamler 400.000 1951, 1953 Occupation on D. C. No CAD liSted on D.C. Negative but there is very 
little gradient in the 
activity level of the 
population 
California mortality Breslow 1. 000. 000 1949, 1951 Occupation on D. C. No CAD listed on D.C. Positive but only after 
grouping the population 
according to general 
mortality 
North Dakota Zukel ~0. 000 1957 Occupation and Cigarette Angina, coronary Positive but the questionnaire 
questionnaire smoking insufficiency AM evaluating physical activity 
only CHF and sudden death was found to be inaccurate 
due to CAD as reported by the authors 
in local medical records 
London Transport Morris 31.000 1949-1950 Drivers vs No {later done AMI, angina, death ?ue Drivers had a higher incidence 
conductors in follow up) to CAD as reported in of CAD but this could be due 
industrial records to the selection of other risk 
factors within this group, later 
studies showed them to be 
heavier, and to have higher BP 
and serum cholesterol 
Israel kibbutzim Brunner 6.000 1946-1961 Sedentary - 80 % or No All11, angina, death due Positive, but no other risk 
more of job time to CAD as reported in factors evaluated 
sitting; active - all industrial records 
others 
u.s. railroad men Taylor 100.000 1955-1956 Switchmen vs clerks No CAD listed on D. C. Positive, but iniluenced by 
and executives differential rate of job 
transfers, those with CAD 
transfer most often from 
active to inactive jobs 
South African railroad Adelstein 20.000 1954-1959 Job titles No CAD listed on D.C. Negative 
m•o 
~ashington D. c. postal Kaho 1. 500 1940-1962 Mail carriers vs clerks No CAD listed on D. C. Positive 
employees 
HIP Frank 301 1961-1963 Questionnaire No Acute .MI Positive but the activity 
questionnaire is influenced 
by bias and selective forces 
favoring such a relationship 
Toronto VA 
' 
Shan off 100 1960 Questionnaire YO' Acute MI Negative for "habitual"' 
physival activity 
Malmo Hospital Forssman 66 1958 Occupation y, Acute 1111 Negative but physical 
activity determined only by 
occupational title 
Prevalence studies 
Peoples Gas Co. Chicago stamler 1.500 1958 Occupation y, Diagnostic ECG,AMI Positive but affects of differ-
sudden death, angina, entia! job transfers obvious 
coronary insufficiency those with CAD most often 
and CHF due to CAD transfer from active to 
inactive jobs 
u.s. railroad men Taylor 2. 000 1957-1959 Switchmen vs clerks y, Diagnostic ECG and Positive but effects of differ-
and executives angina entia! job transfers obvious 
those with CAD most 
often transfer from active 
to inactive jobs 
Evans County, Georgia Me Donough 1. 000 1960 Occupation YO' Diagnostic ECG, angina Positive buth with similar 
and history of 1111 btases as other prevalence 
studies 
Pros11ective studies 
Sin Francisco Paffenbarger 3. 300 1951-1967 Cargo workers vs Yes except CAD listed on D. C. Positive but no cholesterols 
clerks cholesterol obtained and there is a 
selective process for men 
to become clerks or cargo 
workers 
Framingham Kannel 2. 500 1949-1967 Questionnaire YO' CAD listed on D. C. Positive but the physiologic 
phYSiological diagnostic ECG changes parameters are of the uncer-
measurements symptomatic CAD tain relationship to 
p~ysical activity 
London transportation Morris 687 1960-1965 Drivers vs conductors YO' AMI diagnostic ECG Positive but the drivers and 
workers changes angina and the young recruits for bus 
sudden death driving had other risk factors 
for CAD 
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Study Primary Approximate Period of Method of Evaluation Diagnostic Relationship of CAD 
Investigator Population Size Observation Assessing of Risk Criteria for to Physical inactivity 
{Middle-aged Men) Physical Activity Factors CAD and Comments 
Gotesborg Werko 834 1963-1967 Retrospeetive Ye. AMI diagnostic ECG Positive but the activity level 
questionnaire changes and angina was determined retrospectively 
Western collaborative Rosenman 3.180 1960-1965 Questionnaire Ye. Diagnostic ECG changes Positive main emphasis 
angina ANII and death on personality types 
due to AMI 
Seven country Keys Z5. 000 1960-1965 Questionnaire Ye. Diagnostic ECG changes Negative, very heterogeneous 
angina, AMI and death because of different culture 
due to AMI and peoples studied 
Los Angeles Chapman 1.400 1949-1962 Questionnaire y,, AMI, angina, sudden death Negative but only job title 
coronary insufficiency used for activity level 
u.s. railroad men Taylor 2. 000 1960-1965 Switchmen vs clerks Ye. ANII, angina, sudden Negative 
and executives death due to AMJ and diag-
nostic ECG changes 
Western Electric, Chicago Paul 1. 700 1957-1965 Job evaluation and Ye. AMJ, angina. and death Negative 
title and interview due to CAD 
Peoples Gas Co. Chicago Stamler 1. 240 1958-1965 Job title Ye. CAD listed on D. C. Negative but inadequate 
physical activity gradient 
within the population 
Rehabilitation studies 
Cleveland rehabiltation Hellerstein 254 1960-1967 Physical training with Yes; and ap- Death Positive but volunteers and 
group parameters of Cv propriate treat- selection results in a 
fitness measured ment of risk healthier post infarction 
factors group 
Israel rehabiltation group Gottenheimer 1.103 1961-1966 Physical training with No Death Positive but volunteers and 
parameters of CV selection results in a 
fitness measured healthier post infarction 
group 
Patholog:ical Studies 
National British Necrop- Crawford and 4. 000 1954-1956 Last occupation No Macroscopic estimation Negative, no difference in the 
sy Series Morris degree of atherosclerosis of 
luminal obstruction among 
the activity levels, ischemic 
myocardial fibrosis appeared 
more common in inactive 
occupations 
Israel Traumatic Death Mitrani 172 1968 Last occupation No Macroscopic estimation Negative, no significant dif-
Autopsy Series and calculation of terence in atherosclerotic 
luminal obstruction narrowing though there was 
slightly less in the active 
occupations 
New York Medical Spain and 207 1957-1958 Last occupation No Macroscopic estimation Negative, no difference in the 
Examiner Autopsy Bradess degree of atherosclerosis 
between the activity levels 
Oxford study Rose 170 1962-1963 Last occupation No Degree of atheroscle- Undiseased portion of RCA 
rosis not studied, macro- studied to judge size of 
scopic estimation of in- coronary arterial tree; small 
farct size RCA tended to be larger in 
active occupations though 
data only suggestive 
Autopsy of Clarence Currens and 1958 Lifelong history of No Macroscopic estimation Coronary arteries 2-3 x normal 
DeMarr P.O. White marathon running diameter with mild atheroscle-
rotic involvement but no luminal 
obstruction rather than 
secondary to rurming this could be 
genetically endowed and explain 
why he became a great runner 
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ANNEX 8 CHAPTER II 
PREVALENCE OF DEFINITE AND BORDERLINE 
HYPERTENSION- UNITED STATES POPULATION BY AGE 
White males 
Age group (years) definite hypertension * borderline hypertension ** 
18-79 12.8 17.7 
18-24 1.7 11.6 
25-34 3, 6 11.7 
35-44 11.8 14.9 
45-54 16.5 17.3 
55-64 20.2 28.4 
65-74 25.0 26.6 
75-79 30.3 27.1 
* 160 mm Hg or over systolic, or 95 mm Hg or over diastolic 
** Below 160 mm Hg systolic and below 95 mm Hg diastolic but not 
simultaneously below 140 and 90 mm Hg. ' 
(Lew, 1973) 
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ANNEX 9 CHAPTER II 
VARIATIONS IN MORTALITY AMONG MEN ACCORDING TO 
SYSTOLIC AND DIASTOLIC PRESSURES. 
RATIOS OF ACTUAL TO EXPECTED MORTALITY-
STANDARD MALE RISKS - 100% 
122 
Mortality Ratio (%)* 
Systolic Diastolic Issue Ages Blood Pressure Blood Pressure 
(mm Hg) (mm Hg) 15-39 yr 40-69 yr All Ages 
128-137 < 83 111 108 109 
83-87 133 125 127 
88-92 157 134 140 
93-97 221 156 168 
98-102 ( 127) 213 197 
138-147 < 83 130 142 141 
83-87 171 150 153 
88-92 213 166 170 
93-97 238 195 199 
98-102 288 215 224 
148-157 < 88 186 179 180 
88-92 196 191 191 
93-97 258 221 224 
98-102 499 243 269 
158-167 < 88 (167) 219 215 
88-92 (235) 240 240 
93-97 (441) 260 268 
98-102 (350) 286 289 
* Where the number of policies terminated by death is 10 to 34, the mortality 
ratio is enclosed in parentheses. 
(Lew, 1973) 
ANNEX 10 CHAPTER II 
PREVALENCE OF ELEVATED SERUM CHOLESTEROL IN THE 
GENERAL POPULATION OF THE UNITED STATES 
Prevalence (%) 
Age Group (yr) 
260 mg or Higher 300 mg or Higher 
Men 
18-74 17,7 4.7 
18-24 3.9 0.6 
25-34 10.3 1.9 
35-44 20.1 7.0 
45-54 25.7 5,3 
55-64 23.4 6.9 
65-74 21. 6 6.1 
Women 
18-74 22.7 8.2 
18-24 4.4 1.7 
25-34 7.4 1.4 
35-44 12.7 2.8 
45-54 27.9 6.2 
55-64 49.6 20.8 
65-74 51. 0 26.7 
NOTE: From National Center for Health Statistics, Public Health Service 
Publication No. 1000, Series 11, No. 22, Serum Cholesterol Levels of Adults, 
United States, 1960-62, Tables 1 and 2, March 1967. 
(Lew, 1973) 
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ANNEX 11 CHAPTER III 
REASONS FOR NOT PARTICIPATING IN SCREENING II 
124 
Participants screening I, who did not appear for screening H 
Specified reasons for non~appearance 
I. deceased between screening I and screening II 
diagnosis: malignity. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5 
cardiovascular diseases . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2 
accident. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 
unknown..................................................... 1 
total . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 9 
2. patients with prolonged diseases 
cardiovascular diseases and hypertension. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3 
chronic respiratory complaints. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . 1 
abnormalities of the tractus locomotorius. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 
abnormalities of the tractus digestivus. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3 
accidents . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4 
other diagnosis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4 
diagnosis unknown. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 
total.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 17 
3. moved/unreachable 
moved . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3 
dismissed. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3 
prolonged stay abroad. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 
total . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 7 
4. refusers (statement of reasons) 
not interested . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6 
not willing to give reasons. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5 
feels well and sees no reasons why . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3 
miscellaneous ........................................................... . 8 
total . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 22 
THE MOTIVES OF INITIAL REFUSERS THAT YET PARTICIPATED IN 
SCREENING H AFTER PERSONAL CONTACT 
actual back complaints when the invitation was received. . . . . . . . . . . . . . . . . . . . . . . . 2 
fear of costs involved . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3 
complaints conseming screening I. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4 
no need for further examination in view of actual curative care . . . . . . . . . . . . . . . . . . . 5 
no need for examination in view of the fact that there are no complaints . . . . . . . . . . . 6 
miscellaneous . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4 
no invitation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 
total . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 25 
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ANNEX 12 CHAPTER III 
PREPARATION FOR THE DETERMINATION OF THE FAST-
ING BLOOD SUGAR 
126 
Dear Sir, 
Occupational Health Service for the Port of Rotterdam 
St. Jobsweg 7 
Rotterdam-3006 
Telephone 010-76 36 44 
Rotterdam, 
We expect you ........... day .............. at 8.30 a.m. at the Occupational Health Service for 
the Port of Rotterdam, St. J obsweg 7, Rotterdam for a bloodtest. 
In order to achieve maximum results of the test it will be essential that you adhere 
strictly to the following instructions. 
Please do not drink beer or coca cola on ........... day ................. , further you may 
consume any food or beverage untillO:OO p.m. 
After 10.00 p.m. absolutely no food or drink, apart from one glass of water getting up in 
the morning. 
Immediately after the blood has been sampled restrictions for food and drink will end. 
Yours sincerely, 
ANNEX 13 CHAPTER III 
QUESTIONNAIRE PERIODICAL MEDICAL EXAMINATION 
"COPIH" 
Punchcard number 
O.H.S. 
Examination number 
Date 
A 
1. What is your profession or function ? 
2. How long have you been working for your present employer ? 
3. How long have you been working in this function ? 
4. If married, how old is your wife ? 
5. How many children do you have ? 
6. Who is your physician ? 
Name: 
Address : 
B 
1. Have you ever had any pain or discomfort in your chest ? 
(do -not include compl~ints on account of a cold). 
2. Have you ever had any pressure or heaviness in your ·chest ? 
(not including complaints on account of a cold). 
3. Have you ever had ATTACKS of pain in the lower jaw, throat, shoulders 
or fingers ? 
If "no" to question 1, 2 and 3 proceed to question 12. 
If "yes" to question 1, 2 QI 3 answer next questions: 
4. Do you get it when you walk uphill or up a stairs, or hurry or walk 
against the wind ? 
5. Do you get it while you are walking at a normal speed on level country ? 
6. What do you do if you get it while you are walking ? 
carry on 
stop or slow down 
place a tablet under the tongue 
7. If you stand still, will the pressure disappear 
in a short time (10 minutes) 
after more than 10 minutes 
not at all 
8. Will you mark where this pain or pressure was generally located ? 
D 
OJ:] 
I I 
[l 
rn years 
rn years 
rn years 
rn 
yes no 
DO 
DO 
DO 
DO 
DO 
D 
D 
D 
D 
D 
D 
127 
128 
yes no 
9. Do you have complaints within 10 minutes after a meal ? 
Do you often have complaints when you are excited or upset ? 10. 
11. 
DO 
DO 
0 Do you have complaints when you come from a warm into a cold surroundings ? D 
12. Have you ever had a severe pain across the front of your chest lasting for 
half an hour or more ? 
If "no" proceed to question 15. If "yes" answer the following questions. 
13. How many of these attacks have you had ? 
14. How long ago did you have your last attack ? 
less than 1 year 
1-3 years ago 
over 3 years ago 
15a. Have you ever been checked for pain in the chest by an internist or a 
cardiologist ? 
If yes, by whom ? 
In which year ? 
b. As far as you know have any irregularities been found during this 
examination ? 
16. Have any anticoagulant been prescribed to you ? 
(Sintrom or Marcoumar) 
17. Are you regularly checked in account of these complaints by a specialist 
or thrombosis service ? 
18. When has been your last visit there ? 
c 
1. Do you get pain in either leg on walking ? 
If "no" proceed to D, if "yes" answer the following questions. 
2. Does this pain issues from the back ? 
When this pain issues from the back proceed to D. 
3. Does this pain begin when you are standing still or sitting ? 
4. In what part of your leg do you feel it ? 
in the calf 
someplace else 
5. Do you get it when you walk uphill or hurry ? 
6. Do you get pain or discomfort when walking at normal speed on level 
country ? 
If "no" to these questions proceed to D, if "yes" to one of the questions 
answer the following questions. 
7. Does the pain ever disappear while you are walking ? 
8, What do you do if you get it while you are walking ? 
9. When you stop, does the pain disappear 
stop or slow down 
carry on 
within short time (10 minutes) 
after more than 10 minutes 
not at all 
10. Have you ever been examined for pain in one of the legs when you walk 
by a cardiologist or internist ? 
If so, by whom ? 
When has this been ? 
DO 
DO 
0 
0 
0 
DO 
DO 
DO 
DO 
DO 
DO 
DO 
0 
0 
DO 
DO 
DO 
0 
0 
0 
0 
0 
DO 
D 
1. Do you get swollen ankles or feet in the evening ? 
2. Do you sleep with more than one pillow ? 
3. Do you usually have to leave your bed more than once per night to urinate ? 
E 
1. Have you ever had raised blood pressure ? 
If "no" proceed to F, if "yes" answer the following questions 
2. Are you following a diet for that reason ? 
3, Are you using medicine for that ? 
F 
1. Have you ever smoked ? 
If "no" proceed to G, if "yes" fill in the following table . 
2. How much do/ did you smoke : now 
cigarettes {per day) 
hand-rolled (packets per week) 
cigars (per week) 
small cigars (per week) 
pipe tobacco (packets per week) 
1 year ago 
cigarettes (per day) 
hand-rolled (packets per week) 
cigars (per week) 
small cigars (per week) 
pipe tobacco (packets per week) 
3 or more years ago 
cigarettes (per day) 
hand-rolled (packets per week) 
cigars (per week) 
small cigars (per week) 
pipe tobacco (packets per week) 
3. If you have decreased or stopped smoking, did you do so on account of 
chest complaints ? 
G 
1. Do you work mainly sitting down ? 
standing ? 
walking ? 
bending forward, kneeling, bending ? 
yes no 
DO 
DO 
DO 
DO 
0 0 
DO 
DO 
DO 
0 
0 
0 
0 
129 
130 
2. Have your previous functions been 
3. How do you go to your work? 
physically more strenuous ? 
as strenuous ? 
less strenuous ? 
question inapplicable ? 
walking 
by bycicle 
by moped or motorbike 
by car 
by tram, bus, train 
yes no 
by commute bus (company transport) 
D 
D 
D 
D 
D 
D 
D 
D 
D 
D 
4. Do you have, apart from your work, several times a week indoor or 
outdoor activities such as carpentry, paperhanging, paint jobs, gardening, 
domestic activities ? 
5. Are you active in sport or regular physical training ? 
6, If so, how many hours per week ? 
7, Does your work regularly include short periods of extra heavy physical 
effort, such as 
H 
climbing stairs and ladders ? 
lifting or carrying heavy loads ? 
strenuous pushing or pulling ? 
1. Are you a diabetes patient ? 
If "no" proceed to I, if "yes" answer the following questions. 
2. How many years have you suffered from this disease ? 
3. Do you have a diet for this reason ? 
4. Do you use medicine for this reason ? 
1. How many elder brothers do you have (have you had) ? 
2. How many elder sisters do you have (have you had) ? 
3, How many younger brothers do you have (have you had) ? 
4. How many younger sisters do you have (have you had) ? 
Has (or had) anyone in your family (father, mother, brothers or sisters) 
one or more of the following diseases ? 
5, Father 
6, Mother 
7a. Brothers 
heart failure 
stroke 
hypertension 
diabetes 
heart failure 
stroke 
hypertension 
diabetes 
heart failure 
stroke 
hypertension 
diabetes 
DO 
DO 
DO 
D 
D 
D 
DO 
DO 
DO 
DO 
DO 
rn 
DO 
DO 
before after 
55 55 
DO 
DO 
DO 
DO 
DO 
DO 
DO 
DO 
DO 
DO 
DO 
DO 
7b. How many brothers are concerned ? 
Sa. Sisters heart failure 
stroke 
hypertension 
diabetes 
8b. How many sisters are concerned ? 
9, Are in your family (parents, brothers, sisters) any cases of sudden 
death before the age of 55 from other causes than by accident ? 
J 
Cross what is applicable father 
mother 
number of brothers 
number of sisters 
1. Generally speaking, does your job run smoothly ? 
2. Would you actually take things a bit more easy ? 
3. Do you generally feel in the mood to pay visits, to do things with your 
hand, to play cards, to read or to study after the day's work is done ? 
4. Have you felt insecure or irresolute lately ? 
5. Do you regularly have tense or irritated moods or do you worry a lot ? 
6. Do you have complaints about headaches, dizzy spells or stomach 
trouble ? 
7. Have you slept badly lately ? 
8, When you wake up in the morning do you usually feel fit for the chores of 
the coming day ? 
9, Generally speaking, do you feel comfortable and well off ? 
10. Are you making a joke now and then ? 
11. Are you often singing or whistling ? 
K 
1. Do you do your work with pleasure ? generally speaking, yes 
varying 
mostly not 
2. Would you like to have a higher function then you have now ? 
3. Do you often work overtime hours or do you often take work home ? 
4. Does your house satisfy you ? 
5. How many children are still living in your house ? 
6. Are there any problems in your family or close vicinity that mean extra 
burden to you ? 
7. Generally speaking how long does it take you to go from your home to 
your job (only out) ? 
less than 20 minutes 
20 minutes to one hour 
1 to 2 hours 
longer than two hours 
8. Do you think the trip from and to your work unpleasant ? 
9. How many hours are you away from home on a working day ? 
(round off on half hours) 
before after 
55 55 
DO 
DO 
DO 
DO 
DO 
D D 
D 
D 
D 
D 
yes no 
DO 
DO 
DO 
DO 
DO 
DO 
DO 
DO 
DO 
DO 
DO 
D 
D 
D 
DO 
DO 
DO 
DO 
DO 
D 
D 
D 
D 
DO 
DOD 
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10. Do you work: 
L 
in shifts (varying duties) 
exclusively day duty or night duty ? 
1. Are you very short of breath when hurrying on level country or 
slightly uphill ? 
2. Are you very shortwinded when you are walking with other people 
on level country at a normal speed ? 
3. Do you have to stop to catch your breath when you walk on level country 
at your own speed ? 
4. Are you short of breath when you are washing or dressing ? 
M 
1. Do you usually cough first thing in the morning (when getting up) ? 
(count a cough with first smoke or on "first going out of doors". 
Exclude clearing throat or a single cough). 
2. Do you usually cough during the day or at night ? 
(ignore an occasional cough) 
If ''no" proceed toN, if "yes" to one of the two questions, answer the 
following questions 
3. Do you cough like this on most days for as much as 3 months each year ? 
4. Do you usually bring up any phlegm from your chest first thing in 
the morning (when getting up) ? (count bringing up phlegm with first 
smoke or on first going out of doors. Exclude phlegm from nose. 
Include swallowed phlegm). 
5, Do you usually bring up any phlegm from your chest during the day 
or at night ? 
6. Do you bring up any phlegm most days, as indicated, from your chest 
during at least three months per year ? 
N 
1. Have you ever gone through a period with daily complaints of pain in 
the stomach, stomach acid, eructations ? 
2. W erf:l these complaints related to eating ? 
3. Have you ever had gallstone trouble ? 
0 
1. Have you had any complaints about your health which you did not see 
when reading this questionnaire ? 
2. If so, which are these complaints ? 
3. Do you feel the need of consultinl{ your occupational health officer ? 
yes no 
DO 
DO 
DO 
DO 
DO 
DO 
DO 
DO 
DO 
DO 
DO 
DO 
DO 
DO 
DO 
DO 
DO 
COPIH VRAGENLIJST 
Ponskaartnummer 
B. G. D. 
Onderzoeknummer 
Datum 
A 
1. W at is uw beroep of funktie ? 
2, Hoe lang werkt u bij uw huidige werkgever ? 
3. Hoe lang werkt u in deze funktie ? 
4. Indien gehuwd, hoe oud is uw echtgenote ? 
5. Hoeveel kinderen hebt u ? 
6. Wie is uw huisarts ? 
B 
Naam 
Adres 
1. Hebt u wel eens pijn of een onaangenaam gevoel in de borst gehad ? 
(klachten bij verkoudheid niet meerekenen) 
2. Hebt u wel eens een drukkend of zwaar gevoel in de borst gehad ? 
(klachten bij verkoudheid niet meerekenen). 
3. Hebt u wel eens aanvallen van pijn in de onderkaak, keel, schouders 
of vingers ? 
Indien "neen" op vraag 1, 2 §13, ga dan verder naar vraag 12, 
Indien "ja'' op vraag 1, 2 of 3, beantwoord dan de volgende vragen: 
4. Krijgt u last als u een belling of trap oploopt, zich voorthaast of 
tegen de wind in loopt ? 
5, Krijgt u last indien u in gewoon tempo op vlak terrein loopt ? 
6, Wat doet u als u last krijgt terwijl u loopt ? 
7. Indien U stilstaat, verdwijnt de last dan 
gewoon doorlopen 
langzamer lopen of stilstaan 
een tablet onder de tong nemen 
binnen korte tijd (10 minuten) ? 
na meer dan 10 minuten ? 
helemaal niet ? 
B. Wilt u aangeven waar deze pijn of dit drukkend gevoel meestal zat ? 
0 
ITIJ 
I I 
[] 
rn jaar 
rn jaar 
rn jaar 
rn 
ja nee 
DO 
DO 
DO 
DO 
DO 
0 
0 
0 
0 
0 
0 
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134 
9. Krijgt u last binnen 10 minuten na een maaltijd ? 
10. Krijgt u vaak last wanneer u opgewonden of overstuur bent ? 
11. Krijgt u last als u van de warmte in de kou komt ? 
12. Hebt u ooit een ernstige pijn in of op het voorste gedeelte van uw borst 
gehad, die een half uur of !anger duurde ? 
Indien "neen" op vraag 12, ga dan verder naar vraag 15. Indien "ja" be-
antwoord dan de volgende vragen. 
13. Hebt u meer dan eens zo'n aanval gehad ? 
14. Hoe lang geleden had u de laatste aanval ? 
minder dan 1 jaar 
1 - 3 jaar geleden 
meer dan 3 jaar geleden 
15a. Bent u wel eens voor pijn in de borst door een internist of hartspecia-
list onderzocht ? 
Zo ja door wie ? 
In welk jaar ? 
b. Zijn er bij dit onderzoek naar u weet afwijkingen gevonden ? 
16. Krijgt u "bloedverdunnende" middelen" (Sintrom of Marcoumar) 
17. Staat u voor deze klachten onder geregelde controle van een specialist of 
thrombose-dienst ? 
18. Wanneer bent u daar voor bet laatst geweest ? 
c 
1. Hebt u we! eens pijn in een van de benen gedurende bet !open ? 
Indien "neen" ga dan verder naar D, indien "ja" beantwoord dan de 
volgende vragen, 
2. Komt deze pijn uit de rug ? 
Indien deze pijn uit de rug komt ga dan verder naar D 
3. Begint deze pijn wanneer u stilstaat of zit ? 
4. In welk gedeelte van de benen voelt u de pijn ? 
in de kuit 
ergens anders 
5. Krijgt u deze pijn wanneer u een belling oploopt, zich voorthaast ? 
6. Krijgt u pijn of last indien u in gewoon tempo op vlak terrein loopt ? 
Indien "neen" op deze vragen ga dan naar D, indien "ja" op €€n van 
de vragen beantwoord dan de volgende vragen. 
7. Verdwijnt de pijn ooit terwijl u loopt ? 
B. Wat doet u indien u last krijgt terwijl u loopt ? 
stilstaan of langzamer !open 
doorlopen 
9. Wanneer u stilstaat, verdwijnt de pijn dan 
binnen korte tijd (10 minuten) ? 
na meer dan 10 minuten ? 
helemaal niet ? 
10. Bent u wel eens voor pijn in een van de benen bij het lopendoor een 
hartspecialist of internist onderzocht ? 
Zo ja, door wie ? 
Wanneer is dit geweest ? 
ja neen 
DO 
DO 
DO 
DO 
DO 
D 
D 
D 
DO 
DO 
DO 
DO 
DO 
DO 
DO 
D 
D 
DO 
DO 
DO 
D 
D 
0 
0 
D 
DO 
D 
1. Hebt u 's avonds dikk.e en.kels of voeten ? 
2. Slaapt u met meer dan €€n kussen ? 
3. Moet u gewoonlijk meer dan eens per nacht uw bed uit om te urineren ? 
E 
1. Is bij u ooit een verhoogde bloeddruk gevonden ? 
Indien "neen" ga dan verder naar F, indien "ja" beantwoord dan de 
volgende vragen. 
2. Houdt u hiervoor dieet ? 
3, Gebruikt u hiervoor geneesmiddelen ? 
F 
i 
1. Hebt u ooit gerookt ? 
Indien "neen" ga dan verder naar G, indien "ja" vul dan onderstaande 
tabel in. 
2. Hoeveel rookt(e) u nu 
sigaretten (per dag) 
shag (pakjes per week) 
sigaren (per week) 
kleine sigaartjes (per week) 
pijptabak (pak.jes per week) 
1 jaar geleden 
sigaretten (per aag) 
shag (pakjes l)er week) 
sigaren (per week) 
kleine sigaartjes (per week) 
pijptabak (pak:jes per week) 
3 jaar of langer geleden 
sigaretten (per dag) 
shag (pakjes per week) 
sigaren (per week) 
kleine sigaartjes (per week) 
pijptabak (pakjes per week) 
3. Indien u het roken verminderd of gestaakt hebt, is dat dan gebeurd wegens 
bor stklachten ? 
G 
1. Werkt u voornamelijk zittend ? 
staand ? 
lopend ? 
voorovergebogen, knielend, bukkend ? 
N. B. Alle van toepassing zijnde hokjes aank:ruisen, eventueel meer dan 1). 
ja neen 
DO 
DO 
DO 
DO 
DO 
DO 
DO 
DO 
D 
D 
D 
D 
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2. Waren uw vorige funkties lichamelijk zwaarder ? 
even zwaar ? 
3. Hoe gaat u naar uw werk ? 
lichter ? 
vraag niet van toepassing ? 
lop end 
per fiets 
per brommer of motorfiets 
per auto 
per tram, bus, trein 
per pendelbus (bedrijfsvervoer} 
4. Hebt u naast uw werk nog meermalen per week bezigheden thuis of buitens-
huis, zoals timmeren, behangen, schilderen, tuinwerk, huishoudelijke 
werkzaamheden ? 
5. Doet u aan sport of traint u regelmatig ? 
6. Indien ja, hoeveel uren per week ? 
7. Kamen bij uw werkzaamheden regelmatig kortdurende perioden van extra 
H 
zware lichamelijk inspanning voor, zoals b. v. 
1. Bent u lijdende aan suikerziekte ? 
trappen of ladders beklimmen ? 
tillen of dragen van lasten ? 
zwaar trekken of duwen ? 
Indien "neen" ga dan verder naar I, indien "ja" beantwoord dan de 
volgende vragen. 
2. Hoeveel jar en lijdt u hieraan ? 
3. Houdt u hiervoor dieet ? 
4. Gebruikt u hiervoor geneesmiddelen ? 
1. Hoeveel oudere broers hebt u (gehad} ? 
2. Hoeveel oudere zusters hebt u (gehad} ? 
3. Hoeveel jongere broers hebt u (gehad} ? 
4. Hoeveel jongere zusters hebt u (gehad) ? 
ja neen 
D 
D 
D 
D 
D 
D 
D 
D 
D 
D 
DO 
DO 
DD 
D 
D 
D 
DO 
DD 
DO 
DO 
DD 
OJ 
DD 
DD 
Is iemand van uw naaste familie (vader, moeder, broers of zusters} 
lijdende (geweest} aan een of meer van de hier genoemde ziekten ? 
v66r bet na het 
55e jaar 55e jaar 
5. Vader hartinfarct 
6. Moeder 
7a. Broers 
beroerte 
hoge bloeddruk 
suikerziekte 
hartinfarct 
beroerte 
hoge bloeddruk 
suikerziekte 
hartinfarct 
beroerte 
hoge bloeddruk 
suikerziekte 
DD 
DO 
DO 
DO 
DO 
DO 
DD 
DO 
DO 
DO 
DO 
DO 
7b. Hoeveel broers betreft dit ? 
Sa. Zusters bartinfarct 
beroerte 
boge bloeddruk 
suikerziekte 
Sb. Hoeveel zusters betreft dit ? 
J 
9. Zijn er in uw naaste familie (ouders, broers en zusters) gevallen bekend 
van plotselinge dood voor bet 55e jaar anders dan door ongeval ? 
Aankruisen wat van toepassing is 
vader 
moeder 
aantal broers 
aantal zusters 
1. Gaat bet werk u in het algemeen gemakkelijk ai ? 
2. Zoudt u eigenlijk alles wat kalmer aan Willen doen ? 
3. Heeft u doorgaans na afloop van het werk nag zin om op visite te gaan 
te knutselen, te kaarten, te lezen of te studeren ? 
4. Voelt u zicb de laatste tijd onzeker of besluiteloos ? 
5. Voelt u zicb regelmatig gespannen en prikkelbaar of piekert u veel ? 
6. Heeft u wel eens last van boofdpijn, duizelingen of maagklachten ? 
7. Slaapt u de laatste tijd slecht ? 
8. Als u 's morgens wakker wordt, voelt u zicb dan doorgaans opgewas-
sen tegen de komende dag ? 
9. Hebt u bet over 't algemeen naar uw zin ? 
10. Maakt u nog wel eens een grapje ? 
11. Loopt u vaak te zingen of te fluiten ? 
K 
1. Doet u uw werk met plezier ? meestal wel 
wisselend 
meestal niet 
2. Zoudt u graag een hogere funktie willen hebben dan u nu hebt ? 
3. Verricht u vaak overwerk of neemt u vaak werk mee naar huis ? 
4. Woont u naar uw zin ? 
5. Hoeveel kinderen wonen bij u tbuis ? 
6. Zijn er problemen in uw gezin of naaste omgeving, die u extra zorg 
geven ? 
7. Hoe lang bent u gemiddeld onderweg van huis naar werk ? 
(alleen beenweg) 
korter dan 20 minuten 
20 minuten tot 1 uur 
1 tot 2 uur 
langer dan 2 uur 
8. Vindt u bet reizen naar en van uw werk onaangenaam ? 
9. Hoeveel uren bent u op een werkdag van huis ? (aironden op halve uren) 
v66r het 
55e jaar 
na het 
55e jaar 
DO 
DO 
DO 
DO 
DO 
DO 
D 
0 
D 
D 
ja neen 
DO 
DO 
DO 
DO 
DO 
DO 
DO 
DO 
DO 
DO 
DO 
D 
D 
D 
DO 
DO 
DO 
DO 
DO 
D 
D 
D 
D 
DO 
ODD 
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138 
ja neen 
10. Werkt u: 
in ploegendienst (wisselende diensten) 0 0 
uitsluitend dagdienst of nacbtdienst ? 0 O 
L 
1. Wordt u erg kortademig wanneer u zicb voorthaast op vlak terrein of 
tegen een licbte belling oploopt ? 
2. Wordt u erg kortademig terwijl u met anderen in normaal tempo op 
vlak terrein loopt ? 
3. Moet u stil gaan staan om op adem te komen, wanneer u in uw eigen 
tempo op vlak terrein loopt 7 
4. Bent u kortademig bij bet wassen of aankleden ? 
M 
1. Hoest u 's morgens gewoonlijk mete en al (bij bet opstaan) ? (boesten 
bij bet eerste roken of bij bet "eerste naar buiten gaan" meetellen. 
Keel scbrapen of een enkele kuch niet meerekenen). 
2. Hoest u gewoonlijk in de loop van de dag of 's nachts ? (af en toe hoes-
ten verwaarlozen). 
Indien "neen" ga dan verder naar N, indien "ja" op EEn van de twee 
vragen, beantwoord dan de volgende vragen: 
3. Hoest u, zoals juist aangegeven, de meeste dagen gedurende tenminste 
drie maanden per jaar ? 
4. Geeft u 's morgens gewoonlijk meteen al (bij bet opstaan) enig slijm 
op uit de lucbtwegen? (Slijm opgeven bij bet eerste roken of bij bet 
eerste naar buiten gaan meetellen. Slijm uit de neus niet meetellen. 
Wel ingeslilct slijm meetellen). 
5. Geeft u overdag of's nacbts enig slijm op uit de luchtwegen ? 
6. Geeft u, zoals juist aangegeven, de meeste dagen enig slijm op uit de 
luchtwegen gedurende ten minste drie maanden per jaar? 
N 
1. Hebt u wel eens een periode doorgemaakt, waarin u dagelijks last had 
van maagpijn, zuurbranden, oprispingen ? 
2. Hingen deze klachten samen met eten ? 
3. Hebt u ooit last van galstenen (gehad) ? 
0 
1. Hebt u klachten over uw gezondheid, die u bij bet doorlezen van deze 
vragenlijst niet bent tegengekomen ? 
2. Zo ja, waaruit bestaan dan deze klachten ? 
3. Heeft u behoefte aan een gesprek met de bedrijfsarts ? 
DO 
DO 
DO 
DO 
DO 
DO 
DO 
DO 
DO 
DO 
DO 
DO 
DO 
DO 
DO 
ANNEX 14 CHAPTER III 
REASONS WHY NO EXERCISE TEST HAS BEEN PERFORMED 
seriou_s resting ~CG abnormalities whether or not in combination with 
angina pector1s . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 9 
peripheral vascular disease . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4 
orthopedic abnormalities. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2 
refusal . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2 
total.... . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 18 
139 
ANNEX 15 CHAPTER III 
INDICATIONS FOR THE INTERRUPTION OF THE EXERCISE 
TEST 
140 
Generally speaking the exercise was terminated WHEN A MINUTE HAD PASSED 
after any of the following took place: 
the heart frequency had passed 170 beats/min.; 
the ventricular frequency during atrial fibrillation had risen to 150 
beats/min. or over; 
the systolic blood pressure had increased to 280 mm Hg or over; 
the diastolic blood pressure compared to the starting value at rest had 
increased to 20 mm Hg or over (measured several times); 
the diastolic blood pressure had increased to 140 mm Hg or over; 
the product of systolic blood pressure and cardiac frequency had exceeded 
35.000; 
the respiratory frequency had increased to 35/min. or more; 
ventricular extrasystoles quadripled or when bigemini, trigemini occurred; 
the QRS complex had gradually widened to over 0.12 seconds; 
ST-J depressions compared to the starting picture were observed in excess of 
1 Yz millimetres or more with a horizontal or declining ST ·segment; 
a complete T·top inversion took place; 
the person gave the clinical impression of being close to his maximum stress 
level; 
the person examined became markedly pale or showed signs of cyanosis; 
the person examined became clearly dyspneic; 
the person examined indicated that he was practically exhausted; 
there were complaints of pain in the legs; 
The rate of revolutions of the pedals decreased to 45/min. or less, while the 
examinee was urged to continue. 
The exercise has IMMEDIATELY been stopped by the physician (regardless of time) 
when: 
more than one ventricular extrasystole in succession was observed on the 
scope (bouts of bref ventricular tachycardia); 
when ventricular extrasystoles were observed near the T·waves of the 
preceding sinus beats (Ron T phenomenon); 
a paroxysm of supraventricular tachycardia occurred with a frequency that 
exceeded the standard for the level of exertion performed; 
paroxysmal atrial fibrillation occurred; 
a sudden widening of the QRS-complex to more than 0.12 seconds 
manifested itself (complete bundlebranch block) took place; 
a second or third degree atrioventricular block arose; 
the person examined reported angina pectoris; 
the person examined complained of dizziness or lightheaded feeling; 
a blood pressure fall was registrated of 30 mm Hg or more systolically 
compared with the previous measurement (measured several times); 
the clinical condition of the person examined necessitated so for other 
reasons. 
141 
ANNEX 16 CHAPTER III 
CODING CRITERIA OF THE EXERCISE ECG 
142 
I. Description. 
no disturbances. 
supraventricular- or ventricular extrasystoles not influenced by the exercise 
test. 
intraventricular conduction disturbances not influenced by the exercise test. 
pathologic QRS-complex not influenced by the exercise test. 
atrioventricular conduction disturbances not influenced by the exercise test. 
ST-J-depression with an ascendingST-segment. 
excessive supraventricular tachycardia. 
supraventricular- or ventricular extrasystoles clearly increasing during 
exercise. 
atrioventricular- or intraventricular conduction disturbances clearly 
increasing during exercise. 
ST -segment disturbances with an initial horizontal or descending ST · 
segment. 
T -top inversion. 
ventricular tachycardia. 
II. Interpretation 
No disturbances. 
possible ischemia cordis. 
probable ischemia cordis. 
other disturbances. 
ANNEX 17 CHAPTER III 
MODEL OF THE LETTER WITH CASE INFORMATION TO THE 
GENERAL PRACTITIONER 
OCCUPATIONAL HEALTH SERVICE 
FOR THE PORT OF ROTTERDAM 
Occupational Health Service 
St. Jobsweg 7 
Rotterdam3006 
Telephone 010-76 36 44 
Dear colleague, 
We were visited by your patient 
mr. 
born: 
at: 
address: 
function: 
Rotterdam, 
for a regular medical examination on . .......................................... . 
Previous periodical medical examination has (not) been effected (on .. ............... ) 
History: 
Height: 
Weight: 
Blood pressure in recumbent position: 
Varices: 
Ankle/foot oedema: 
Tractus Locomotorius: 
Blood: Hb mmol/1 = % 
BSR mm first hour 
Urine: Albumen: negative/positive 
Glucose: negative/positive 
Urine sedimentation: 
Lungfunction: P.E.F. = 
E.C.G.: 
F.E.V. 1 sec. = 
F.E.V. 5 sec. = 
V.C.exp. = 
F.E.V. 1/F.E.V. 5 = 
em 
kg. 
mmHg 
yes/no 
yes/no 
Cholesterol: 
Total lipids: 
Bloodsugar: 
I/ min. 
cl. 
cl. 
cl. 
% 
Odelca: No/the following abnormalities of heart and lungs. 
Exercisetest on the bicycle ergometer: 
g/1 = 
g/1 
mmol/1= 
mg% 
mg% 
mg% 
The stress proceeded according to a stepwise schedule. 
The initial load is 3 minutes of 15 Watt, followed by 3 minutes of 45 and 75 Watt. The 
next 3 steps at loads of 105 Watt, 135 Watt and 165 Watt have to be maintained for 5 
minutes each. 
The above mentioned schedule has/has not been fully completed. 
The program was stopped in the ............ minute of the ........................ Watt phase on 
account of ........... . 
143 
144 
The course of cardiac frequency, blood pressure and respiratory frequency has been 
represented in the following schedule: 
Stress Cardiac frequency 
beats/min 
Blood pressure 
nun Hg 
Respiratory frequency 
R/rnin 
E.C.G. during stress and recovery phases: (the bipolar thorax leads CM 4 and CM 6 
have been registered) 
Summary: 
Advice capacity for work: 
Sincere fraternal regards, 
ANNEX18 CHAPTERIV 
REGIONAL DISTRIBUTION OF THE GENERAL PRACTITI-
ONERS VISITED 
145 
ANNEX19 CHAPTERIV 
MODEL OF INTRODUCTORY LETTER TO THE GENERAL 
PRACTITIONERS IN PREPARATION OF THE INTERVIEW 
146 
OCCUPATIONAL HEALTH SERVICE 
FOR THE PORT OF ROTTERDAM 
Occupational Health Service 
St. Jobsweg 7 
Rotterdam·3006 
Telephone 010·76 36 44 
Dear colleque, 
In 1971 the Occupational Health Service for the Port of Rotterdam has started a study 
concerning the cardio-respiratory condition of dockworkers in the age of 55 to 65 years 
(thesis Baart). The results of each individual examination have been sent by letter to 
the general practitioner of the person examined. In 1972/1973 I have repeated this 
study examining the same people with the same standards. 
When pathology was found, both in the first and the second examinations the person 
examined has been advised to go to his own doctor. 
In order to obtain some information about the results of these directions, I have the 
intention to visit the doctors of the participants involved in order to collect this 
information in a standardized way with the aid of a questionnaire. I will report these 
results and the follow-up information in the form of a thesis. 
I hope you will allow me to contact you one of these days by telephone to ask your 
co-operation in this research and, if necessary, to give additional explanation. 
I sincerely hope you will be willing ~o co-operate, and remain, 
with fraternal regards, 
A. Schelling, M.D. 
ANNEX20 CHAPTERIV 
QUESTIONNAIRE VISIT GENERAL PRACTITIONER 
Translation 
patient number 
date inquiry 
name patient 
address 
residence 
function before screening I 
function after screening I 
function after screening II 
present doctor (screening TI) nr. 
name 
address 
residence 
pass. previous doctor (screening I) nr. 
name 
address 
I I I 
0 
0 
0 
I I 
residence ---------~~--~~-
date letter I 
date letter II 
final minute exercise test I 
final minute exercise test II 
RISK PROFILE 
smoking 
blood pressure 
cholesterol 
total lipids 
weight 
G.T.T. 
ECG 
-
ischemia 
- rhythm/ cond. disturb. 
- other disturbances 
I 
'I i= *=i=~=l=i 
' Ll j_j_~j_J__j 
0 
0 
minute of the 1 1 1 I Watt phase 
minute of the rrn watt phase 
I n 
pos.O neg.o pas. 0 
I I I mm Hg I I I I I I I I mmHg 
I I I I mg% I I I 
I I I I I rug% I I I I 
I I I I kg. I I I 
DODO DO rn rn 
pos.O neg.o pas. 0 
pos.D neg.o pas. 0 
pos.D neg. 0 pas. 0 
neg. 0 
I I I I 
I mg% 
I mg% 
I kg. 
rn 
neg_.. 0 
neg. 0 
neg. 0 
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PART I 
148 
SCREENING I 
below standard 
blood pressure 
over standard 
below standard 
cholesterol 
over standard 
below standard 
G.T.T. 
over standard 
inapplicable 
SCREENING II 
below standard 
blood pressure 
over standard 
below standard 
cholesterol 
over standard 
below standard 
G.T.T. over standard 
inapplicable 
1. Did you receive letter II of date I I I I 
2. Did you receive letter I of date I I I 
3. How long has patient belonged to your practice ? 
4. Does your patient come under the National Health 
system? (sick found) 
I 
I 
Explication : people with incomes just over the 
National Health system will sometimes not be 
insured for the fees of general practitioners so that 
they will possibly sooner be directed to specia-
lists in order to avoid putting them to expenses. 
5. Has patient followed our advice to consult you for 
the disturbances we have found ? 
6. When you have received letter I: 
Has the information we have supplied you concer-
ning pathology and risk factors, been a reason 
0 
0 
0 
0 
0 
0 
~ 
0 
0 
~ 
GJ 
G 
0 
II] 
I? 
I? 
for you to take the initiative on behalf of your patient 
(e. g. to visit him, to send him a notice to come to 
your consulting hour etc.) ? 
impossible to check [Q] 
yes:( straight from 0. H. S. [jJ 
from addressee [1] 
no QJ 
impossible to check [Q] 
straight from 0. H. S . [jJ 
yes . / [1] ''-from addressee 
no QJ 
< 6 months [jJ 
6-12 months [1] 
~12 months QJ 
impossible to check [Q] 
yes [jJ 
no [1] 
impossible to check [Q] 
yes [jJ 
no [1] 
impossible to check [Q] 
yes [jJ 
no [1] 
Continue with questionnaire part I if: question 5: yes and/or 
question 6: yes 
7. With which of the following disturbances have you 
been familiar before date letter I ? 
(or more possibilities) 
8. Have our determinations been repeated by you or at 
your request after you had received our letter ? 
impossible yes 
to check 
8.1. bloodpressure 
8. 2. cholesterol 
8. 3. G.T.T. 
9. If so, by whom? (one or more possibilities) 
10. Have the results confirmed our findings {again 
deviating from the standard) ? 
impossible yes to check 
10.1 bloodpressure 
10.2 cholesterol 
10.3 G.T.T. 
11. Which were the findings ? 
measured impossible 
value 
11.1. bldpr. (Pd mm Hg) 
II. 2. chol. (mg%) * 
II. 3. G. T. T. (mmol/1) 
* Place where determined ? 
12. Has a treatment been prescribed ? 
impossible 
to check 
12.1. hypertension 
12.2. hyperchol ester ole mia 
12. 3. disturbed G. T. T. 
13. Who took care of the treatment (or more 
possibilities) ? 
to check 
yes 
no 
hypertension 
hyper cholesterolemia 
disturbed G. T. T. 
no 
no 
< 
general practitioner 
internist 
cardiologist 
other specialist 
I 2 
100 ~100 
< 260 260-300 
< 5, 6 5, 6-6, 6 
no 
general practitioner 
internist 
cardiologist 
other specialist 
3 
,?300 
~6, 6 
149 
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14, If patient has not been remitted, what has been the 
main reason not to send him on ? 
When question 12 confirmative, please answer also 
question 15 and 16. 
15. What sort of treatment has been given ? 
impossible diet/ 
to check regimen advice *) 
15. 1. hypertension 
15. 2. hypercholesterolemia 
15. 3. disturbed G. T. T. 
impossible to check [Q] 
indication not serious enough ITJ 
I have all facilities for fur-
ther diagnosis and assistance []] 
remittance to specialist 
difficult because of: 
age 11] 
distance [i] 
time burden [iJ 
{over)burdening specialist [ill 
other reasons, such as [1] 
medica- both 
mental **) ') ") 
*) which advice ....•....••..•.......•.•..•...........•....•....•..•..•.. 
**) which medication ..........•.......•..........•..•.•.....•..•.•..•..•.• 
16. Has the manner of treatment changed during accompaniment ? 
impossible yes no to check 
16.1. hypertension 
16. 2. hypercholesterolemia 
16. 3. disturbed G. T. T. 
If question 16 has been answered with yes, please answer question 17 also. 
17. In which way has the method of treatment been changed ? 
impossible diet/ medica- both 
to check regimen mental**) ') ") advice *) 
17.1. hypertension 
17. 2. hypercholesterolemia 
17. 3. disturbed G. T. T. 
*) which advice •.•..•...•..•..•....••••..... · ..••••.•....••.•.•••.•..•.•... 
**)which medication •..•..••.••....•...••.....•..•.•.....•..•.•..••.•.••.• 
18. Are there regular check-ups ? 
19. Has the person examined been satisfied or dissatis-
fied as regards examination or advice 0. H. S. ? 
impossible to check 
at least once a month 
at least once 3 months 
at least once 6 months 
at least once 12 months 
19.1 As regards examination ? impossible to check 
When dissatisfied (4; 5) why ? ••••••••. , • . . • • . . • . • • satisfied 
19. 2, As regards advice ? 
When dissatisfied (4; 5) why ? ................... . 
20. Did you observe undesired side effects with the above 
mentioned person examined as regards examination or 
advice (fear, disturbance psychic equilibrium and 
such). 
dissatisfied 
impossible to check 
satisfied 
dissatisfied 
20.1. As regards examination ? impossible to check 
If so,_ which ? ..••.•..•..••••..•.. , •. , •..•...• , , yes 
no 
20. 2. As regards advice given ? impossible to check 
If so, which ? ~ ••.•.•••••..•.••..•••••.•• , , • . • • • yes 
PART II Patient number 
21. Do you consider large scale cardiovascular 
screening-examination signiiicant at this 
moment in The Netherlands ? 
22, Do you think that tracing of "high risk" groups as 
regards cardiovascular heart diseases must be 
effected by: 
Which other method ? ........................ . 
23, When large scale screening examination on cardio-
vascular heart diseases will be organized, many 
people in the "high risk" group will be traced, Do 
you consider accompaniment of these people by you 
as general practitioner feasable ?· 
24. 1. Do you expect that when cardiovascular screening 
teams will check your patients every three years 
this will have favourable or unfavourable effect on 
the physical state of health of the people ? 
no 
no opinion 
recommendable 
not appropriate 
screening teams 
general practitioner 
other method 
no opinion 
fully 
absolutely not 
no opinion 
favourable 
unfavourable 
@] 
ITl 
[]] 
@] 
ITl 
[]] 
@] 
ITl 
[]] 
QJ 
[I] 
IIl 
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24. 2. Do you expect that when cardiovascular screening 
teams will check your patients every three years 
this will have favourable or unfavourable effect on 
the mental state of health of the people ? 
25. Do you expect that when screening teams will check 
your patients every three years this will change your 
consulting hours quantitatively in the sense of : 
26. 1. Do you think that a decrease of risk factors will 
reduce the chance of cardiovascular diseases for 
adults under 40 ? 
26. 2. for people of 40 - 55 years ? 
26. 3. for people of 55 - 65 years ? 
26. 4. for people over 65 ? 
27, 1. Do you consider cardiovascular screening by our 
standards, excl. exercise testing as possible to be 
realised by you as general practitioner at your 
present working conditions for adult patients 
under 40 ? 
27. 2. for people of 40 - 55 years ? 
27. 3. for people of 55 - 65 years ? 
27. 4. for people over 65 ? 
28. When the answer is no, what is the major reason ? 
no opinion 
favourable 
unfavourable 
no opinion 
busier 
no influence 
less busy 
no opinion 
yes 
no 
no opinion 
yes 
no 
no opinion 
yes 
no 
no opinion 
yes 
no 
no opinion 
yes 
no 
no opinion [QJ 
yes [] 
no ~ 
no opinion [QJ 
yes [] 
no ~ 
no opinion [Q] 
yes [] 
no ~ 
insufficient knowledge of 
ECG's [] 
no time rn 
too large practice []] 
insufficient staff [!] 
insufficient accommodation [lJ 
no laboratory available [§] 
not interested [1] 
consider it inappropriate []] 
other impediments, such as ~ 
29. Do you have your own ECG facilities available ? 
30. Do you judge the ECG's yoursell ? 
31. Who do you consider the right person to tell the 
results of a screening examination to the person 
examined ? 
31.1. When no abnormalities have been found ? 
31. 2. In case of borderline abnormalities ? 
31.3 In case of pathology ? 
32. Do you consider it acceptable that in case of bar-
derline abnormalities screening teams give the 
following advice without referring to the general 
practitioner: lose weight, stop smoking, diet 
low in cholesterol, diet low in salt ? 
33. Do you feel the need of a possibility to refer 
people within your practice at your initiative, 
to be checked by a cardiovascular screening 
team? 
34. Which information do you prefer from a screening 
team? 
35. Do you consider the performance of a screening 
examination by an Occupational Health Service 
right ? 
yes 
no 
yes 
no 
screening team 
general practitioner 
to be decide independently 
for each case 
otherwise, such as •..•.• 
screening team 
general practitioner 
to be decided independently 
for each case 
otherwise, such as .•.•..• 
screening team 
general practitioner 
to be decided independently 
for each case 
otherwise, such as •.•.•.. 
no opinion 
acceptable 
unacceptable 
no opinion 
regularly 
seldom 
no 
extensive policy suggestion 
concise with policy 
suggestion 
extensive without policy 
[) 
[II 
[I] 
II] 
[) 
[II 
[I] 
II] 
[) 
[II 
rn 
III 
[QJ 
IIl 
rn 
rn 
III 
[[] 
[OJ 
IIl 
IIJ 
rn 
IIl 
suggestion [I] 
concise without policy 
suggestion [!] 
no opinion 
correct 
incorrect 
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36. Do you consider it a motivation of an 0. H. S. to no opinion [QJ 
perform a screening test in the interest of the 
interest man [jJ man or of the company ? 
[]] 
[l] 
rn 
interest company [[] 
37. Generally speaking, have you had favourable or no opinion [Q] 
unfavourable experiences with industrial favourable [jJ physicians ? 
[]] 
[l] 
rn 
unfavourable [[] 
38. What is the total number of patients in your < 2000 [jJ 
practice (National Health+ private patients) ? 2000 2499 []] 
2500 2999 [l] 
3000 3499 rn 
~3500 [[] 
39. Do you have subsidiary functions, medical or yes [jJ 
not medical ? 
no []] 
40. If question 39 yes: 
which subsidiary function(s) do you have ? medical adviser insurance 
company [jJ 
controlling of patients [l] 
occupational health officer []] 
N. V. S. H. physician 
( = Dutch Society for Sexual [j] Reform) 
other [@ 
41. If question 39 yes : < 4 hours III How many hours a week do you spend in your 4 8 hours []] subsidiary Junction (s) ? 
8 16 hours []] 
~16 hours [}] 
42. For how many years have you been a general ~ 5 years III practitioner ? 6 10 years []] 
11 15 years []] 
16 20 years [iJ 
21 25 years []] 
;;: 26 years []] 
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HUISARTSEN VRAGENLIJST 
patH~ntnummer 
datum enqu€!t e 
naam patient 
adres 
woonplaats 
funktie voor onderzoek I 
funktie na onderzoek I 
funktie na onderzoek II 
huidige huisarts (onderzoek II) no. 
naam 
adres 
woonplaats 
event. vorige huisarts (onderzoek I) no. 
naam 
adres 
woonplaats 
datum brief I 
datum brief II 
' i=l i=f==l=i=i 
' '-1 L_L___L_L~ 
laatste minuut inspanning onderzoek I : 0 minuut van de fase van I I I I Watt 
laatste minuut inspanning onderzoek II : 0 minuut van de fase van ITTJ Watt 
RISICOPROFIEL I II 
roken pos.D neg.o pas. D 
bloeddruk I I I I mmHg I I I I I I I I mmHg 
cholesterol I I I I mg% I I I I 
totaal lipiden I I I I I mg% I I I I 
gewicht I I I I kg .. I I I I 
G.T.T. moo DO DO DO 
ECG- ischaemie pos.O neg.o pas. 0 
ritme/gel. stoorn. pos.D neg.o pas. 0 
andere afwijkingen pos.D neg. 0 pas. D 
I 
I I 
I I 
D 
0 
0 
I I 
I I 
neg. 0 
I I I I 
mg% 
mg% 
kg. 
DO 
neg.._. 0 
neg. D 
neg. 0 
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DEELI 
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ONDERZOEK I 
onder norm 0 bloeddruk 0 boven norm 
onder norm 0 
cholesterol 0 boven norm 
onder norm 0 G.T.T. ~ boven norm 
niet van toepassing ~ 
ONDERZOEK TI 
onder norm 0 bloeddruk GJ boven norm 
onder norm G 
cholesterol GJ boven norm 
onder norm 0 G.T.T. 0 boven norm 
niet van toepassing [I] 
1. Heeft u brief IT d. d. I I I I I ontvangen ? 
2. He eft u brief I d. d. LLLLJ'--'-.Jl ontvangen ? 
3. Hoe lang behoort patient tot uw praktijk ? 
4, Is patient verplicht verzekerd (ziekenfonds) ? 
Explicatie: mensen met een inkomen net hoven 
de "ziekenfondsgrens" zijn soms niet voor 
huisartskosten verzekerd waardoor ze eventueel 
eerder worden verwezen om ze niet op kosten 
te jagen. 
5. Heeft patient ons advies opgevolgd u te consul-
teren i. v. m. de door ons gevonden aiwijkingen ? 
6. Indien u brief I heeft ontvangen: 
Vormde de door ons verstrekte informatie be-
treffende pathologie en risicofactoren voor u een 
aanleiding om een initiatief te nemen ten bate 
van patient (bijv. bezoeken, oproep sturen om op 
spreekuur te komen e. d.) ? 
niet na te gaan [QJ 
ja'< direct van B. G. D. [jJ 
van geadresseerde ~ 
neen QJ 
niet na te gaan [QJ 
direct van B. G. D. [jJ 
ja:< ~ van geadresseerde 
neen QJ 
< 6 maanden ITl 
6-12 maanden QJ 
)-12 maanden QJ 
niet na te gaan [QJ 
ja ITl 
neen ~ 
niet na te gaan [QJ 
ja ITl 
neen QJ 
niet na te gaan [QJ 
ja [jJ 
neen QJ 
Vragenlijst deel I afmaken indien: vraag 5: ja en/of 
vraag 6: ja 
7. Welke van de onderstaande afwijkingen war en u 
reeds bekend voor datum brief I ? 
(eventueel meerdere mogelijkheden) 
8. Zijn onze bepalingen door of namens u herhaald 
na ontvangst van onze brief ? 
niet na ja te gaan 
8.1. bloeddruk 
8. 2. cholesterol 
8. 3. G. T. T. 
geen 
hypertensie 
hypercholesterolaemie 
gestoorde G. T. T. 
neen 
9. Zo ja, door wie? (eventueel meerdere mogelijkheden) huisarts 
10. Waren de resultaten conform onze bevindingen 
(wederom afwijkend van de norm) ? 
niet na ja te gaan 
10. 1 bloeddruk 
10.2 cholesterol 
10.3 G.T.T. 
11. Welke waren de bevindingen ? 
gemeten niet na 
waarde te gaan 
11.1. blddr. (Pct mm Hg) 
11. 2. chol. (mgo/c,) * 
11. 3. G. T. T. (mmo1/l) 
* Waar bepaald ? •••••••••.••.••. 
12. Is behandeling ingesteld ? 
niet na ja te gaan 
12.1. hypertensie 
12. 2. hypercholesterolaemie 
12. 3. gestoorde G. T. T. 
13. Wie verzorgde de behandeling (eventueel meer-
dere mogelijkheden) ? 
internist 
cardioloog 
andere specialist 
neen 
1 2 
< 100 ~100 
< 260 260-300 
< 5, 6 5, 6-6, 6 
neen 
huisarts 
internist 
cardioloog 
andere specialist 
3 
:;.<:300 
~ 6,6 
specialisme •.•...••.....• 
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14. Indien patient niet is verwezen, wat was de voor-
naamste reden om niet te verwijzen ? 
Indien vraag 12 ja, oak vraag 15 en 16 beantwoorden. 
15. Welke behandeling vond plaats? 
niet na dieet/ leefregel 
te gaan advies *) 
15. 1. hypertensie 
15. 2. hypercholesterolaemie 
15. 3. gestoorde G. T. T. 
niet na te gaan [QJ 
indicatie niet ernstig genoeg m 
beschik zelf over alle facili-
teiten om verder te diagnos-
tiseren en te begeleiden [1] 
verwijzing naar een specia-
list is te bezwaarlijk i. v. m.: 
leeftijd []] 
reisafstand [!] 
tijdsbelasting rKJ 
(over} belasting specialist [ill 
andere zoals............. m 
medica- be ide 
menteus **) ') *') 
*) welk advies •.............••..............••.•..•...............•....•.•. 
**) welke medicijnen ••..•...........•....................•......••......•... 
16. Is gedurende de begeleiding de behandelingswijze gewijzigd ? 
niet na 
te gaan ja neen 
16. 1. hypertensie 
16. 2. hype rchol est erola em i e 
16. 3. gestoorde G. T. T. 
Indien vraag 16 met ja is beantwoord, oak vraag 17 beantwoorden. 
17. Op welke manier is de behandelingswijze gewijzigd ? 
niet na dieet/ medica- · beide 
te gaan leefregel menteus **) ') *') 
advies *) 
17.1. hypertensie 
17.2. hyper chol est erola em ie 
17. 3. gestoorde G. T. T. 
*) welk advies •.......•.............•......•..•....•......................• 
**) welke medicijnen .........•...............•................•..•....•...•• 
18, Vindt regelmatig contrOle plaats ? 
19. Was onderzochte tevreden of ontevreden 
t. a. v. onderzoek of advisering op de B. G. D. ? 
niet na te gaan [QJ 
minstens 1x per maand [!] 
minstens lx per 3 maanden W 
minstens 1x per 6 maanden [1] 
minstens 1x per 12 maanden m 
neen [[] 
DEEL II 
19.1 T.a.v. onderzoek? 
Indien ontevreden (4; 5), waarover ? .•.....•.• 
19.2. T.a.v. advisering? 
Indien ontevreden (4; 5), waarover ? •••••.••• 
20. Heeft u bij bovenstaande onderzochte ongewenste 
bijwerkingen geconstateerd t. g. v. onderzoek of 
advisering (angst, verstoring psychisch even-
wicht, e. d. ) ? 
20.1. T.g.v. onderzoek? 
Indien ja, welke ? •••••••••••••••••••••••••• 
20. 2, T. g. v. advisering ? 
Indien ja, welke ? •••• , ••••• .' ••••••.•••••••• 
Patientnummer 
21. Acht u bet zinvol op dit moment op grate schaal 
cardiovasculair screeningsonderzoek te gaan 
verrichten in Nederland ? 
22. Bent u van mening dat opsporing van "high risk" 
groepen t.a. v. cardiovasculaire hartziekten dient 
te geschieden door 
Op welke andere wijze ? .... , .•..•...•.•..•...• 
23. Bij screeningsonderzoek op cardiovasculaire hart-
ziekten op grate schaal zullen veel mensen, behoren-
de tot de , high risk'' groep opgespoord worden. Acht 
u begeleiding van deze mensen door u als huisarts 
mogelijk ? 
24.1. Verwacht u, dat indien cardiovasculaire scree-
ningsteams driejaarlijks uw patienten onder-
zoeken dit een gunstige of ongunstige invloed zal 
hebben op de lichamelijke gezondheidstoestand 
van de mensen ? 
niet na te gaan 
tevreden 
ontevreden 
niet nate gaan 
tevreden 
ontevreden 
niet na te gaan 
ja 
neen 
niet na te gaan 
ja 
neen 
geen mening 
toe te juichen 
niet zinvol 
screeningsteams 
huisarts 
andere wijze 
geen mening 
volledig 
absoluut niet 
geen mening 
gunstig 
ongunstig 
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24. 2. Verwacht u, dat indien cardiovasculaire scree-
ningsteams driejaarlijks uw patH!nten onderzoe-
ken dit een gunstige of ongunstige invloed zal 
hebben op de geestelijke gezond.heidstoestand 
van de mensen ? 
25. Verwacht u, dat indien screeningsteams drie-
jaarlijks uw patiJ:;nten onderzoeken uw spreekuur 
daardoor kwantitatief verandert in de zin van: 
26.1. Bent u van mening dat verlagen van de risico-
factoren de kans op cardiovasculaire ziekten 
vermindert bij volwassenen onder de 40 jaar ? 
26. 2. Bij mens en van 40 - 55 jaar ? 
26. 3. Bij mensen van 55 - 65 jaar ? 
26. 4. Bij mensen hoven 65 jaar ? 
27 .1. Acht u cardiovasculaire screening volgens onze 
normen, excl. inspanningsonderzoek door u als 
huisarts realiseerbaar onder uw huidige werk-
omstandigheden bij uw volwassen patienten 
onder de 40 jaar ? 
27. 2. Bij men sen van 40 -55 jaar ? 
27. 3. Bij mens en van 55 - 65 jaar ? 
27. 4. Bij mensen hoven 65 jaar ? 
28. lndien neen, wat vormt de voornaamste 
belemmering ? 
geen mening 
gunstig 
ongunstig 
geen mening 
drukker 
niet beinvloed 
minder druk 
geen mening 
ja 
neen 
geen mening 
ja 
neen 
geen mening 
ja 
neen 
geen mening 
ja 
neen 
geen mening 
ja 
neen 
geen mening 
ja 
neen 
geen mening 
ja 
neen 
geen mening 
ja 
neen 
@] 
IIl 
[]] 
@] 
IIl 
[]] 
@] 
IIl 
[]] 
onvoldoende kennis van ECG's ITJ 
geen tijd m 
te grate praktijk II) 
onvoldoende personeel [!] 
onvoldoende ruimte [§] 
geen~laboratorium ter be-
schikking [§] 
geen interesse [1] 
acht bet niet zinvol [§] 
andere belemmeringen zoals ill] 
29. Heeft u de beschikking over een eigen ECGapparaat? 
30. Beoordeelt u zeli de ECG's ? 
31. Wie dient het resultaat van een screeningsonder-
zoek naar uw mening aan de onderzochte mede 
te delen ? 
31.1. Indien er geen bijzonderheden zijn gevonden: 
31. 2. Bij borderline afwijkingen : 
31. 3. Bij pathologie : 
32. Acht u het aanvaardbaar dat screeningsteams 
bij borderline afwijkingen zonder verwijzing 
naar de huisarts de volgende adviezen geven: 
vermageren, roken stak.en, cholesterolarm 
dieet volgen, zoutgebruik beperken ? 
33. Heeft u behoefte aan de mogelijkheid om personen 
uit uw praktijk op uw initiatief naar het onderzoek 
van een cardiovasculair screeningsteam te 
verwijzen ? 
34. Welke berichtgeving prefereert u van een 
screeningsteam ? 
35. Vindt u het verrichten van screeningsonderzoek 
door een Bedrijfsgeneeskundige Dienst juist ? 
ja 
neen 
ja 
neen 
screeningsteam 
huisarts 
per geval beoordelen 
ander s zoals •.....•...... 
screeningsteam 
huisarts 
per geval beoordelen 
anders zoals .••••.••••.• 
screeningsteam 
huisarts 
per geval beoordelen 
anders zoals ••..•.•••..•. 
geen mening 
aanvaardbaar 
onaanvaardbaar 
geen mening 
regelmatig 
sporadisch 
neen 
uitvoerig met beleidsvoorstel 
beknopt met beleidsvoorstel 
uitvoerig zonder 
beleidsvoorstel 
beknopt zonder 
beleidsvoorstel 
geen mening 
juist 
onjuist 
[] 
m 
[II 
[] 
[] 
m 
[II 
[] 
[j] 
m 
rn 
[i] 
[QJ 
[jJ 
rn 
rn 
[i] 
[[] 
[QJ 
[jJ 
rn 
rn 
[jJ 
rn 
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36. Ziet u ala motivatie van een B. G. D. om scree· geen mening []] 
ningsonderzoek te doen het belang van de man of belang man rn dat van het bedrijf ? 
rn 
Ill 
m 
belang bedrijf []] 
37. Heeft u in het algemeen gunstige of ongunstige geen mening []] 
ervaringen met bedrijfsartsen ? gunstig rn 
rn 
Ill 
rn 
ongunstig []] 
38. Hoeveel patiianten omvat uw praktijk totaal ? < 2000 rn (ziekenfonds + particuliere pati~nten) 2000 - 2499 rn 
2500 - 2999 Ill 
3000 - 3499 rn 
#3500 []] 
39. Heeft u een of meer al of niet medische ja rn 
nevenfunkties ? rn neen 
40. lndien vraag 39 ja: medisch adviseur 
welke nevenfunktie(s) heeft u ? verzekeringsmij rn 
ziektecontrOle Ill 
bedrijfsarts I]] 
N. V. S. H. arts IITl 
andere @g 
41. lndien vraag 39 ja: <4 uur [!] 
Hoeveel uur per week besteedt u aan uw neven- 4 
-
8 uur rn funktie(s) ? 
8 - 16 uur rn 
).16 uur 8J 
42. Hoeveel jaar bent u reeds huisarts ? .:«;;: 5 jaar [!] 
6 10 jaar rn 
11 15 jaar I]] 
16 20 jaar [iJ 
21 - 25 jaar I]] 
#26 jaar rn 
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ANNEX 22 CHAPTER V 
EXTREME VALUES 
Cardiac frequency (b/min) .................................. . < 50 > 100 
Systolic blood pressure in recumbent position (mm Hg) .. · · · · · .. . < 100 > 180 
Diastolic blood pressure in recumbent position (phase IV) ....... . < 70 > 100 
Diastolic blood pressure in recumbent position (phase V) ....... . < 70 > 100 
Length (em) .............................................. . <160 > 200 
Weight (kg) .............................................. . < 60 > 100 
Hb (mmol/1) .............................................. . < 6,0 > 11,0 
Fasting serum cholesterol (g/1) .............................. . < 2,0 > 3,6 
Fasting total lipids (g/1) ......•.............................. < 6,0 > 12,0 
Fasting bloodsugar (mmol/1) ................................ . < 3,0 > 6,7 
F.E.V.1 sec. (1) ..................... · ....... · · · · · · · · · · · · · · · < 1,0 > 3,0 
F.E.V. 5 sec. (1) ........................................... . < 2,0 > 5,0 
V.C. exp. (1) .............................................. . < 2,0 > 5,0 
Systolic blood pressure during exercise (rom Hg) .... , ...... , ... . <100 >280 
Diastolic blood pressure during exercise (rom Hg) ........... , .. . >120 
Respiratory frequency during exercise (R/min) ................. . < 10 >180 
Cardiac frequency during exercise (B/min) .................... . < 50 > 180 
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ANNEX 23 CHAPTER VI 
ANSWERING OF QUESTION BS OF THE QUESTIONNAIRE 
PERIODICAL MEDICAL EXAMINATION "COPIH" 
166 
SCREENlliG I SCREENlliG II 
Location A+B A B c 
A+B 2 2.7 1.3 1.3 
A 39 52.0 26,7 2.7 17.3 
B 4 5.3 1.3 1.3 1.3 1.3 
c 26 34.7 12.0 2.7 13,3 
D 4 5,3 4.0 1.3 
Total 75 100.0 1.3 44.0 8.0 34,7 
Numbers Percentages 
Will you mark where this pain or pressure was generally located? 
Location of chest complaints. 
right left 
D A 
D 
5.3 
6,7 
12.0 
ANNEX 24 CHAPTER VI 
ANSWERING OF QUESTION F2 OF THE QUESTIONNAIRE 
PERIODICAL MEDICAL EXAMINATION "COPIH" 
"How many cigarettes do you smoke per day (including handrolled cigarettes)?" 
SCREENING I SCREENING II 
cigarettes cigarettes per day 
per day 
1-10 10-20 20-30 )/30 
0 90 21. 3 0.7 
1 -10 81 19.2 
10-20 225 53. 3 4.0 
20-30 24 5.7 0.9 0.·7 
~ 30 2 0.5 0.2 
Total 422 100.0 27.3 28.7 39.1 4.5 0.5 
Numbers Percentages 
167 
ANNEX 25 CHAPTER VI 
CODING LIST REST-ECG ACCORDING TO MINNESOTA CODE 
CODING LIST - ECG's 
Subject number : Lf -~:;::::;:=:;;:=~ 
Date : 
Name : 
Birth-date I I 
Serial number EGG : D 
MINNESOTA CODE (1968) 
Column 
67 0 
2 
3 
4 
5 
6 
7 
8 
9 
68 0 
l 
168 
Code 
No EGG available 
le EGG 
2e EGG 
3e EGG 
4e EGG 
5e EGG 
6e EGG 
7e EGG 
8e EGG 
9e EGG 
No Q pathology 
Class I (any of l-1-1 through 1-l-7) 
1-1-1 Q/R amplitude ratio 1/3 or more plus Q duration 
0.03 sec or more in any of leads I,II,V2,3,4,5,6 
1-1-2 Q duration 0. 04 sec or more in any of leads 
I, II, Vl , 2, 3, 4 , 5, 6 
1-1-3 Q duration 0. 04 sec or more, plus R amplitude of 
3 mm or more in lead aVL 
1-1-4 Q duration 0. OS sec or more in lead III plus any 
Q wave of at least 1. 0 mm amplitude in aVF 
1-1-5 Q duration 0.05 sec or·more in lead aVF 
l-1-6 QS pattern when R wave is present in adjacent 
lead to the right on the chest in any of leads 
V2,3,4,5,6 
1-1-7 QS pattern in all of leads Vl-V4,Vl-VS orVl-V6 
Column Code 
67 0 
D 
D 
D 
D 
D 
LJ 
D 
D 
D 
68 D 
D 
Column Code 
68 2 
68 3 
Class II (any of 1-2-1 through 1-2-8) 
1-2-1 Q/R amplitude ratio 1/3 or more, plus Q duration 
at least 0. 02 sec and less than 0. 03 sec in any 
of leads I , II, V2 , 3, 4, 5, 6 
1-2-2 Q duration at least 0. 03 sec and less than 0. 04 
sec in any of.leads I ,II, V2, 3,4 ,5, 6 
1-2-3 QS pattern in lead II 
1-2-4 Q duration of at least D. 04 sec and less than 
0. 05 sec in lead III, plus any Q wave of at least 
1. 0 mm amplitude in aVF 
1-2-5 Q duration at least 0.04 sec and less than 
0. OS sec in lead aVF 
1-2-6 Q amplitude of 5 mm or more in either of leads 
III, aVF 
l-2-7 QS pattern in all of leads V1 through V3 
1-2-8 R amplitude decreasing to 2 mm or less, and 
absence of .codes 3-2, 7-2, or 7-3, between any 
of leads V2 and V3,V3 and V4,V4 and VS, or 
VS and V6 
Class III (any of 1-3-1 through l-3-6) 
1-3-1 Q/R amplitude ratio at least l/5 and less than 
1/3 plus Q duration of at least D. 02 sec and less 
than D.03 sec in any of leads I,II,V2,3,4,5,6 
1-3-2 QS pattern in absence of code 3-1, in each of 
leads Vl and V2 
1-3-3 Q duration of at least 0. 03 sec and less than 
0. D4 sec, plus R amplitude of 3 mm or more in 
lead aVL 
1-3-4 Q duration of at least D. 03 sec and less than 
0. D4 sec in lead III, plus any Q wave of at least 
1. 0 mm amplitude in lead aVF 
1-3-5 Q duration of at least D.03 sec and less than 
0. D4 sec in lead aVF 
1-3-6 QS pattern in each of leads III and aVF 
Column Code 
68 D 
68 D 
169 
Column Code Column Code 
69 0 Geen QRS as deviatie 69 D 
2-1 Left: D QRS axis from -30° through -90° in leads l 1 II 1 III. 
(The algebraic sum of major positive and major 
negative QRS waves must be zero or positive in I 1 
negative in III 1 and zero or negative in II). 
2 2-2 Right: 0 0 D QR8 axis from +120 through -150 in leads I 1 II 1 III. 
{The algebraic sum of major positive and major 
negative QR8 waves must be negative in I, and zero 
or positive in III 1 and in I must be one-half or more 
of that in III.) 
3 2-3 Right (optional co'be when 2-2 is not present): D QRS axis from +90 through +119° in leads I,II 1 III. 
(The algebraic sum of major positive and major 
negative QRS waves must be zero or negative in I 
and positive in II and III.) 
4 2-4 Extreme axis deviation (usually 81 1 82 1 83 pattern): D QRS axis from -90° through -149° in leads I 1 II and III. 
(The algebraic sum of major positive and major 
negative QR8 waves must be negative in each of leads 
!,II and III.) 
5 2-5 Indeterminate axis: 
QRS axis approximately 90° from the frontal plane. D 
(The algebraic sum of major positive and major 
negative QRS waves is zero in each of leads I 1 II and 
III 1 or the information from these three leads is 
incongruous . ) 
70 0 No high amplitude R waves 70 D 
3-1 Left: D 
R amplitude greater than 26 mm in either of 
leads V5 or 6; or 
R amplitude greater than 2 0 mm in any of 
leads I 1 II 1 III 1 aVF; or 
R amplitude greater than 12 mm in lead aVL 
2 3-2 Right: D 
R amplitude equal to or greater than 5. 0 mm and 
R amplitude equal to or greater than S amplitude in 
lead Vl 1 when a decr.easing R/S amplitude ratio 
occurs somewhere to the left of Vl on the chest. 
(Includes code 7-3 1 which meets the above criteria.) 
3 3-3 Left (optional code when 3-1 is ngt present): 
R amplitude greater than 15 mm but less than 20 mm 
in lead I, or R amplitude ~n V5 or 6 1 plus S amplitude 
in Vl greater than 35 mm. 
170 
Column Code Column Code 
71 0 Normal ST segment 71 D 
1 4-1 8-T-J depression 1. 0 mm or more and 8-T segment D 
horizontal or downward sloping in any of leads 
I,II,aVL,aVF,V1,2,3,4,5,6 (requires aT-wave 
code in 5). 
2 4-2 8-T-J depression at least 0. 5 mm and less than 
1. 0 mm and 8-T segment horizontal or downward 
D 
sloping in any of leads I ,II, aVL,aVF, V1,2 1 3,4 ,5, 6. 
(Requires a T-Wave code in 5.) 
3 4-3 No 8-T-J depression as much as 0. 5 mm 1 but 8-T I 
segment downward sloping and segment or T-wave 
nadir at least 0. 5 mm below P-R baseline in any of 
leads I,II,aVL,V2,3 1 4 1 5 1 6. (Requires a T-wave 
code in 5.) 
4 4-4 8-T-J depression of 1. 0 mm or more and 8-T segment ! I 
upward sloping, or U-shaped, in any of leads 
I,II,aVL, V1 1 2, 3,4 1 5, 6. 
72 0 No T wave disturbances 72 D 
1 5-1 T amplitude negative, minus 5 mm or more in any ! 
of leads I,II,V2,3 1 4,5 1 6 or in lead aVL when 
R amplitude is 5 nun or more 1 or in lead aVF when 
QR8 is mainly upright. 
2 5-2 T amplitude negative or diphasic (positive-negative I ' 
or negative-positive type) with negative phase at 
least minus 1. 0 mm but not a-s deep as minus 5 mm 
in any of leads I.II,V2,3,4,5,6 or in lead aVL 
when R amplitude is 5 mm or more 1 or in lead aVF 
when QR8 is mainly upright. 
3 5-3 T amplitude zero (flat), or negative, or diphasic I 
(negative-positive type) with less than 1. 0 mm 
negative phase in any of leads I,II,V3,4 1 5,6, or 
in lead aVL when R amplitude is 5 mm or more, 
not coded in lead a VF. 
4 5-4 (Optional code): T amplitude positive and T/R I 
amplitude ratio less than 1/20 in any of leads 
I, II, aVL, V3 1 4,5 1 6; R-wave amplitude must be 
10 mm or more. 
171 
Column Code Column Code 
73 0 Normal A-V conduction 73 D 
l 6-l Complete (third degree) A-V block (permanent or D intermittent) in any lead. 
2 6-2 Partial (second degree) A-V block in any lead. D (2:1 or 3:1 block, Wenckebach, etc.) 
3 6-3 P-R (P-Q) interval O. 22 sec or more in any of D leads I,II,III,aVL,aVF. 
4 6-4 Wolff-Parkinson-White syndrome: D P-R (P-Q) interval less than 0.12 sec, plus QRS 
duration 0.12 sec or more, plus R peak du·ration 
0. 06 sec or more, coexisting in the same beats 
of any of leads I,II,aVL,V4,5, or 6. 
5 6-5 Short P-R (P-Q) interval: D P-R (P-Q) interval less than 0.12 sec in all beats 
in any two of the following leads: I,II,III,aVL,aVF 
(in the absence of 8-6 and 8-7). 
74 0 Normal intraventricular conduction 74 D 
l 7-1 Complete left bundle branch block (in absence of D 6-4): 
QRS duration 0.12 sec or more in any of leads I,II, 
III,aVL,aVF; and R peak duration 0.06 sec or more, 
and the absence of codable Q waves, in any of 
leads l,l!,aVL,V5,6. 
2 7-2 Complete right bundle branch block {in absence D of 6-4): 
QRS duration 0.12 sec or more in any of leads I,II, 
III, aVL, aVF plus R prime greater than R, or R peak 
duration 0.06 sec or more in either of leads Vl,V2. 
3 7-3 Incomplete right bundle branch block: D QRS duration less than 0.12 sec in each of leads 
I,II,III,aVL,aVF and R prime greater than R in 
either of leads Vl, 2. (Report as 3-2 if those 
criteria are met.) 
4 7-4 Intraventricular block (in absence of 6-4, 7-1, or D 7-2): 
QRS duration 0.12 sec or more in any of leads 
LII ,III, aVL, aVF. 
5 7-5 R-R prime, not meeting criteria of 7-2 or 7-3, in D 
either of leads Vl or VZ. 
6 7-6 Incomplete left bundle branch block: D QRS duration at least 0.10 sec and less than 
0.12 sec, in the absence of codable Q waves, 
in each of leads I,aVL, and VS or V6. 
172 
Column Code Column Code 
75 
76 
0 
I 
2 
3 
4 
5 
6 
7 
8 
9 
No arrhythmias 
8-1 Frequent premature atrial, nodal, or ventricular 
beats (10% or more of recorded cycles). 
8-2 Ventricular tachycardia (over 1 00/min). 
8-3 Atrial fibrillation or flutter. 
8-4 Supraventricular tachycardia (over 1 00/min). 
8-5 Ventricular (idioventricular) rhythm (up to 1 00/min). 
8-6 A-V nodal rhythm {up to 1 00/min). Defined as a 
negative P wave in lead aVF plus a P-R interval of 
0.12 sec or less iri any two of leads I,II,III,aVL. 1 aVF. 
8-7 Sinus tachycardia (over 1 00/min). 
8-8 Sinus bradycardia (under 50/min). 
8-0 Any combination of arrhythmias above or 
8-9 arrhythmias not mentioned above. 
75 
0 
I 
No "miscellaneous" disturbances 76 
2 
3 
9-1 Low QRS amplitude: 
QRS peak-to-peak amplitude less than 5 mm in each 
of leads I 1 II,III, or QRS peak-to-peak amplitude 
less than 10 mm .in each of leads V1, 2, 3 1 4 1 5 1 6. 
9-2 8-T segment maximum elevation or 1. 0 mm or more in 
any of leads I 1 II 1 I!I 1 aVL 1 aVF 1 VS orV6 1 or 
S-T segment maximum. elevation of 2. 0 mm or more in 
any of leads V1 1 V2 1 V3 1 V4. (Do not code in the 
presence of codes 6-4, 7-1 1 7-2, or 7-4 .) 
9-3 P wave amplitude of 2. 5 mm or more in any of leads 
ll,ll!,aVF. 
4 9-4-1 QRS transition zone to the right {on the chest) of 
lead V3. (Do not code in the presence of codes 
6-4,7-1,7-2, or7-4.) 
5 9-4-2 QRS transition zone at lead V4 or to the left of V4 on 
the chest. (Do not code in the presence of codes 
6-4, 7-1, 7-3, or 7-4.) 
6 
7 
8 
9-5 T wave amplitude greater than 12 mm in any of leads 
I, II, III I aVL 1 aVF 1 V1 1 2, 3,4 1 5, 6. (Do not code in the 
presence of codes 6-4, 7-1~ 7-2, or 7-4.) 
9-8 Findings questionable due to wandering baseline, 
"noise" I or other technical defect in the record. 
9-0 Any combination of items above. 
D 
D 
D 
D 
D 
D 
D 
D 
D 
D 
D 
D 
D 
D 
D 
D 
D 
D 
D 
173 
Subject number : Ll -;=:~:::;::::;::::~ 
Date : 
Name : 
Birth-date I I 
Serial number ECG : D 
INTERPRETATION MINNESOTA CODE 
Column Code Column Code 
25 0 No disturbances 25 D 
4 Probable IHD (column 68, code l or 2 D 
or column 74, code l) 
3 Possible IHD (column 68, code 3 D 
or column 71, code l or 2 
or column 72 , code l' 2 or 3) 
2 Column 71' code 3 or 4 D 
Othe~ disturbances according to Minnesota Code D 
CLINICAL JUDGEMENT EGG 
Rhythm 
QRS 
S-T, T 
Advice 
Signature 
return : 
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ANNEX 42 CHAPTER VI 
RELATION BETWEEN THE ANSWERS TO QUESTION 42 AND 
26 OF THE GENERAL PRACTITIONARS QUESTIONNAIRE 
Question 42: For how many years have you been a general practitioner ? 
answer : -( 5 years 
6 - 10 years 
11 - 15 years 
16 - 20 years 
21 - 25 years 
~ 26 years 
Question 26: Do you think that a reduction of the risk factors will reduce the 
mortality and morbidity risk due to cardiovascular diseases: 
answer : 
question 26.1: adults under 40 
26.2: people of 40 - 55 years 
26. 3: people of 55 - 65 years 
26, 4: people over 65 
no opinion 
yes 
no 
191 
question 42 
question 26,1 ~ 5 6-15 16-25 J- 26 total 
no opinion 1 0 2 0 3 
yes 1) 15 38 24 19 96 
no 1) 0 0 2 2 4 
total 16 38 28 21 103 
1) Wilcoxon z = 1. 98 P 2 = 0, 05; significant 
question 42 
question 26, 2 < 5 6-15 16-25 J-26 total 
no opinion 3 0 2 0 5 
yes 2) 13 37 24 20 94 
no 2) 0 1 2 1 4 
total 16 38 28 21 103 
2) Wilcoxon z = 0. 73; not significant 
question 42 
question 26. 3 < 5 6-15 16-25 }26 total 
no opinion 2 3 4 1 10 
yes 3) 11 30 20 19 80 
no 3) 3 5 4 1 13 
total 16 38 28 21 103 
3) Wilcoxon z = 1.12; not significant 
question 42 
question 26, 4 
< 5 6-15 16-25 } 26 total 
no opinion 2 5 4 1 12 
yes 4) 8 24 16 17 65 
no 4) 6 9 8 3 26 
total 16 38 28 21 103 
4) Wilcoxon z = 1. 50; not significant 
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ANNEX 43 CHAPTER VI 
RELATION BETWEEN THE ANSWERS TO QUESTION 38 AND 
26 OF THE GENERAL PRACTITIONERS QUESTIONNAIRE 
Question 38: What is the total number of patients in your practice 
(National Health + private patients) ? 
Answer: < 2500 
2500-3500 
> 3500 
Question 26: Do you think that a reduction of the risk factors will reduce the 
mortality and morbidity risk due to cardiovascular diseases for: 
Answer: 
question 26. 1: adults under 40 
26.2: people of 40 - 55 years 
26.3: people of 55 - 65 years 
26. 4: people over 65 
no opinion 
yes 
no 
193 
question 38 
question 26. 1 < 2500 2500-3500 > 3500 total 
no opinion 0 1 2 3 
yes 1) 23 43 30 96 
no 1) 0 0 4 4 
total 23 44 36 103 
1) Wilcoxon z = 2. 41; P2 = 0. 02; significant 
question 38 
question 26. 2 < 2500 2500-3500 > 3500 total 
no opinion 0 3 2 5 
yes 2) 22 41 31 94 
no 2) 1 0 3 4 
total 23 44 36 103 
2) Wilcoxon z = 1. 15; not significant 
question 38 
question 26. 3 < 2500 2500-3500 > 3500 total 
no opinion 1 2 7 10 
yes 3) 20 35 25 80 
no 3) 2 7 4 13 
total 23 44 36 103 
3) Wilcoxon z = 0. 04; not significant 
question 38 
question 26.4 < 2500 2500-3500 > 3500 total 
no opinion 2 5 5 12 
yes 4) 14 29 22 65 
no 4) 7 10 9 26 
total 23 44 36 103 
4) Wilcoxon z = 0. 59; not significant 
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ANNEX 44 CHAPTER VI 
RELATION BETWEEN THE ANSWERS TO QUESTION 42 AND 
31 OF THE GENERAL PRACTITIONERS QUESTIONNAIRE 
question 42 : For how many years have you been a general practitioner ? 
answer < 5 years 
6 - 10 years 
11 - 15 years 
16 20 years 
21 - 25 years 
J- 26 years 
Question 31: Who do you consider the right person to tell the results of a 
screening examination to the person examined ? 
question 31.1: When no abnormalities have been found 
31.2: In case of borderline abnormalities 
answer 
31. 3: In case of pathology 
: screening team 
general practitioner 
to be decided independently for each case 
otherwise, such as . . . . . . . . . . 
!95 
question 42 
question 31. 1 
.(: 5 11-15 16-20 >- 26 total 
screening team 1) 11 21 19 9 60 
general practitioner 1) 5 16 8 11 40 
each case 0 0 0 0 0 
otherwise 0 1 1 1 3 
total 16 38 28 21 103 
1) Wilcoxon z = 0. 70; not significant 
question 42 
question 31. 2 < 5 11-15 16-20 p 26 total 
screening team 2) 3 8 5 5 21 
general practitioner 2) 13 29 22 16 80 
each case 0 0 1 0 1 
otherwise 0 1 0 0 1 
total 16 38 28 21 103 
2) Wilcoxon z = 0. 28 not significant 
question 42 
question 31. 3 < 5 11-15 16-20 >/ 26 total 
screening team 3) 2 5 3 3 13 
general practitioner 3) 14 33 25 18 90 
each case 0 0 0 0 0 
otherwise 0 0 0 0 0 
total 16 38 28 21 103 
3) Wilcoxon z = 0,10; not significant 
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ANNEX45 CHAPTERVI 
RELATION BETWEEN THE ANSWERS TO QUESTION 38 AND 
31 OF THE GENERAL PRACTITIONERS QUESTIONNAIRE 
question 38 : What is the total number of patients in your practice 
(National Health+ private patients) ? 
answer < 2500 
2500-3500 
> 3500 
Question 31: Who do you consider the right person to tell the results of a 
screening examination to the person examined ? 
question 31. 1: When no abnormalities have been found 
31. 2: In case of borderline abnormalities 
31. 3: In case of pathology 
answer screening team 
general practitioner 
to be decided independently for each case 
otherwise, such as 0 e 0 e • 0 • e 0 0 
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question 38 
question 31, 1 < 2500 2500-3500 > 3500 total 
screening team 1) 10 25 25 60 
general practitioner 1) 13 16 11 40 
each case 0 0 0 0 
otherwise 0 3 0 3 
total 23 44 36 103 
1) Wilcoxon z = 2.15; P2 = 0. 03; significant 
question 38 
question 31. 2 < 2500 2500-3500 > 3500 total 
screening team 2) 3 7 11 21 
general practitioner 2) 20 35 25 80 
each case 0 1 0 1 
otherwise 0 1 0 1 
total 23 44 36 103 
2) Wilcoxon z = 1. 89; P2 0. 06 not significant 
question 38 
question 31. 3 < 2500 2500-3500 > 3500 total 
screening team 3) 2 4 7 13 
general practitioner 3) 21 40 29 90 
each case 0 0 0 0 
otherwise 0 0 0 0 
total 23 44 36 103 
3) Wilcoxon z = 1. 49; not significant 
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